000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|985|2688|lyfalmen|||1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||985||985|2688||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|21689|30343|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||21689||21689|30343||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002|30.06.2017|R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|33625|45439|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||33625||33625|45439||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6412|10157|lyfalmen|V0457|8594|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6412||6412|10157||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|16483|24019|lyfalmen|V0475|21290|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16483||16483|24019||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|21290|29838|lyfalmen|V0540|20458|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21290||21290|29838||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|3302|5877|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||3302||3302|5877||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|3215|6270|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||3215||3215|6270||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|8843|13503|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||8843||8843|13503||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3495|4765|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||2494||2494|4765||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2027|4122|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||2027||2027|4122||1 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3382|5987|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3382||3382|5987||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2090|4208|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2090||2090|4208||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8102|12483|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||8102||8102|12483||1 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2132|4266|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2132||2132|4266||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|26197|36044|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||26197||26197|36044||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2515|4793|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||2515||2515|4793||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|68849|89990|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||68849||68849|89990||2 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|3765|6514|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||3765||3765|6514||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3369|5969|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3369||3369|5969||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11140|16665|lyfalmen|V0115|11565|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11140||11140|16665||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1409|3271|lyfalmen|V0050|2198|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1409||1409|3271||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|18826|27244|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||18826||18826|27244||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4235|7161|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4235||4235|7161||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1945|4009|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||1945||1945|4009||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15293|22381|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||15293||15293|22381||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|10849|16264|lyfalmen|V0637|15438|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||10849||10849|16264||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20950|29408|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||20950||20950|29408||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1686|3652|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||1686||1686|3652||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3442|6069|lyfalmen|V0444|6069|1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||3442||3442|6069||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1660|2571|lyfalmen|V0291|2571|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2571||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|2557|4851|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||2557||2557|4851||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|3098|4016|lyfalmen|V0292|4016|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|4016||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1295|3114|lyfalmen|V0004|2562|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1295||1295|3114||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000|30.06.2017|R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4764|5599|lyfalmen|||2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3100||3100|5599||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2638|4963|lyfalmen|V0005|2404|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2638||2638|4963||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|17860|25914|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||17860||17860|25914||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2170|4319|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2170||2170|4319||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|10552|15856|lyfalmen|V0492|7173|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||10552||10552|15856||1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|TCA|0|0|1|100|IKR|||lyfalmen|V0362|1738|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2562||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|738|2348|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||738||738|2348||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|20090|28320|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||20090||20090|28320||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9175|11424|lyfalmen|V0089|2258|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||7332||7332|11424||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5477|8870|lyfalmen|V0515|3584|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||5477||5477|8870||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|8941|13638|lyfalmen|V0253|5589|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||8941||8941|13638||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|17202|25009|lyfalmen|V0516|5158|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||17202||17202|25009||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|6316|10025|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||6316||6316|10025||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|9327|14169|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||9327||9327|14169||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|5737|11055|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||5737||5737|11055||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4500|7526|lyfalmen|V0356|6467|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4500||4500|7526||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4219|7139|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4219||4219|7139||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2173|4323|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2173||2173|4323||1 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|24532|33938|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||24532||24532|33938||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|1540|3451|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1540||1540|3451||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|27723|37346|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||27226||27226|37346||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|0|TCA|0|0|0|100|IKR|1002|2280|lyfalmen|V0151|2129|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2280||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2389|2816|lyfalmen|V0322|2600|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2816||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984|30.06.2017|R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1539|3450|lyfalmen|V0469||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1539||1539|3450||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|13271|19598|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||13271||13271|19598||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|5549|8969|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||5549||5549|8969||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990|30.06.2017|L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2631|4953|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||2631||2631|4953||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3195|5729|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3195||3195|5729||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4180|7085|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4180||4180|7085||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|5837|9366|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5837||5837|9366||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|14769|21660|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||14769||14769|21660||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|4552|4576|lyfalmen|V0381|4071|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||2357||2357|4576||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5395|10406|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5395||5395|10406||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2277|4466|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2277||2277|4466||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3036|5511|lyfalmen|V0226|2300|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3036||3036|5511||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1449|3326|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||1449||1449|3326||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2002|2394|lyfalmen|V0494|2020|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||772||772|2394||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2426|4671|lyfalmen|V0318|4671|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2426||2426|4671||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2140|4277|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2140||2140|4277||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4346|4642|lyfalmen|V0320|2708|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2405||2405|4642||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1549|3464|lyfalmen|V0317|3464|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1549||1549|3464||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1884||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|26216|36068|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||26216||26216|36068||3 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|5940|9508|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5940||5940|9508||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|589|2142|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||589||589|2142||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3797|6558|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||3797||3797|6558||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|253|1680|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||253||253|1680||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|647|2222|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||647||647|2222||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|1108|2857|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1108||1108|2857||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1174|2948|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||1174||1174|2948||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008|31.05.2017|R|0|0|0|0|0|0|MBV|0|0|0|100|XEU|2628|4949|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2628||2628|4949||1 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6142|5637|lyfalmen|V0148|3045|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3128||3128|5637||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2322|3849|lyfalmen|V0353|3849|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1829||1829|3849||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|1789|3794|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1789||1789|3794||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2009|3702|lyfalmen|V0337|2983|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1722||1722|3702||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|13499|19912|lyfalmen|V0356|19400|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||13499||13499|19912||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2131|4265|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2131||2131|4265||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|37881|49742|lyfalmen|V0451|42218|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||37027||37027|49742||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1254|3058|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1254||1254|3058||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4191|7100|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4191||4191|7100||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4315|7271|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4315||4315|7271||1 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1310|3135|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1310||1310|3135||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|2620|4938|lyfalmen|V0020|1235|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||2620||2620|4938||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4123|7007|lyfalmen|V0020|3706|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4123||4123|7007||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3011|5476|lyfalmen|V0020|1853|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3011||3011|5476||2 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3424|6045|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Cetrorelix||3424||3424|6045||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|3815|6583|lyfalmen|V0324|1920|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3815||3815|6583||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|12572|21669|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||12572||12572|21669||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6124|9761|lyfalmen|V0325|2061|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6124||6124|9761||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|1923|3979|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||1923||1923|3979||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10767|15418|lyfalmen|V0326|2763|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||10234||10234|15418||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RPO|0|0|1|100|IKR|1816|2224|lyfalmen|V0169|2224|2|14|0|12,2500|LYFIS ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|2224||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4048|6903|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4048||4048|6903||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|70313|91842|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||70313||70313|91842||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3876|6667|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3876||3876|6667||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|53717|70852|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||53717||53717|70852||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|1630|3575|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB|Flúkloxacillín||1630||1630|3575||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|2498|4910|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||2498|4910||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|9764|14771|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9764||9764|14771||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|NOK|348310|395094|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||313016||313016|395094||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10263|15458|lyfalmen|V0099|4034|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||10263||10263|15458||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8710|13320|lyfalmen|V0117|6026|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8710||8710|13320||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12744|18873|lyfalmen|V0118|9533|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12744||12744|18873||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1442|3317|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1442||1442|3317||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15597|22799|lyfalmen|V0195|19515|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15597||15597|22799||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|67073|87744|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||67073||67073|87744||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|173790|221936|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||173790||173790|221936||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2138|4275|lyfalmen|V0374|3266|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2138||2138|4275||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5475|8868|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||5475||5475|8868||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|78727|102484|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||78727||78727|102484||3 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|16177|23598|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||16177||16177|23598||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4244|7173|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||4244||4244|7173||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|173326|221359|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||173326|221359||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3448|6078|lyfalmen|V0618|3882|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||3448||3448|6078||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|11556|17237|lyfalmen|V0589|6840|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||11556||11556|17237||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1540|2708|lyfalmen|V0290|2571|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2708||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|2804|5191|lyfalmen|||1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||2804||2804|5191||1 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|NEL|0|0|0|100|USD|1073|2809|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1073||1073|2809||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|253|1680|lyfalmen|V0502|904|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||253||253|1680||2 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1049|2776|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1049||1049|2776||1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|793|2423|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||793||793|2423||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|736|2345|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||736||736|2345||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|2017|4108|lyfalmen|V0226|4108|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2017||2017|4108||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|3040|5516|lyfalmen|V0227|5516|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3040||3040|5516||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4117|6998|lyfalmen|V0228|6998|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||4117||4117|6998||1 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|NOK|96463|124917|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thyrotropin alfa||96463||96463|124917||1 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5494|9469|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5494||5494|9469||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|8313|15942|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||8313||8313|15942||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RAT|0|0|1|100|XEU|||lyfalmen|V0575|2210|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||2210||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2025|4119|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2025||2025|4119||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|72478|94580|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||72478||72478|94580||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|75188|98008|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||75188||75188|98008||2 008904|D10AF0101|Dalacin|húðlausn|10|mg/ml|60|ml|1|glas||D10AF01|01.01.1994||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1519|3423|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1519||1519|3423||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|4947|8141|lyfalmen|V0145|7417|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||4947|8141||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|9809|14833|lyfalmen|V0145|14833|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||9809|14833||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1228|2674|lyfalmen|V0064|2674|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||975||975|2674||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4383|5736|lyfalmen|V0064|5348|2|60|0|60,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5736||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5488|8885|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5488||5488|8885||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2469|3950|lyfalmen|V0063|3950|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||1902||1902|3950||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5488|8885|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5488||5488|8885||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|8406|12902|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||8406||8406|12902||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5488|8885|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5488||5488|8885||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|36550|49139|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||36550||36550|49139||1 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|3637|6338|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||3637||3637|6338||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|799|2432|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||799||799|2432||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|882|2546|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||882||882|2546||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1020|2736|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1020||1020|2736||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1277|3089|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1277||1277|3089||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4615|7684|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4615||4615|7684||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5193|8479|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5193||5193|8479||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4615|7684|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4615||4615|7684||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|130817|168489|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||130817||130817|168489||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|3524|6182|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||3524||3524|6182||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|39610|53009|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||39610||39610|53009||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6908|9827|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6172||6172|9827||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7486|10808|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||6885||6885|10808||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|5951|9523|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||5951||5951|9523||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7486|10808|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||6885||6885|10808||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6034|9637|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6034||6034|9637||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6908|9239|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||5745||5745|9239||1 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|1507|3406|lyfalmen|V0329|1999|1|30|0|15,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||1507||1507|3406||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|105269|136715|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||105269||105269|136715||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|4735|7849|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||4735||4735|7849||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|8997|13715|lyfalmen|V0331|2787|1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||8997||8997|13715||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|12685|18791|lyfalmen|||1|96|0|144,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||12685||12685|18791||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|15046|22041|lyfalmen|V0605|4085|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||15046||15046|22041||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7910|12219|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||7910||7910|12219||1 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6457|10219|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||6457||6457|10219||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|874|2535|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||874||874|2535||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|229115|290744|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||229115||229115|290744||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|229115|290744|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||229115||229115|290744||3 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|387330|487520|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||387330||387330|487520||1 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|516071|647637|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||516071||516071|647637||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|31109|42257|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||31109||31109|42257||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|1940|4002|lyfsjukr|||1|10|0|5,0000|Vistor hf|Meda AB|Kloxacillín||1940||1940|4002||1 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2231|2571|lyfalmen|V0058|2571|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||900||900|2571||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|14195|20870|lyfalmen|V0204|6159|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||14195||14195|20870||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|14029|20641|lyfalmen|V0716|8623|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||14029||14029|20641||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2980|3259|lyfalmen|V0059|3259|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||1400||1400|3259||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24169|33479|lyfalmen|V0683|8208|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24169||24169|33479||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OTS|0|0|0|100|DKK|24004|33271|lyfalmen|V0684|8208|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24004||24004|33271||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3171|5696|lyfalmen|V0825|3868|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3171||3171|5696||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3294|5866|lyfalmen|V0826|4175|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3294||3294|5866||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11415|17043|lyfalmen|V0327|2763|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11415||11415|17043||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|841|2489|lyfalmen|V0827|2215|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||841||841|2489||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1718|2982|lyfalmen|V0069|2115|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1199||1199|2982||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4440|7443|lyfalmen|V0357|6556|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4440||4440|7443||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4249|6924|lyfalmen|V0691|3995|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4063||4063|6924||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5479|6424|lyfalmen|V0624|3753|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||3700||3700|6424||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1354|2661|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1354||1354|2661||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|3311|5889|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3311||3311|5889||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|44639|59370|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||44639||44639|59370||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2201|4326|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2201||2201|4326||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|TCA|0|0|0|100|IKR|1425|2379|lyfalmen|V0152|2129|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2379||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|3925|4164|lyfalmen|V0323|4003|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|4164||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|2843|5245|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||2843||2843|5245||2 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|1573|3497|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1573||1573|3497||2 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|19813|28602|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||19813||19813|28602||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2608|4921|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||2608||2608|4921||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|4760|7883|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||4760||4760|7883||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|6833|8182|lyfalmen|V0622|4542|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4977||4977|8182||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|669|2253|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||669||669|2253||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|2986|5442|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||2986||2986|5442||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|4386|7369|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||4386||4386|7369||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1960|2356|lyfalmen|V0250|1924|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Gabapentín||744||744|2356||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2566|2712|lyfalmen|V0251|2223|2|100|0|22,2200|LYFIS ehf|ratiopharm GmbH|Gabapentín||1003||1003|2712||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|4140|7030|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||4140||4140|7030||1 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|6697|10550|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6697||6697|10550||1 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|4477|7494|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||4477||4477|7494||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ROB|0|0|0|100|XEU|1506|3405|lyfalmen|V0042|3405|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Nordic (A)|Doxazósín||1506||1506|3405||1 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|233188|258266|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||203001||203001|258266||1 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|895|2564|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||895||895|2564||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1866||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|535|1745|lyfalmen|V0562|1745|2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Íbúprófen||300||300|1745||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1719|3698|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||1719||1719|3698||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|263|1694|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||263||263|1694||2 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4329|7290|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4329||4329|7290||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1706|3680|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1706||1706|3680||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3252|5808|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||3252||3252|5808||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|130439|168019|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||130439||130439|168019||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|237410|301061|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||237410||237410|301061||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1688|3655|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1688||1688|3655||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5117|8375|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5117||5117|8375||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|12756|18889|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||12756||12756|18889||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|39672|53087|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||39672||39672|53087||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1125|2880|lyfalmen|V0479|2708|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1125||1125|2880||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1431|3301|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1431||1431|3301||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|13321|19667|lyfalmen|V0357|19667|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||13321||13321|19667||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|257|1685|lyfalmen|V0563|1685|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||257||257|1685||2 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|1778|3494|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||1778||1778|3494||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|58167|76480|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||58167|76480||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|649|2034|lyfalmen|V0564|2034|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||510||510|2034||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|660|2240|lyfalmen|V0596|1921|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||660||660|2240||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|18616|26955|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||18616||18616|26955||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|48240|63924|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||48240||48240|63924||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|32327|43797|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||32327||32327|43797||1 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|507922|637502|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||507922||507922|637502||3 015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|43546|57987|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Carbon monoxide||43546||43546|57987||3 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1916|3729|lyfalmen|V0673|2983|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||1742||1742|3729||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5628|9078|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||5628||5628|9078||1 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|766|2386|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||766||766|2386||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1278|2331|lyfalmen|V0234|1453|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||726||726|2331||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1825|2331|lyfalmen|V0233|1897|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||726||726|2331||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6611|10431|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||6611||6611|10431||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|223621|283911|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||223621||223621|283911||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|63500|83225|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||63500|83225||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3736|6474|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||3736||3736|6474||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9499|14406|lyfalmen|V0828|13615|1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9499||9499|14406||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3736|6474|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||3736||3736|6474||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10268|15465|lyfalmen|V0900|14609|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10268||10268|15465||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3736|6474|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||3736||3736|6474||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9399|14269|lyfalmen|V0829|13615|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9399||9399|14269||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|49558|65591|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||49558||49558|65591||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|15476|22633|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||15476||15476|22633||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|30952|42058|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||30952||30952|42058||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2779|4790|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2779||2779|4790||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4272|7363|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4272||4272|7363||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2311|3983|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2311||2311|3983||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2345|4042|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2345||2345|4042||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4101|7068|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4101||4101|7068||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1449|3326|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1449||1449|3326||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1621|3563|lyfalmen|||1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1621||1621|3563||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1049|2776|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1049||1049|2776||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2254|3885|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2254||2254|3885||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|1173|2946|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1173||1173|2946||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|779|2404|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||779||779|2404||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|826|2469|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||826||826|2469||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1924|3980|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||1924||1924|3980||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4799|7937|lyfalmen|V0686|2210|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||4799||4799|7937||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7273|11342|lyfalmen|V0687|3443|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||7273||7273|11342||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|3601|6288|lyfalmen|||2|1000|0|1000,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||3601||3601|6288||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1270|3080|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1270||1270|3080||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10448|15712|lyfalmen|V0689|4789|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||10448||10448|15712||1 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992|30.04.2017|R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5989|9575|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5989||5989|9575||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|67734|88580|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||67734||67734|88580||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2650|4979|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||2650||2650|4979||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1867|3901|lyfalmen|V0685|1193|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||1867||1867|3901||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|923|2602|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||923||923|2602||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|12372|18361|lyfalmen|V0690|5186|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||12372||12372|18361||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||6159||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24169|33479|lyfalmen|V0682|8208|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24169||24169|33479||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1397|2383|lyfalmen|V0169|1906|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||764||764|2383||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|102137|132819|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||102137||102137|132819||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5286|8607|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5286||5286|8607||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2159|4303|lyfalmen|V0240|4303|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2159||2159|4303||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|3985|6817|lyfalmen|V0433|6817|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3985||3985|6817||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|36218|48719|lyfalmen|V0721|15199|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||36218||36218|48719||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|53359|70399|lyfalmen|V0722|27112|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||53359||53359|70399||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|19837|28635|lyfalmen|V0720|12683|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||19837||19837|28635||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|NOK|51524|61409|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||46251||46251|61409||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1258|3063|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1258|3063||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|27889|37831|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||27610||27610|37831||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2176|4327|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2176||2176|4327||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1080|2818|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1080||1080|2818||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|186409|237630|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||186409||186409|237630||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|4759|7882|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||4759||4759|7882||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|4345|7312|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||4345||4345|7312||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|98379|127340|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||98379||98379|127340||1 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|75206|98031|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||75206||75206|98031||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|IKR|33527|45315|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||33527||33527|45315||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|3957|6778|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||3957||3957|6778||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|7194|11234|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||7194||7194|11234||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|6150|9797|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||6150||6150|9797||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|829|2473|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||829||829|2473||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|1913|3965|lyfalmen|||1|30|0|150,0000|Vistor hf|Meda AB|Prednisón||1913||1913|3965||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1047|2773|lyfalmen|V0168|2675|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||1047||1047|2773||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4732|9148|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4732||4732|9148||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|6269|9960|lyfalmen|V0107|2846|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||6269||6269|9960||1 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|846|1918|lyfalmen|V0243|1581|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||426||426|1918||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5127|8389|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5127||5127|8389||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|9664|14633|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||9664||9664|14633||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|13036|19275|lyfalmen|V0441|16830|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13036||13036|19275||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|618|2182|lyfalmen|V0414|1974|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||618||618|2182||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4129|7015|lyfalmen|V0438|5859|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||4129||4129|7015||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|771|2393|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||771||771|2393||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|10733|16105|lyfalmen|V0440|13942|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||10733||10733|16105||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|22606|31502|lyfalmen|V0111|8744|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||22606||22606|31502||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|33975|45882|lyfsjukr|||1|3|0||Williams & Halls efh|medac Gesellschaft|BCG bóluefni||33975||33975|45882||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|6313|10021|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||6313||6313|10021||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|216|1629|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||216||216|1629||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|63177|82817|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||63177||63177|82817||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|39659|53071|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||39659||39659|53071||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|744|1462|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||744||744|1462||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3979|6808|lyfalmen|V0221|6018|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3979||3979|6808||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4498|7523|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||4498||4498|7523||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2880|5296|lyfalmen|V0220|4798|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||2880||2880|5296||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|126248|162807|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||126248||126248|162807||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|13674|20153|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||13674||13674|20153||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1586|3515|lyfalmen|V0219|3059|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||1586||1586|3515||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16354|23841|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||16354||16354|23841||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|14705|21572|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||14705||14705|21572||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19789|28569|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||19789||19789|28569||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|63124|82750|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||63124||63124|82750||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4891|8064|lyfalmen|V0223|6491|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||4891||4891|8064||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7614|11812|lyfalmen|V0215|7867|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7614||7614|11812||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|31562|42830|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||31562||31562|42830||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|15781|23053|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||15781||15781|23053||2 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|1|0|1|0|1|THE|0|0|0|100|XEU|523625|657032|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||523625||523625|657032||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3448|6712|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3448||3448|6712||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGH|0|0|0|100|SEK|273|1673|lyfalmen|V0633|1673|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||248||248|1673||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|23036|43874|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||23036||23036|43874||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4816|7961|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4816||4816|7961||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|35721|48090|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||35721||35721|48090||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4816|7961|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4816||4816|7961||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|829|2226|lyfalmen|V0496|2192|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||650||650|2226||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|766|2185|lyfalmen|V0648|2145|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||620||620|2185||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1160|2708|lyfalmen|V0649|2708|2|100|0|400,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||1000||1000|2708||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|2620|4938|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||2620||2620|4938||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|11508|17171|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||11508||11508|17171||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|131685|169569|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||131685||131685|169569||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|711|2094|lyfalmen|V0159|2056|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||554||554|2094||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|119785|154769|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||119785||119785|154769||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|9090|13843|lyfalmen|V0812|11496|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||9090||9090|13843||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|9090|13843|lyfalmen|V0813|11496|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||9090||9090|13843||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|9090|13843|lyfalmen|V0814|11496|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||9090||9090|13843||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|9090|13843|lyfalmen|V0815|11496|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||9090||9090|13843||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|9090|13843|lyfalmen|V0816|11496|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||9090||9090|13843||2 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|231|1650|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||231|1650||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|RGO|0|0|0|100|DKK|43290|57663|lyfsjukr|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Lamívúdín og abacavír||43290||43290|57663||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|883|2414|lyfalmen|V0160|2379|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||786||786|2414||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|1972|4046|lyfalmen|||2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||1972||1972|4046||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1752|3743|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||1752||1752|3743||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|17523|25450|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||17523||17523|25450||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1583|3511|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1583||1583|3511||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|68537|89596|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||68537||68537|89596||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|35760|48140|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||35760||35760|48140||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2472|3575|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||1630||1630|3575||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|4695|4047|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||1973||1973|4047||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|16625|24214|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||16625||16625|24214||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|411|1897|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||411||411|1897||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1275|3087|lyfalmen|V0820|3087|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1275||1275|3087||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|4631|3200|lyfalmen|V0599|3200|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||1357||1357|3200||2 020711|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1565|2697|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1565||1565|2697||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCP|0|0|0|100|DKK|42182|56262|lyfalmen|||1|180|0||Vistor hf|UCB Pharma Ltd.|sodium oxybate||||42182|56262||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|1830|3154|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||1830||1830|3154||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1212|3000|lyfalmen|V0174|2226|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1212||1212|3000||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|1938|3999|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||1938||1938|3999||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1605|3541|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1605||1605|3541||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|581|1847|lyfalmen|V0188|1717|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1847||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|HEG|0|0|0|100|XEU|1362|3206|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1362||1362|3206||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|1287|2405|lyfalmen|V0189|2232|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2405||1 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12077|17955|lyfalmen|V0490|2247|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||12077||12077|17955||1 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|23223|32283|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||23223||23223|32283||3 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1114|2865|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1114||1114|2865||1 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|42550|56728|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||42550||42550|56728||3 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3035|5509|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3035||3035|5509||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|9421|14299|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||9421||9421|14299||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9235|14043|lyfalmen|V0214|9440|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9235||9235|14043||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5008|8225|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5008||5008|8225||1 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|10641|15978|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10641||10641|15978||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|11139|16663|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||11139||11139|16663||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14509|21302|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||14509||14509|21302||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|12811|18965|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||12811||12811|18965||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17146|24932|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||17146||17146|24932||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6405|10148|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||6405||6405|10148||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3233|5782|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||3233||3233|5782||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|13727|20226|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||13727||13727|20226||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|2448|4701|lyfalmen|V0692|2206|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||2448||2448|4701||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4135|7023|lyfalmen|V0693|3042|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4135||4135|7023||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|13395|19769|lyfalmen|V0694|6700|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||13395||13395|19769||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|54174|71430|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||54174||54174|71430||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|58340|76699|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||58340||58340|76699||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|1897|3943|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||1897||1897|3943||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|78967|102788|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||78967||78967|102788||2 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3089|5583|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3089||3089|5583||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|203801|259261|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||203801||203801|259261||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|211841|269260|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||211841||211841|269260||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8912|15361|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||8912||8912|15361||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|11363|16972|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||11363||11363|16972||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1600|2758|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||1600||1600|2758||2 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1011|1743|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1011||1011|1743||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2679|2562|lyfalmen|V0056|2171|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||894||894|2562||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4750|3279|lyfalmen|V0057|2247|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1415||1415|3279||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1515|2611|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1515||1515|2611||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|428|1921|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||428||428|1921||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1290|3107|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1290||1290|3107||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|981|1691|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||981||981|1691||2 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2129|3358|lyfalmen|V0321|3358|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3358||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4902||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|17457|25360|lyfalmen|||1|8|0|40,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||17457||17457|25360||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|8729|13346|lyfalmen|||1|4|0|20,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||8729||8729|13346||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3288||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|1407|3268|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|3268||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|2450|3658|lyfalmen|V0125|2249|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3658||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|56437|74292|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||56437||56437|74292||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|18146|26308|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||18146||18146|26308||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|28331|38743|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||28331||28331|38743||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2983|lyfalmen|V0125|2249|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1200||1200|2983||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|13790|20312|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||13790||13790|20312||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|5231|4497|lyfalmen|V0125|4497|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||2300||2300|4497||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|14000|16059|lyfalmen|V0256|16059|2|100|0|44,4400|LYFIS ehf|ratiopharm GmbH|Gabapentín||10700||10700|16059||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|7500|9865|lyfalmen|V0254|9865|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Gabapentín||6200||6200|9865||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|14493|21280|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||14493||14493|21280||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1738|2374|lyfalmen|V0250|1924|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||757||757|2374||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2243|2690|lyfalmen|V0251|2223|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||987||987|2690||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|13537|19964|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||13537||13537|19964||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|11948|17777|lyfalmen|V0029|5206|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||11948||11948|17777||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1843|3868|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1843||1843|3868||2 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|93557|111487|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||85845||85845|111487||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2571|lyfalmen|V0066|2220|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2571||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2777|lyfalmen|V0449|2533|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2777||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|536|2070|lyfalmen|V0448|1935|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||536||536|2070||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|6149|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|6149||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|2983|lyfalmen|V0673|2983|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1200||1200|2983||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|52448|69247|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||52448||52448|69247||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1967|4039|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1967||1967|4039||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1575|3500|lyfalmen|V0222|2945|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1575||1575|3500||1 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|43873|58401|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||43873||43873|58401||3 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|987|2514|lyfalmen|V0048|2514|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||859||859|2514||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1628|3274|lyfalmen|V0049|3176|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1411||1411|3274||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2868|5023|lyfalmen|V0054|5023|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||2682||2682|5023||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17146|24932|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||17146||17146|24932||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5398|8762|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5398||5398|8762||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006|30.04.2017|R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|294|1736|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||294||294|1736||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5398|8762|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5398||5398|8762||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|9095|13850|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9095||9095|13850||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|9110|13871|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9110||9110|13871||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|3892|6689|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||3892||3892|6689||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|OPH|0|0|0|100|DKK|38307|51361|lyfalmen|V0715|51361|1|100|0|1,2500|Artasan ehf|Novartis Europharm Ltd|Zoledronsýra||38307||38307|51361||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|9204|14000|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||9204||9204|14000||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1108|2857|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1108||1108|2857||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|3892|6689|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||3892||3892|6689||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5398|8762|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5398||5398|8762||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5398|8762|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5398||5398|8762||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1108|2857|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1108||1108|2857||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1848|3875|lyfalmen|||2|100|0|66,6660|LYFIS ehf|ratiopharm GmbH|Metóprólól||1848||1848|3875||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|437|1933|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||437||437|1933||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|13727|20226|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||13727||13727|20226||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1212|2433|lyfalmen|V0051|2433|2|100|0|33,3333|LYFIS ehf|ratiopharm GmbH|Metóprólól||800||800|2433||2 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|52496|69307|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||52496||52496|69307||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|6802|13075|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||6802||6802|13075||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|11041|16529|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||11041||11041|16529||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|3725|6459|lyfalmen|V0205|1342|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||3725||3725|6459||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|9982|15071|lyfalmen|V0205|4025|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||9982||9982|15071||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|31924|43288|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||31924||31924|43288||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|4782|7914|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||4782||4782|7914||2 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17146|24932|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||17146||17146|24932||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|713|2269|lyfalmen|V0597|2269|2|28|0|3,7300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||681||681|2269||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2389|4239|lyfalmen|V0598|4239|2|98|0|13,0700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2112||2112|4239||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|36599|49201|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||36599|49201||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|31831|43170|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||31831||31831|43170||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|2755|4749|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||2755||2755|4749||1 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|65220|85401|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||65220||65220|85401||1 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1551|3048|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1551||1551|3048||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|812|2233|lyfalmen|V0447|2233|2|100|0|20,0000|Alvogen|Alvogen ehf|Lóperamíð||655||655|2233||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|6573|11329|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||6573||6573|11329||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|13727|20226|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||13727||13727|20226||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|30278|41206|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||30278||30278|41206||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|151389|194075|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||151389||151389|194075||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1290|3107|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1290|3107||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|4888|8060|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||4888|8060||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|2548|4839|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||2548|4839||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|10093|15224|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||10093|15224||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|15125|22150|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||15125|22150||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|20157|28405|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||20157|28405||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|931|2613|lyfalmen|||2|100|0|25,0000|Vistor hf|Meda AB|Nítrófúrantóín||931||931|2613||1 026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|786944|984528|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||786944|984528||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4027|4116|lyfalmen|V0099|4116|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||2023||2023|4116||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|761|2379|lyfalmen|V0160|2379|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||761||761|2379||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|526|2056|lyfalmen|V0159|2056|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||526||526|2056||2 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|14596|21422|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||14596||14596|21422||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3259|lyfalmen|V0823|3072|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3259||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|512|2036|lyfalmen|||2|50|0|1,2500|Vistor hf|Meda AB|Nítrófúrantóín||512||512|2036||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1786|3790|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||1786||1786|3790||1 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9270|6168|lyfalmen|V0341|6168|2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3514||3514|6168||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9982|6168|lyfalmen|V0342|6168|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3514||3514|6168||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1829|3849|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1829||1829|3849||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|4702|7804|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||4702||4702|7804||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|428|1921|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||428||428|1921||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|493|2010|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||493||493|2010||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|14557|21368|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||14557||14557|21368||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|16724|24351|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||16724|24351||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|16509|24055|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16509||16509|24055||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|22843|31802|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22843||22843|31802||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|33753|45601|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||33753|45601||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|3049|5528|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||3049||3049|5528||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|16123|23523|lyfalmen|V0387|23523|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||16123||16123|23523||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2777||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|14274|20978|lyfalmen|V0386|20978|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||14274||14274|20978||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1322|2955|lyfalmen|V0364|2955|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||1179||1179|2955||2 028249|C10AA0507|Atorvastatin Hexal|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.10.2015|30.04.2017|R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2735|2866|lyfalmen|||2|100|0|200,0000|Artasan ehf|Hexal A/S|Atorvastatín||1115||1115|2866||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|35927|48351|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||35927||35927|48351||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|1865|3899|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||1865||1865|3899||1 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013|30.06.2017|R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|29920|40753|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||29920||29920|40753||1 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|29965|40810|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||29965|40810||1 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1214|3003|lyfalmen|V0202|3003|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1214||1214|3003||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1361|3205|lyfalmen|V0428|2523|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1361||1361|3205||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|1191|2971|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1191||1191|2971||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5416|3948|lyfalmen|V0245|3733|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1901||1901|3948||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|9651|8462|lyfalmen|V0232|8050|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5180||5180|8462||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|565|2104|lyfalmen|V0266|2104|2|30|0|1,0600|Alvogen|Alvogen|Pramipexól||561||561|2104||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|5645|10880|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||5645||5645|10880||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2304|3632|lyfalmen|V0267|3632|2|100|0|7,2000|Alvogen|Alvogen|Pramipexól||1671||1671|3632||1 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1250|1992|lyfalmen|V0551|1992|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|1992||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4589|3410|lyfalmen|V0552|3410|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3410||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|2052|lyfalmen|V0555|2052|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|2052||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2116|lyfalmen|V0556|2116|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|2116||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|SDF|0|0|1|100|IKR|1121|2708|lyfalmen|V0625|1946|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2708||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|4675|7766|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||4675||4675|7766||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|11653|17371|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||11653||11653|17371||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2056|4162|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2056||2056|4162||1 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26594|36546|lyfalmen|V0802|36546|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26594||26594|36546||2 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26624|36584|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26624||26624|36584||2 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26624|36584|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26624||26624|36584||2 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|UAK|0|0|0|100|XEU|1036|2758|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1036||1036|2758||1 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|8784|13422|lyfalmen|V0801|12079|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||8784||8784|13422||2 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|UAK|0|0|0|100|GBP|221|1636|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||221||221|1636||1 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|TER|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|TERALI PRODUCTS|Meklózín|||||||1 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26350|36238|lyfalmen|V0801|36238|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26350||26350|36238||2 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|8864|13532|lyfalmen|V0802|12182|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||8864||8864|13532||2 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26594|36546|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26594||26594|36546||2 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|26624|36584|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||26624||26624|36584||2 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|41742|55706|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||41742||41742|55706||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|13945|20526|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||13945||13945|20526||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|3034|5508|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3034||3034|5508||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8751|13377|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||8751|13377||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8490|13017|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||8490|13017||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|4187|7095|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||4187||4187|7095||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|67626|88444|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||67626||67626|88444||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|135252|174005|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||135252||135252|174005||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2694|lyfalmen|V0168|2675|2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og ensímblokkar||990||990|2694||2 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|5830|9356|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||5830||5830|9356||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|PGB|0|0|0|100|IKR|12900|19087|lyfalmen|V0277|5124|1|100|0|33,3333|Icepharma hf|BGP Products ApS|Klózapín||12900||12900|19087||2 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|0|0|PGB|0|0|0|100|IKR|4000|6837|lyfalmen|V0276|2364|1|100|0|8,3333|Icepharma hf|BGP Products ApS|Klózapín||4000||4000|6837||2 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|11675|20123|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11675||11675|20123||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|900|2434|lyfalmen|V0051|2433|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||801||801|2434||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2537||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2066|4175|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2066||2066|4175||2 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1888|3930|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||1888||1888|3930||2 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4129|7015|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4129||4129|7015||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|15505|22673|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||15505||15505|22673||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1303|3125|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1303||1303|3125||2 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3311|2897|lyfalmen|||2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1137||1137|2897||2 032399|C09CA0106|Losatrix|filmhtfl|25|mg|98|stk|1|þpakki||C09CA01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1832|3853|lyfalmen|||2|98|0|49,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||1832||1832|3853||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|15009|21990|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15009||15009|21990||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|10367|17869|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||10367||10367|17869||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|965|2660|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||965||965|2660||2 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|2281|lyfalmen|V0069|2158|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||690||690|2281||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|15213|22271|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||15213|22271||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|30341|41286|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||30341|41286||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|870|1500|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||870||870|1500||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2192|4349|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2192||2192|4349||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6515|12531|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||6515|12531||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|7471|11615|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||7471||7471|11615||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4387|7370|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||4387||4387|7370||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|12950|19156|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||12950||12950|19156||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1062|2793|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1062||1062|2793||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1135|2232|lyfalmen|V0189|2232|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||654||654|2232||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|471|1717|lyfalmen|V0188|1717|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||280||280|1717||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|11992|11017|lyfalmen|V0185|11017|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||7037||7037|11017||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|60113|78941|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||60113||60113|78941||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1765|3469|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||1765|3469||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|XEU|1348|2426|lyfalmen|V0098|2426|2|100|0|100,0000|LYFIS ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||795||795|2426||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000|30.06.2017|R|0|0|0|0|0|0|SSS|0|0|1|100|XEU|548|2086|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||548||548|2086||1 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|11999|17847|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||11999||11999|17847||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|48028|63656|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||48028||48028|63656||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1147|2910|lyfalmen|V0367|2910|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1147||1147|2910||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1919|3973|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1919||1919|3973||1 034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|79176|103052|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||79176||79176|103052||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|5459|8846|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||5459||5459|8846||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1598|3531|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1598||1598|3531||1 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|1777|3778|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||1777|3778||1 035153|N02AB0306|Instanyl|nefúði|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|6856|10768|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||6856||6856|10768||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|11145|16672|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11145||11145|16672||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|781|2345|lyfalmen|V0050|2198|2|100|0|15,8300|LYFIS ehf|ratiopharm GmbH|Metóprólól||736||736|2345||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|1844|2257|lyfalmen|V0244|2257|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2257||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|949|2638|lyfalmen|V0048|2514|2|100|0|31,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||949||949|2638||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1694|3414|lyfalmen|V0049|3176|2|100|0|63,3300|LYFIS ehf|ratiopharm GmbH|Metóprólól||1513||1513|3414||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5937|9503|lyfalmen|V0080|5199|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5937||5937|9503||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3702|5297|lyfalmen|V0054|5023|2|100|0|126,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||2881||2881|5297||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4409|2846|lyfalmen|V0233|2846|2|18|0|18,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2846||2 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GZE|0|0|0|100|NOK|19953|28795|lyfalmen|V0680|23310|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||19953||19953|28795||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5277|8595|lyfalmen|V0081|5199|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5277||5277|8595||1 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|5908|9464|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||5908|9464||2 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|528|2058|lyfalmen|||1|20|0|8,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||528||528|2058||1 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|14097|20735|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14097||14097|20735||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|929|2610|lyfalmen|||1|60|0|3,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||929||929|2610||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3169|5462|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||3169||3169|5462||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036577|L01XE0104|Imatinib Mylan|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|126354|147223|lyfsjukr|||2|30|0||Icepharma hf|Mylan AB|Imatiníb||113718||113718|147223||2 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|1834|3856|lyfalmen|||1|125|0|6,2500|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||1834||1834|3856||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|556|2097|lyfalmen|||1|30|0|12,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||556||556|2097||1 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|7669|5376|lyfalmen|V0689|4789|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2938||2938|5376||2 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2433|lyfalmen|V0006|1129|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||800||800|2433||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5665|5750|lyfalmen|V0532|5559|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||3210||3210|5750||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|9179|7943|lyfalmen|V0533|7874|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4803||4803|7943||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|14720|14642|lyfalmen|V0534|14497|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||9670||9670|14642||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1766|3762|lyfalmen|V0434|3762|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1766||1766|3762||2 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3533|5048|lyfalmen|V0054|5023|2|100|0|126,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2700||2700|5048||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2708|lyfalmen|V0322|2653|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2708||2 037793|L02BB0308|Bicacta|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.03.2016||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13096|7549|lyfalmen|V0421|5761|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||4517||4517|7549||1 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2244||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3246||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5250|8558|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5250|8558||1 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2164|3094|lyfalmen|V0335|3094|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||1280||1280|3094||1 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2485|3373|lyfalmen|V0321|3358|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1483||1483|3373||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2383|lyfalmen|V0110|2383|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2383||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|733|2341|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||733||733|2341||2 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|10229|15411|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||10229|15411||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|21739|30406|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||21739||21739|30406||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|13831|13857|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||9100||9100|13857||2 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1216|3005|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1216||1216|3005||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4218|7137|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||4218||4218|7137||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|13719|20215|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||13719||13719|20215||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2276|4464|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2276||2276|4464||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|290|1731|lyfalmen|V0541|1711|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||290||290|1731||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|417|1732|lyfalmen|V0542|1706|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||291||291|1732||2 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|756|2372|lyfalmen|V0821|2158|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||756||756|2372||1 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1325|3155|lyfalmen|V0822|2708|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1325||1325|3155||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1630|2383|lyfalmen|V0110|2335|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2383||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|4878|3946|lyfalmen|V0182|3946|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1899||1899|3946||1 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|1246|1924|lyfalmen|V0033|1882|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||430||430|1924||1 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|6928|10867|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||6928||6928|10867||1 040484|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|15|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||2057||1 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|63590|83339|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||63590|83339||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|691|2283|lyfalmen|V0174|2226|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||691||691|2283||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2339|4085|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|4085||2 040891|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2060|4167|lyfalmen|||2|28|0|56,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2060||2060|4167||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|6348|10069|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||6348||6348|10069||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|6480|10251|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||6480||6480|10251||2 041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|40997|77950|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||40997||40997|77950||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2537|4373|vetorma|||0|100|0||Vistor hf|Intervet International BV|||2537||2537|4373||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|767|2387|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||767|2387||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9590|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9590||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9590|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9590||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|987|2690|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||987||987|2690||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1707|3681|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1707||1707|3681||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2843|5245|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2843||2843|5245||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1545|3458|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1545||1545|3458||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2043|4144|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2043||2043|4144||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1492|3385|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1492||1492|3385||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1690|3658|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1690||1690|3658||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|1621|3563|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||1621||1621|3563||1 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2331|4540|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2331||2331|4540||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4375|8471|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4375||4375|8471||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1628|3573|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||1628||1628|3573||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|2561|4857|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2561||2561|4857||2 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|999|2707|lyfalmen|V0560|2707|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||999||999|2707||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|371|1842|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||371||371|1842||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|11180|5158|lyfalmen|V0516|5158|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||2780||2780|5158||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2717|5071|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2717||2717|5071||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|400|1882|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||400||400|1882||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|10249|15438|lyfalmen|V0637|15438|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||10249||10249|15438||3 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|1|0|1|ZAA|0|0|0|100|DKK|10649|15989|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||10649||10649|15989||2 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|270264|341922|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||270264|341922||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|358411|451552|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||358411|451552||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|3989|6822|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||3989||3989|6822||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|11612|17315|lyfalmen|V0635|15784|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||11612||11612|17315||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|30935|42037|lyfalmen|V0636|21913|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||30935||30935|42037||1 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|4944|8137|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||4944||4944|8137||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1050|2050|lyfalmen|V0109|2009|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|2050||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|868|1921|lyfalmen|V0108|1883|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1921||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1466|3350|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1466|3350||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2104|4228|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2104|4228||2 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGH|0|0|1|100|XEU|282|1720|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||282||282|1720||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGH|0|0|0|100|SEK|1418|3283|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1418||1418|3283||1 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1125|2880|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1125||1125|2880|30.4.2017|1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|591|2145|lyfalmen|V0648|2145|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||591||591|2145||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|467|1663|lyfalmen|V0021|1607|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||241||241|1663||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|567|1829|lyfalmen|V0022|1745|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||361||361|1829||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|727|2042|lyfalmen|V0023|2020|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||516||516|2042||1 046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|5416|8786|lyfsjukr|||1|1|0||Icepharma hf|Hospira UK Ltd|Gemcitabín||5416||5416|8786||1 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2433|lyfalmen|V0625|2433|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2433||2 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|4372|4025|lyfalmen|V0205|4025|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1957||1957|4025||1 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|658|2237|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||658||658|2237||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19759|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19759||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63058|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63058||5 047986|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|7605|4459|lyfalmen|V0420|3800|2|30|0|30,0000|Alvogen|Alvogen ehf|Bíkalútamíð||2272||2272|4459||1 047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|10728|5963|lyfalmen|V0421|5761|2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||3365||3365|5963||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|3326|5910|lyfsjukr|||1|250|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||3326||3326|5910||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6142|9786|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6142||6142|9786||1 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|5395|8757|lyfsjukr|||1|100|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||5395||5395|8757||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1914|2142|lyfalmen|V0324|1920|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||589||589|2142||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1141|2902|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1141||1141|2902||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2925|2142|lyfalmen|V0325|2061|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||589||589|2142||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4857|3520|lyfalmen|V0326|2763|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1590||1590|3520||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5233|2977|lyfalmen|V0327|2763|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1195||1195|2977||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|808|2444|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||808||808|2444||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8674|13271|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||8674||8674|13271||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1273|3084|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1273||1273|3084||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|41590|55513|lyfalmen|V0187|11084|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||41590||41590|55513||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|601019|753289|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||601019||601019|753289||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|291|1732|lyfalmen|V0230|1732|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||291||291|1732||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|2915|5344|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||2915||2915|5344||1 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|30195|41101|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||30195||30195|41101||3 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3430|3045|lyfalmen|V0148|3045|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1245||1245|3045||2 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1417|3282|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1417||1417|3282||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3196|3264|lyfalmen|V0599|1920|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1404||1404|3264||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4414|7407|lyfalmen|V0376|3030|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||4414|7407||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|277874|351387|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||277874||277874|351387||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|11052|16544|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||11052||11052|16544||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|733|2341|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||733||733|2341||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2424|4668|lyfalmen|V0655|4668|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||2424||2424|4668||2 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2147|lyfalmen|V0109|2009|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||592||592|2147||1 049597|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2580|lyfalmen|V0110|2383|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2580||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|625|2192|lyfalmen|V0496|2192|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||625||625|2192||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|DKK|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1000|2708|lyfalmen|V0649|2708|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1000||1000|2708||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1674||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1674||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1772||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|57799|76014|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||57799||57799|76014||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|126254|162814|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||126254||126254|162814||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|6313|10021|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||6313||6313|10021||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|15782|23054|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||15782||15782|23054||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|31563|42831|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||31563||31563|42831||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|63010|82605|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||63010||63010|82605||2 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 050068|J05AX6801|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AX68|01.05.2017||R|0|0|0|1|0|1|MLD|0|1|0|100|DKK|1483716|1851117|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme Limited|Elbasvir og grazoprevir||1483716||1483716|1851117||1 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3233||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2639|4964|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||2639||2639|4964||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|21968|30103|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|30103||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|49831|65937|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||49831|65937||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|883|1721|lyfalmen|||2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||283||283|1721||2 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2239|4414|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2239||2239|4414||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8901|13583|lyfalmen|V0688|5233|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||8901||8901|13583||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3907|4317|lyfalmen|V0042|3405|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2169||2169|4317||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4615|5186|lyfalmen|V0002|3879|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2800||2800|5186||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4360|2433|lyfalmen|V0006|1882|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||800||800|2433||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|6304|3052|lyfalmen|V0001|2846|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1250||1250|3052||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|814|2280|lyfalmen|V0363|2280|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||689||689|2280||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2504|4034|lyfalmen|V0365|4034|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||1963||1963|4034||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|15598|22801|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||15598||15598|22801||1 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1116|2171|lyfalmen|V0056|2171|2|100|0|100,0000|Alvogen|Alvogen|Amlódipín||610||610|2171||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|596|2152|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||596||596|2152||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|138|1522|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||138||138|1522||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|325|1779|lyfalmen|V0305|992|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||325||325|1779||2 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|231|1650|lyfalmen|V0439|1650|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||231||231|1650||2 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|475|1986|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||475||475|1986||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|474|1984|lyfalmen|V0305|1984|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||474||474|1984||2 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|411754|517896|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||411754||411754|517896||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2395|4628|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||2395||2395|4628||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|24809|34289|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||24809||24809|34289||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20169|28420|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||20169||20169|28420||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20755|29161|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||20755||20755|29161||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|18198|26379|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||18198||18198|26379||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|8627|lyfalmen|V0682|8208|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||5300||5300|8627||2 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|10648|15988|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||10648||10648|15988||1 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3803|6566|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||3803||3803|6566||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|8619|13195|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||8619||8619|13195||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|25670|35378|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||25670||25670|35378||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4297|7246|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||4297||4297|7246||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1260|3061|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1256||1256|3061||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4101|6976|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||4101||4101|6976||1 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|7435|11565|lyfalmen|V0115|11565|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||7435||7435|11565||2 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|20429|28749|lyfalmen|V0453|27636|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||20429||20429|28749||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|7864|12156|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||7864||7864|12156||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1102|2849|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1102||1102|2849||1 053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|822|2463|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||822||822|2463||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4645|2409|lyfalmen|V0490|2293|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||783||783|2409||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2564|4861|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Haemophilus influenzae B||2564||2564|4861||1 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|4|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1703|3676|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||1703||1703|3676||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2336|4547|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2336||2336|4547||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|29879|40701|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||29879||29879|40701||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|952|2642|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||952||952|2642||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|818|2458|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||818||818|2458||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1066|2799|lyfalmen|V0061|2799|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1066||1066|2799||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|3418|6655|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||||3418|6655||2 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|14548|18919|lyfalmen|||2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||12778||12778|18919||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|5129|4046|lyfalmen|V0187|3695|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||1972||1972|4046||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|1470|3355|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1470|3355||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013|30.06.2017|R|0|0|0|0|0|0|VBA|0|0|0|100|XEU|984|2341|lyfalmen|||2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||733||733|2341||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|6631|10459|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||6631||6631|10459||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|IKR|1470|3286|lyfalmen|V0467|2491|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1420||1420|3286||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000|30.06.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1962|4032|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||1962||1962|4032||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2217|2979|lyfalmen|V0112|2708|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1197||1197|2979||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|3113|3066|lyfalmen|V0113|2660|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|3066||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4522|3066|lyfalmen|V0114|2777|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|3066||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|23040|32051|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||23040||23040|32051||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|19382|33407|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||19382||19382|33407||2 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|2423|4667|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||2423||2423|4667||1 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1043|2767|lyfalmen|||1|40|0|10,0000|Vistor hf|Meda AB|Erýtrómýcín||1043||1043|2767||1 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2672|3167|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1333||1333|3167||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2672|3167|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1333||1333|3167||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1909|3959|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||1909||1909|3959||1 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|154532|197984|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||154532||154532|197984||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6428|10179|lyfalmen|V0095|5706|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||6428||6428|10179||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5429|8804|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||5429||5429|8804||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2576|4877|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2576||2576|4877||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2714|5067|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2714||2714|5067||1 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|14623|21459|lyfalmen|||2|84|0|84,0000|Alvogen|Alvogen|Galantamín||14623||14623|21459||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3517|6173|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||3517||3517|6173||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1912|3963|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||1912||1912|3963||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|224355|284824|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||224355||224355|284824||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|299854|378724|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||299854||299854|378724||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|9108|7206|lyfalmen|V0607|7180|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||4268||4268|7206||2 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|78351|102009|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||78351|102009||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|14505|21296|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||14505|21296||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|NOK|297|1741|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||297||297|1741||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|297078|375271|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||297078||297078|375271||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|71682|93574|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||71682||71682|93574||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|116445|200705|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||116445|200705||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|176891|304889|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||176891|304889||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|664|2246|lyfalmen|||1|100|0|2,5000|Vistor hf|Meda AB|Trímetóprím||664||664|2246||1 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|26428|36336|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||26428||26428|36336||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3787|6544|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||3787||3787|6544||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|846|2496|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||846||846|2496||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1219|3010|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1219||1219|3010||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|2374|2571|lyfalmen|V0006|1054|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||900||900|2571||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|7942|12263|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||7942||7942|12263||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|67617|88432|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||67617||67617|88432||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|45838|60886|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||45838||45838|60886||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|22146|30921|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||22146||22146|30921||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|18844|27269|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||18844||18844|27269||1 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|3936|6749|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||3936|6749||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|6421|10170|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||6421||6421|10170||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|32105|43517|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||32105||32105|43517||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1490|3059|lyfalmen|V0219|3059|2|5|0|7,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1255||1255|3059||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|2643|4798|lyfalmen|V0220|4798|2|5|0|15,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||2518||2518|4798||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|3811|6018|lyfalmen|V0221|6018|2|5|0|22,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||3405||3405|6018||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|4563|6491|lyfalmen|V0223|6491|2|5|0|30,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||3748||3748|6491||2 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007|30.06.2017|R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|252466|319787|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||252466||252466|319787||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007|30.06.2017|R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|134263|172775|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||134263||134263|172775||1 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|14883|21817|lyfalmen|V0713|21817|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||14883||14883|21817||1 060759|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|672|1745|lyfalmen|V0022|1745|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1745||2 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|NOK|95162|123271|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||95162|123271||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|75941|98960|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||75941||75941|98960||2 061293|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|10093|8214|lyfalmen|||2|28|0|18,6670|LYFIS ehf|ratiopharm GmbH|Aripiprazól||5000||5000|8214|30.4.2017|2 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1994|2708|lyfalmen|V0112|2708|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1000||1000|2708||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|4389|7373|lyfalmen|V0133|6075|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||4389||4389|7373||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4107|6985|lyfalmen|V0133|6075|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4107||4107|6985||1 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2979|5432|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||2979||2979|5432||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|11396|17017|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||11396||11396|17017||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|15859|23160|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||15859||15859|23160||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|10492|11084|lyfalmen|V0187|11084|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||7085||7085|11084||1 062575|J05AX1501|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AX15|01.09.2015||R|0|0|0|1|0|1|GIL|0|1|0|100|XEU|1530601|1909429|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||1530601|1909429||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|40997|77950|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||40997||40997|77950||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|666|2248|lyfalmen|V0308|2169|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||666||666|2248||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008|31.05.2017|R|1|0|0|0|G|0|AGH|0|0|1|100|IKR|1677|3640|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1677||1677|3640||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12941|22305|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||12941||12941|22305||2 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|55965|73695|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||55965||55965|73695||1 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|9003|11602|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||7462||7462|11602||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|4112|6992|lyfalmen|||1|10|0|1,6667|Artasan ehf|Novartis Healthcare A/S|Famcíclóvír||4112||4112|6992||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|1314|2400|lyfalmen|V0276|2364|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||776||776|2400||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|4054|5124|lyfalmen|V0277|5124|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||2755||2755|5124||1 063514|C07AB0214|Bloxazoc|forðatfl|50|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|500|1951|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||450||450|1951||2 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2755||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1561|3480|lyfalmen|V0123|3460|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1561||1561|3480||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|2984|5439|lyfalmen|V0458|3209|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2984||2984|5439||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|5592|9029|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||5592||5592|9029||1 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|106403|138125|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||106403||106403|138125||2 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|699|2294|lyfalmen|V0309|1994|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||699||699|2294||1 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1465|3348|lyfalmen|V0310|2910|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1465||1465|3348||1 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|672788|842549|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||672788|842549||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|311464|393164|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||311464|393164||2 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|2749596|3425517|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2749596|3425517||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|1223250|1527170|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1223250|1527170||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1469|3286|lyfalmen|V0009|3286|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1420||1420|3286||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|4686|5442|lyfalmen|V0029|5206|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||2986||2986|5442||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|850|1671|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||850||850|1671||1 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4853|8365|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||4853|8365||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|NOK|1462|3344|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1462||1462|3344||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|721|2107|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Inflúensa, hreinsaðir mótefnavakar||563||563|2107||1 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|35417|47706|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||35417||35417|47706||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|597|2153|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||597||597|2153||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|12963|16830|lyfalmen|V0441|16830|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||11260||11260|16830||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|343|1804|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||343||343|1804||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1403|3263|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1403||1403|3263||1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11361|16969|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||11361||11361|16969||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7916|12227|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||7916||7916|12227||2 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8600|11828|lyfalmen|||2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||7626||7626|11828||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|37851|50784|lyfalmen|V0451|42218|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||37851||37851|50784||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|954|2224|lyfalmen|V0163|2224|2|70|0|5,6000|LYFIS ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|2224||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1172|2945|lyfalmen|V0222|2945|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1172||1172|2945||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|2501|4774|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||2501||2501|4774||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|529|2060|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||529||529|2060||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|1450|3328|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1450||1450|3328||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|2547|4837|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2547||2547|4837||1 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|7738|11982|lyfalmen|||0|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||7738||7738|11982||3 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|3228|6295|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||3228||3228|6295||2 066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|7021|8623|lyfalmen|V0716|8623|2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||5297||5297|8623||1 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4243|7172|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||4243||4243|7172||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22040|30786|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||22040||22040|30786||1 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|677|2264|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||677||677|2264||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1036|2758|lyfalmen|V0006|1882|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1036||1036|2758||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|689|2280|lyfalmen|V0036|2280|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||689||689|2280||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|2800|5186|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||2800||2800|5186||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6328|10042|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6328||6328|10042||1 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|93251|120854|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtricitabine, tenofovir alafenamide og rilpivirine||||93251|120854||2 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1811|3824|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||1811|3824||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|77403|100810|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||77403||77403|100810||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1064|2796|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1064||1064|2796||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|3632|6331|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||3632||3632|6331||1 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2231|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||2957||1 068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|4939|3771|lyfalmen|V0182|3758|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1772||1772|3771||1 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|5072|5502|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3030||3030|5502||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín|||||||2 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2340|4553|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2340||2340|4553||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1804|3815|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||1804||1804|3815||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1686|3652|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||1686||1686|3652||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3456||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3639||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3410||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3589||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|10168|15327|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||10168||10168|15327||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|32093|43502|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||32093||32093|43502||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|289491|365835|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||289491||289491|365835||1 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4002|6840|lyfalmen|V0589|6840|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||4002||4002|6840||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|7435|11565|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7435||7435|11565||1 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|5020|8652|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||5020||5020|8652||1 070971|N06AB0606|Sertralin Hexal|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016|30.04.2017|R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2831|3172|lyfalmen|||2|100|0|200,0000|Artasan ehf|Hexal A/S|Sertralín||1337||1337|3172||1 071029|C07AB0214|Bloxazoc|forðatfl|25|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|445|1944|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||445||445|1944||2 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|42415|56557|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||42415||42415|56557||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|214513|272584|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||214513||214513|272584||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3482|2937|lyfalmen|V0686|2210|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1166||1166|2937||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|53908|71093|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||53908||53908|71093||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|454|1957|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||454||454|1957||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|346|1808|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||346||346|1808||2 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|5044|9740|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||5044||5044|9740||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|4686|5206|lyfalmen|V0029|5206|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||2815||2815|5206||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184235|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184235||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184235|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184235||5 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2482|4748|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2482||2482|4748||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|403|1886|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||403||403|1886||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|42392|56528|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||42392||42392|56528||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6361|5966|lyfalmen|V0286|5859|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3367||3367|5966||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|333|1763|lyfalmen|V0500|1763|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||313||313|1763||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|264182|334358|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||264182|334358||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|483086|606613|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||483086||483086|606613||1 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2443|4694|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2443||2443|4694||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|209784|266702|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||209784||209784|266702||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|11992|11017|lyfalmen|V0185|11017|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||7037||7037|11017||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|370|1841|lyfalmen|V0439|1650|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||370||370|1841||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1006|2716|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1006||1006|2716||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|926|2606|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2606||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2519|4342|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||2519||2519|4342||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|GBP|694|2287|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||694||694|2287||2 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2287|4480|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2287||2287|4480||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|559|2101|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||559||559|2101||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|LYFIS ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|440|1937|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||440||440|1937||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|716|2317|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||716||716|2317||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5151|5281|lyfalmen|||2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2869||2869|5281||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|474|1984|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||474||474|1984||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|644|2218|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||644||644|2218||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|GBP|547|2085|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||547||547|2085||2 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|GBP|276|1712|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||276||276|1712||2 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|GBP|1602|3537|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||1602||1602|3537||2 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|3946|6763|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||3946||3946|6763||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|11568|17254|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||11568||11568|17254||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4167|7067|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4167||4167|7067||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1401|3260|lyfalmen|V0363|2280|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1401||1401|3260||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|12203|18128|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||12203||12203|18128||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|3144|5659|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5659||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|4555|7601|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||4555||4555|7601||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6144|9788|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6144||6144|9788||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||3775||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2941|4076|lyfalmen|V0445|4076|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||1994||1994|4076||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|875|1720|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||875||875|1720||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|9162|13942|lyfalmen|V0440|13942|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||9162||9162|13942||1 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|3946|6763|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||3946||3946|6763||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|3946|6763|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||3946||3946|6763||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4344|7311|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4344||4344|7311||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|UAK|0|0|0|100|GBP|458|1962|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||458||458|1962||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|TAV|0|0|1|100|XEU|456|1959|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||456||456|1959||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|4595|7656|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||4595||4595|7656||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|14079|20710|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||14079|20710||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|14124|20772|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||14124||14124|20772||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|14151|20809|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||14151||14151|20809||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2295|lyfalmen|V0143|1177|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2295||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3405|lyfalmen|V0143|2354|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3405||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4195|lyfalmen|V0143|3531|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2080||2080|4195||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2447|lyfalmen|V0144|1323|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2447||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3731|lyfalmen|V0144|2646|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3731||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4649|lyfalmen|V0144|3969|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2410||2410|4649||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007|30.04.2017|R|1|0|0|0|0|0|GOV|0|0|0|100|IKR|445|1944|lyfalmen|||2|20|0|2,0000|Alvogen|Alvogen ehf|Risperídón||445||445|1944||1 076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1691|2639|lyfalmen|V0290|2571|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||950||950|2639||1 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1660|2571|lyfalmen|V0291|2571|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||900||900|2571||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1097|2842|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1097||1097|2842||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2571|lyfalmen|V0290|2571|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2571||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|193771|246786|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||193771||193771|246786||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|129181|166455|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||129181||129181|166455||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|64689|84729|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||64689||64689|84729||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|32535|44061|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||32535||32535|44061||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2187|4239|lyfalmen|V0598|4239|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2112||2112|4239||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|324|1778|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||324||324|1778||1 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|1933|2576|lyfalmen|V0005|2576|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||904||904|2576||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|38250|51289|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||38250||38250|51289||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|367|1837|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1837||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|1042|2766|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2766||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2459|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2459||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2226|lyfalmen|V0671|2226|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||650||650|2226||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4531|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4531||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5874|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5874||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8214|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8214||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10003|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10003||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12508|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12508||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|530|2061|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||530||530|2061||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|0|0|0|TEV|0|0|0|100|IKR|8800|10278|lyfalmen|V0275|10278|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Quetíapín||6500||6500|10278||2 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|7268|11335|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||7268||7268|11335||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12251|lyfalmen|V0419|12162|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7933||7933|12251||1 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|22549|42950|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||22549||22549|42950||2 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|343|1804|lyfalmen|||1|20|0|2,5000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||343||343|1804||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|522|2050|lyfalmen|||1|40|0|5,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||522||522|2050||1 078688|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|999|2707|lyfalmen|V0560|2707|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||999||999|2707||2 078699|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1116|2868|lyfalmen|V0561|2868|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1116||1116|2868||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|6378|5016|lyfalmen|V0069|2115|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||2677||2677|5016||1 079109|J05AX1401|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1014133|1267087|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1014133||1014133|1267087||1 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2071|3809|lyfalmen|V0901|3809|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3809||2 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|16293|9345|lyfalmen|V0688|9345|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||5822||5822|9345||1 079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|32241|14657|lyfalmen|V0683|14657|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9681||9681|14657||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2498|4770|lyfalmen|V0315|4770|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2498||2498|4770||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6287|lyfalmen|V0184|4596|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6287||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1483|3373|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1483||1483|3373||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|393|1873|lyfalmen|V0176|1873|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1873||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|638|2210|lyfalmen|V0418|2210|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|2210||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|647|2222|lyfalmen|V0177|2222|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|2222||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|1164|2934|lyfalmen|V0411|2934|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1164||1164|2934||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|2866|5608|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||2866|5608||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|5899|4237|lyfalmen|V0687|3443|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2111||2111|4237||2 080256|A10BB0903|Gliclazid LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|3878|lyfalmen|V0020|1853|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||1850||1850|3878||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|10728|6478|lyfalmen|V0421|5761|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||3739||3739|6478||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7790|13427|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||7790||7790|13427||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BLP|0|0|0|100|XEU|6921|5406|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Letrózól||2960||2960|5406||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1637|3585|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1637||1637|3585||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3942|6758|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||3942||3942|6758||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1193|2320|lyfalmen|V0143|1177|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||718||718|2320||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1926|3983|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||1926||1926|3983||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1205|2503|lyfalmen|V0144|1323|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||851||851|2503||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|10702|16062|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||10702||10702|16062||1 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|24226|33551|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||24226||24226|33551||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|21098|29595|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||21098||21098|29595||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2281|4466|lyfsjukr|||1|1|0|1,0000|Alvogen|Linepharma France|Mifepriston||2277||2277|4466||1 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|7533|11496|lyfalmen|V0815|11496|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7385||7385|11496||2 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|525093|658858|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||525093||525093|658858||1 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|3845|3584|lyfalmen|V0515|3584|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||1636||1636|3584||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|3297|5870|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||3297||3297|5870||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1505|3403|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1505||1505|3403||2 081900|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|5585|6131|lyfalmen|V0204|3080|2|14|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||3487||3487|6131||1 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3359|5955|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3359||3359|5955||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|4730|7842|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||4730||4730|7842||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|12180|7213|lyfalmen|V0184|4504|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||4273||4273|7213||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|20924|29375|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||20924||20924|29375||2 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|9106|15695|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||9106||9106|15695||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|39638|68320|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||39638||39638|68320||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|447|1947|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||447||447|1947||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|525|1986|lyfalmen|V0229|1986|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Paracetamól||475||475|1986||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1912|3963|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1912||1912|3963||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3524|6182|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3524||3524|6182||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2548|4839|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2548||2548|4839||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2774|5150|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2774||2774|5150||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3767|5866|lyfalmen|V0080|5305|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3294||3294|5866||1 083019|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|0|0|1|0|1|ALO|0|1|0|100|XEU|197839|251846|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||197839||197839|251846||1 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2659|4992|lyfalmen|||1|100|0|16,6700|Icepharma hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2659||2659|4992||2 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3765|6514|lyfalmen|V0701|6287|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3765||3765|6514||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7758|4034|lyfalmen|V0686|3947|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1963||1963|4034||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4403|8524|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||4403||4403|8524||2 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|721|2136|lyfalmen|V0231|2136|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||584||584|2136||1 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|3670|4686|lyfalmen|V0624|3753|2|30|0|36,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2437||2437|4686||1 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|117722|152203|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||117722||117722|152203||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1447|3323|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1447||1447|3323||2 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|49043|64940|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||49043||49043|64940||1 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|4894|7867|lyfalmen|V0215|7867|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||4748||4748|7867||2 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|161366|206484|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||161366||161366|206484||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|30764|41821|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||30764||30764|41821||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|9068|13813|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||9068||9068|13813||1 085171|A10BJ0101|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|10969|16429|lyfalmen|||1|60|0|20,0000|Vistor hf|AstraZeneca AB|Exenatide||10969||10969|16429||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|26045|35852|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||26045||26045|35852||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1856|3886|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||1856||1856|3886||2 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|704|2301|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||704||704|2301||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3491|6137|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3491||3491|6137||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|14720|21592|lyfalmen|V0412|19320|1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||14720||14720|21592||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|28250|38641|lyfalmen|V0412|38641|1|750|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||28250||28250|38641||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|12383|17463|lyfalmen|V0652|17395|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||11720||11720|17463||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|64597|84613|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||64597||64597|84613||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|14516|21312|lyfalmen|V0579|21312|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||14516||14516|21312||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|23058|32074|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||23058||23058|32074||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|3023|5493|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3023||3023|5493||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1911|3962|lyfalmen|V0465|3032|1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||1911||1911|3962||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|5642|9097|lyfalmen|V0465|9097|1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||5642||5642|9097||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|267|1699|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||267||267|1699||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1376|3226|lyfalmen|V0364|2955|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1376||1376|3226||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|4123|7007|lyfalmen|V0365|4034|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4123||4123|7007||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|42840|57094|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||42840||42840|57094||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|15905|23223|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||15905||15905|23223||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|5520|8929|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||5520||5520|8929||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|5992|9579|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||5992||5992|9579||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8658|13249|lyfalmen|V0012|5230|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8658||8658|13249||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|20954|29413|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||20954|29413||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|37935|50890|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||37935|50890||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|36610|49215|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||36610||36610|49215||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|11986|17829|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||11986|17829||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|35532|47851|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||35532||35532|47851||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|247|1672|lyfalmen|V0060|1672|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||247||247|1672||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|86882|112799|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||86882||86882|112799||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|168|1563|lyfalmen|V0312|511|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||168||168|1563||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|147|1534|lyfalmen|V0312|1534|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||147||147|1534||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1241|3040|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1241||1241|3040||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|23641|14567|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||9616||9616|14567||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|23641|14567|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||9616||9616|14567||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3955||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1356|3198|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1356||1356|3198||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|23012|39663|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||23012||23012|39663||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3176|6196|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3176||3176|6196||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|18072|31149|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||18072||18072|31149||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2226|4396|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2226||2226|4396||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|DKK|759|2376|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||759||759|2376||1 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2294|4489|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2294||2294|4489||2 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20454|8627|lyfalmen|V0684|8208|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||5300||5300|8627||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7923|12237|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||7923||7923|12237||1 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|3366|5965|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||3366||3366|5965||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2078|3094|lyfalmen|V0334|3094|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||1280||1280|3094||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|5816|9337|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5816||5816|9337||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|10755|16135|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10755||10755|16135||1 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|337328|425331|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||337328||337328|425331||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1050|2777|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1050||1050|2777||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|16621|24209|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||16621||16621|24209||1 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|94463|122387|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||94463||94463|122387||1 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6056||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|86882|112799|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||86882||86882|112799||1 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|15229|22293|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||15229||15229|22293||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|36549|49137|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||36549||36549|49137||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|1738|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||1738||2 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|1419|2529|lyfalmen|V0048|2514|2|100|0|31,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||870||870|2529||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|17603|25561|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||17603||17603|25561||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|70410|91965|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||70410||70410|91965||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|815|2454|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||815||815|2454||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2093|4213|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2093||2093|4213||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|532|2064|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||532||532|2064||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|4128|7014|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||4128||4128|7014||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|92516|119925|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||92516||92516|119925||3 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1368|3215|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1368||1368|3215||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|607|2167|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||607||607|2167||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|10693|16050|lyfsjukr|||1|60|0||Vistor hf|Novartis Healthcare A/S|Flúorescein||||10693|16050||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1856|3886|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||1856||1856|3886||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3211|5751|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3211||3211|5751||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|9425|14304|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||9425||9425|14304||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|2810|5199|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||2810||2810|5199||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|4656|7740|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||4656||4656|7740||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|TRI|0|0|1|100|DKK|2815|5206|lyfalmen|||1|30|0||Vistor hf|Trimb Healthcare AB|Dexametasón||2815||2815|5206||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|724|1800|lyfalmen|V0021|1607|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||340||340|1800||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1251|2038|lyfalmen|V0022|1745|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||513||513|2038||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|825|2467|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||825||825|2467||1 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4892|9452|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||4892||4892|9452||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|974|2672|lyfalmen|V0004|2562|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||974||974|2672||2 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2065|4085|lyfalmen|V0011|2560|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4085||2 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3453|4635|lyfalmen|V0011|4481|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2400||2400|4635||2 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1510|2708|lyfalmen|V0005|2404|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2708||2 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2400|4085|lyfalmen|V0012|2929|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4085||2 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4794|5454|lyfalmen|V0012|5125|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2995||2995|5454||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|3389|5996|lyfalmen|V0009|3286|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||3389||3389|5996||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1610|3548|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||1610||1610|3548||1 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|511|2035|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||511||511|2035||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|969|2665|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||969||969|2665||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2372|2630|lyfalmen|V0203|2628|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||943||943|2630||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|706|2303|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||706||706|2303||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1621|3563|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||1621||1621|3563||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3152|5670|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3152||3152|5670||2 093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|215047|273248|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||215047||215047|273248||1 093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|313778|396042|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||313778||313778|396042||1 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3490|6135|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||3490||3490|6135||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4180|7085|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4180||4180|7085||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|17443|21822|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||14887||14887|21822||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1039|2762|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1039||1039|2762||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4183|7089|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4183|7089||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3097|5594|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3097|5594||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1731|3714|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||1731||1731|3714||2 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|25211|34797|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||25211||25211|34797||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6047|9655|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||6047||6047|9655||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|15654|22878|lyfalmen|V0588|12939|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||15654||15654|22878||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|321819|406042|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||321819||321819|406042||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|321819|406042|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||321819||321819|406042||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|3155|5674|lyfalmen|V0236|5027|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||3155||3155|5674||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4511|7541|lyfalmen|V0236|7541|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||4511||4511|7541||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1262|2480|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1262||1262|2480||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|XEU|748|2361|lyfalmen|V0044|2361|2|25|0|1,2500|LYFIS ehf|ratiopharm GmbH|Acíklóvír||748||748|2361||2 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2500|1882|lyfalmen|V0324|1882|2|98|0|49,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||400||400|1882||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|11999|14497|lyfalmen|V0534|14497|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||9565||9565|14497||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|53813|70973|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||53813||53813|70973||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|HAL|0|0|0|100|XEU|33496|45276|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||33496|45276||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|4570|7877|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||4570||4570|7877||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|28585|39065|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||28585||28585|39065||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|36788|47216|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||35030||35030|47216||1 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|269095|340468|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||269095|340468||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGH|0|0|0|100|DKK|5530|8943|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5530||5530|8943||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|11702|17438|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||11702||11702|17438||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|11877|17679|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||11877||11877|17679||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|13827|20363|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||13827||13827|20363||1 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1559|3478|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1559|3478||1 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2463|4722|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||2463|4722||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|694|1679|lyfalmen|V0225|1679|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||252||252|1679||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6287|lyfalmen|V0701|6287|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníð||3600||3600|6287||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|75284|98129|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||75284||75284|98129||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1693|2064|lyfalmen|V0088|2041|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||532||532|2064||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1762|2294|lyfalmen|V0089|2258|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||699||699|2294||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|RGO|0|0|1|100|DKK|1202|2986|lyfalmen|||1|5|0||Vistor hf|Glaxo Group Limited|Retapamúlín||1202||1202|2986||1 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|10499|15783|lyfalmen|V0347|13902|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||10499||10499|15783||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|530371|665423|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||530371||530371|665423||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|491612|617217|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||491612||491612|617217||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|517486|649397|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||517486||517486|649397||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|567387|711460|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||567387||567387|711460||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|10620|15949|lyfalmen|V0349|15031|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||10620||10620|15949||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|747|2360|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||747||747|2360||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|8619|13195|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8619||8619|13195||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|51892|89441|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||51892||51892|89441||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|5710|11004|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||5710|11004||2 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1540|3451|lyfalmen|V0461|3217|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||1540||1540|3451||2 097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|378|1852|lyfalmen|V0333|844|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||378||378|1852||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7848|12134|lyfalmen|V0334|3094|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||7848||7848|12134||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|14600|21427|lyfalmen|V0335|3094|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||14600|21427||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|24683|34129|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||24683||24683|34129||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4375|8471|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4375||4375|8471||2 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|14296|21009|lyfalmen|V0809|21009|1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||14296||14296|21009||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1796|2235|lyfalmen|V0023|2020|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||656||656|2235||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2140|4277|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2140|4277||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|775|1999|lyfalmen|V0329|1999|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||485||485|1999||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2185|3523|lyfalmen|V0678|2708|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1592||1592|3523||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|3023|3523|lyfalmen|V0679|2708|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1592||1592|3523||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|4028|7812|vetalmen|||0|90|0||Icepharma hf|VETCOOL BV.|Vedaprófen||4028||4028|7812||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|439|1936|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||439||439|1936||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|439|1936|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||439||439|1936||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1022|1882|lyfalmen|V0243|1882|2|50|0|4,1600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||400||400|1882||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1812|2158|lyfalmen|V0244|2015|2|50|0|8,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||600||600|2158||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|5116|3809|lyfalmen|V0245|3809|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3809||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|9166|8214|lyfalmen|V0232|8214|2|100|0|66,6600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||5000||5000|8214||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2793|4071|lyfalmen|V0381|4071|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|4071||2 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|11393|17013|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||11393||11393|17013||1 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|ASZ|0|0|0|100|SEK|51200|67668|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||51200||51200|67668||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1820|2087|lyfalmen|V0284|2087|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||549||549|2087||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3402|3461|lyfalmen|V0285|3461|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1547||1547|3461||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6088|5859|lyfalmen|V0286|5859|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||3289||3289|5859||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3132|2131|lyfalmen|V0685|2131|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||581||581|2131||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1245|1915|lyfalmen|V0247|1889|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||424||424|1915||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2248|3040|lyfalmen|V0248|1973|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1241||1241|3040||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4055|3425|lyfalmen|V0249|3425|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1521||1521|3425||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|123535|159433|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||123535||123535|159433||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|238113|301935|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||238113||238113|301935||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|476209|598060|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||476209||476209|598060||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|438|1935|lyfalmen|V0414|1935|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||438||438|1935||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|4019|6479|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||4019||4019|6479||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|8187|12600|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||8187|12600||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1417|3072|lyfalmen|V0823|3072|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1264||1264|3072||1 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|322|1692|lyfalmen|V0563|1685|2|30|0|15,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||262||262|1692||2 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|1678|2363|lyfalmen|V0685|1193|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||749||749|2363||2 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2158|lyfalmen|V0821|2158|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||600||600|2158||2 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2708|lyfalmen|V0822|2708|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2708||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3049|5528|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3049||3049|5528||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|7739|10087|lyfalmen|V0254|9865|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||6361||6361|10087||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|11322|16915|lyfalmen|V0256|16059|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||11322||11322|16915||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|46666|75226|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||46666||46666|75226||1 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5189||5189|10015||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|956|2156|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||599||599|2156||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|1963|2787|lyfalmen|V0331|2787|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1057||1057|2787||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1850|2339|lyfalmen|V0088|2083|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||732||732|2339||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2348|2572|lyfalmen|V0089|2304|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||901||901|2572||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|8792|16851|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||8792||8792|16851||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4357|7329|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||4357||4357|7329||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|12927|19124|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||12927||12927|19124||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|806|2441|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||806||806|2441||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1179|2955|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1179||1179|2955||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4304|7256|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4304||4304|7256||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|295|1738|lyfalmen|V0230|1732|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||295||295|1738||1 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2218|3089|lyfalmen|V0693|3042|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1277||1277|3089||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|SEK|5006|8222|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||5006||5006|8222||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|14569|8795|lyfalmen|V0684|8208|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||5422||5422|8795||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2395|4628|lyfalmen|V0041|2547|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2395||2395|4628||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|11260|16830|lyfalmen|V0441|16830|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||11260||11260|16830||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1687|lyfalmen|V0060|1672|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||258||258|1687||2 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|1861|3893|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||1861||1861|3893||2 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|0|1|0|0|PMA|0|0|0|100|DKK|5282|7162|lyfalmen|V0657|6975|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||4236||4236|7162||1 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|75580|98504|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||75580||75580|98504||1 103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|2957|5402|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||2957||2957|5402||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2030|2994|lyfalmen|V0088|2041|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|2994||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2590|3581|lyfalmen|V0089|2258|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3581||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1845|3768|lyfalmen|V0069|2115|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3768||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1185|1913|lyfalmen|V0033|1882|2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||422||422|1913||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|4939|3771|lyfalmen|V0182|3758|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1772||1772|3771||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3473|3809|lyfalmen|V0334|3157|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3809||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|6528|3901|lyfalmen|V0335|3157|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1867||1867|3901||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1274|3085|lyfalmen|V0222|2945|2|5|0|3,6000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1274||1274|3085||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|221057|280723|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||221057||221057|280723||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|86985|112929|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||86985||86985|112929||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2810|5502|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||2810||2810|5502||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1992||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|6764|10642|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||6764||6764|10642||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2004|4090|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2004||2004|4090||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4804|7944|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4804||4804|7944||1 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|7508|11666|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||7508||7508|11666||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|5540|8957|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5540||5540|8957||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|2871|5283|lyfalmen|V0017|4661|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||2871||2871|5283||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|3719|6451|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3719||3719|6451||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|3216|5758|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||3216||3216|5758||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|77990|101552|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||77990|101552||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|9216|14017|lyfalmen|V0012|5230|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||9216||9216|14017||2 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|913|2588|lyfalmen|V0545|1862|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||913||913|2588||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2983|2846|lyfalmen|V0107|2846|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||1100||1100|2846||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008|31.05.2017|R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|10192|15360|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||10192||10192|15360||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008|31.05.2017|R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|12813|18968|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||12813||12813|18968||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1572|3495|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||1572||1572|3495||2 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1859|3890|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||1859||1859|3890||2 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1302|3124|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1302||1302|3124||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|2494|3124|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1302||1302|3124||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2492|4762|lyfalmen|V0191|3519|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2492||2492|4762||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|323158|407708|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||323158||323158|407708||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|12437|18450|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||12437||12437|18450||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6878|10799|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||6878||6878|10799||1 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2559|2933|lyfalmen|V0107|2846|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||1163||1163|2933||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|114343|148000|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||114343||114343|148000||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1111|2861|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1111||1111|2861||1 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3289|5859|lyfalmen|V0438|5859|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||3289||3289|5859||1 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|15140|19682|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||13332||13332|19682||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|653|2231|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||653||653|2231||1 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|9076|11496|lyfalmen|V0814|11496|2|28|0|8,7500|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7385||7385|11496||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|8627|lyfalmen|V0683|8208|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||5300||5300|8627||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1655|3610|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||1655||1655|3610||2 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2 108347|J05AX1401|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1014133|1267087|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1014133||1014133|1267087||1 108413|C10A00001|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|51005|67421|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||51005|67421||1 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|38700|51858|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||38700||38700|51858||1 108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|11760|10931|lyfalmen|V0726|10931|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||6974||6974|10931||2 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6917|10852|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||6917||6917|10852||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|52544|69368|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||52544||52544|69368||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|998|2705|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||998||998|2705||1 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|DKK|931|2613|lyfalmen|V0827|2215|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||931||931|2613||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17146|24932|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||17146||17146|24932||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|13727|20226|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||13727||13727|20226||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|1163|2933|lyfalmen|V0584|2933|2|28|0|7,4700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||1163||1163|2933||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|4067|6759|lyfalmen|V0585|6759|2|98|0|26,1300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||3943||3943|6759||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2126|4258|lyfalmen|V0586|4258|2|28|0|14,9300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2126||2126|4258||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|6896|10823|lyfalmen|V0587|10822|2|98|0|52,2700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||6896||6896|10823||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|12215|12939|lyfalmen|V0588|12939|2|98|0|104,5300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||8433||8433|12939||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|319|1771|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||319||319|1771||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6455|6427|lyfalmen|V0694|6153|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||3702||3702|6427||1 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1385|3238|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1385||1385|3238||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2571|lyfalmen|V0291|2571|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2571||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|4016|lyfalmen|V0292|4016|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|4016||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|7126|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4210||4210|7126||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|8214|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8214||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1087|2828|lyfalmen|V0065|1866|1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1087||1087|2828||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|18826|27244|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||18826||18826|27244||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3032|5505|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3032||3032|5505||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|65145|85306|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||65145||65145|85306||1 110820|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|68921|81363|lyfsjukr|||2|60|0||Icepharma hf|Mylan AB|Imatiníb||62028||62028|81363||2 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|0|GER|0|0|0|100|XEU|11352|14493|lyfalmen|||2|1|0||Actavis|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||9562||9562|14493||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2084|3881|lyfalmen|V0373|3881|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||1852||1852|3881||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|513|2038|lyfalmen|V0229|1986|1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||513||513|2038||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|14296|21009|lyfalmen|V0809|21009|1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||14296||14296|21009||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|143709|184523|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||143709||143709|184523||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1627|3571|lyfalmen|||2|100|0|5,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1627||1627|3571||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|40598|16472|lyfalmen|V0717|16472|2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||11000||11000|16472||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4668|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4910||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5476|8869|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5476||5476|8869||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|4933|8122|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||4933||4933|8122||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|1635|3582|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||1635||1635|3582||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2013|4102|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2013||2013|4102||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4156|6477|lyfalmen|V0681|6477|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3738||3738|6477||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|3457|6090|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3457||3457|6090||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|353588|445554|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||353588||353588|445554||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|428|1921|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||428||428|1921||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|542|2078|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||542||542|2078||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|825|2467|lyfalmen|||1|40|0|20,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||825||825|2467||1 113982|B05AA0510|RescueFlow|irl|||250|ml|6|pokar|60/75 g/l|B05AA05|01.03.2017||R|0|0|0|0|0|1|ARM|0|0|0|100|DKK|34615|46691|lyfsjukr|||1|1500|0||Williams & Halls efh|Pharmanovia A/S|Dextran||34615||34615|46691||2 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|682|2270|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||682||682|2270||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|15631|22846|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||15631|22846||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|24941|34456|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||24941|34456||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|2918|5348|lyfalmen|V0824|4400|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||2918||2918|5348||1 114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1552|3468|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1552||1552|3468||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|AEP|0|0|0|100|XEU|7804|12073|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||7804||7804|12073||2 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|4039|6891|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4039||4039|6891||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|11930|lyfalmen|V0420|11400|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||7700||7700|11930||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4281|7379|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4281||4281|7379||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1740|2477|lyfalmen|V0278|2477|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||832||832|2477||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2294|2532|lyfalmen|V0279|2532|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||872||872|2532||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6672|3729|lyfalmen|V0280|3729|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1742||1742|3729||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8225|3098|lyfalmen|V0282|2786|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1283||1283|3098||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|8594|lyfalmen|V0457|8594|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8594||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12373|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12373||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|17396|21290|lyfalmen|V0475|21290|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||14500||14500|21290||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20458|lyfalmen|V0540|20458|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20458||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|67466|88241|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||67466||67466|88241||1 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1345|3183|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1345||1345|3183||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|6250|9934|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||6250||6250|9934||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|857|2444|lyfalmen|V0158|2444|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||808||808|2444||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|2364|lyfalmen|V0276|2364|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||750||750|2364||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8069|12438|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8069||8069|12438||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1345|3183|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1345||1345|3183||1 115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|130|1511|lyfalmen|V0505|1511|1|25|0|12,5000|Vistor hf|TERALI PRODUCTS|Meklózín||130||130|1511||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|7372|11479|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||7372||7372|11479||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|36643|49256|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||36643||36643|49256||1 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2454|4709|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2454||2454|4709||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2481|4747|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||2481||2481|4747||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|1297|3117|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1297||1297|3117||1 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|13952|10324|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||6533||6533|10324||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|535|1977|lyfalmen|V0562|1745|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||469||469|1977||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|266|1698|lyfalmen|V0563|1685|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||266||266|1698||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|641|2198|lyfalmen|V0564|2034|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||629||629|2198||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|11176|16714|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||11176||11176|16714||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3155|5674|lyfalmen|V0081|5305|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3155||3155|5674||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|4356|7327|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||4356||4356|7327||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|4667|7755|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||4667||4667|7755||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|11982|17824|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||11982||11982|17824||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|396|1877|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||396|1877||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|6900|13261|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||6900||6900|13261||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1089|2831|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1089||1089|2831||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3116|5621|lyfalmen|V0435|5527|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3116||3116|5621||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|9489|12693|lyfalmen|V0275|10278|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||8254||8254|12693||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|16771|21415|lyfalmen|V0273|20877|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||14591||14591|21415||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1045|2770|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1045||1045|2770||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|26590|32528|lyfalmen|V0272|32528|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||23417||23417|32528||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|33541|45333|lyfalmen|V0261|43384|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||33541|45333||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|42520|56690|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||42520||42520|56690||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5185|8937|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||5185||5185|8937||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|4211|8160|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||4211||4211|8160||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|8171|15673|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||8171||8171|15673||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1277|3089|lyfalmen|V0278|2477|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1277||1277|3089||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2094|3629|lyfalmen|V0279|2532|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1669||1669|3629||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7152|3114|lyfalmen|V0282|2786|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1295||1295|3114||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1235|3032|lyfalmen|V0283|2638|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1235||1235|3032||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14424|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14424||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6672|4592|lyfalmen|V0280|3729|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2369||2369|4592||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|3804|7387|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||3804||3804|7387||2 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|15485|22645|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15485||15485|22645||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2158|4302|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2158||2158|4302||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|XEU|345|1807|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||345||345|1807||2 118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.09.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2795|2933|lyfalmen|V0107|2846|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||1163||1163|2933||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|GBP|919|2597|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||919||919|2597||2 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2800|4400|lyfalmen|V0824|4400|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2229||2229|4400||2 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|2880|5296|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||2880||2880|5296||2 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|680|1994|lyfalmen|V0309|1994|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||481||481|1994||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|239082|303141|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||239082||239082|303141||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|221961|281847|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||221961||221961|281847||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|822|2463|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Cýklópentólat||822||822|2463||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|30307|41243|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||30307||30307|41243||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|9728|lyfalmen|V0118|9728|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6100||6100|9728||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|20710|29104|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||20710||20710|29104||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|320006|403787|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||320006||320006|403787||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|3286|5855|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3286||3286|5855||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|5361|8711|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Rókúrón, brómíð||5361||5361|8711||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|403|1886|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||403||403|1886||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|364|1833|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||364||364|1833||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1205|2990|lyfalmen|V0314|2604|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1205||1205|2990||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|243|1666|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||243||243|1666||1 121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|209|1619|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||209||209|1619||1 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2619|4937|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2619||2619|4937||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||2 122354|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|12204|9000|lyfalmen|V0682|8208|2|56|0|18,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||5571||5571|9000||1 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7393|12743|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||7393||7393|12743||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|209784|266702|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||209784||209784|266702||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|420|1910|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||420||420|1910||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|607|2167|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||607||607|2167||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|1003|2712|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1003||1003|2712||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|21992|37905|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||21992||21992|37905||2 123435|N05AX1205|Aripiprazol Krka|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|5668|8764|lyfalmen|V0716|8623|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||5400||5400|8764||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|SEK|14738|21617|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||14738||14738|21617||1 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|16892|29115|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||16892||16892|29115||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|207|1617|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||207|1617||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|16461|23989|lyfalmen|V0579|21312|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||16461||16461|23989||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1285|2526|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1285|2526||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SNC|0|0|0|100|NOK|21816|30503|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||||21816|30503||1 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|22954|31942|lyfalmen|||0|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||22954||22954|31942||3 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|6667|10508|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||6667||6667|10508||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|706|2303|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||706||706|2303||1 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8034|12390|lyfalmen|V0464|12390|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||8034||8034|12390||1 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|645|2220|lyfalmen|V0066|2220|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||645||645|2220||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|XEU|8960|13664|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||8960||8960|13664||2 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|3534|lyfalmen|V0285|3461|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||1600||1600|3534||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|23998|33263|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||23998||23998|33263||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|47995|63614|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||47995||47995|63614||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|95991|124320|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||95991||95991|124320||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|1|0|1|FIN|0|1|0|100|DKK|95844|124134|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||95844||95844|124134||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|24251|33583|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||24251|33583||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2655|4986|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2655|4986||1 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|5262|8574|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||5262||5262|8574||2 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2354|4572|lyfalmen|V0011|4572|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2354||2354|4572||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2805|lyfalmen|V0313|2805|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2805||2 128034|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|10|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015|31.05.2017|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|504|2025|lyfalmen|||2|10|0|6,6700|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||504||504|2025||1 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|5201|8490|lyfalmen|V0279|2532|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5201||5201|8490||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10211|19543|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||10211||10211|19543||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|930|2612|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||930||930|2612||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2773|5149|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2773||2773|5149||1 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2433|lyfalmen|V0003|2003|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2433||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|20465|28794|lyfalmen|V0282|2786|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20465||20465|28794||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|228|1646|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||228||228|1646||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15968|23310|lyfalmen|V0680|23310|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||15968||15968|23310||2 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MAB|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Meda AB|Natríumhýdrógenkarbonat|||||2770||1 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2364|4586|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2364||2364|4586||1 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|7533|11496|lyfalmen|V0812|11496|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7385||7385|11496||2 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|14998|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14998||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1492|3385|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1492||1492|3385||2 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|225662|286450|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||225662||225662|286450||1 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|14558|27790|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||14558||14558|27790||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1166|2937|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1166||1166|2937||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|8034|12390|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||8034|12390||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|36902|59486|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||36902|59486||1 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|4991|9639|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||4991||4991|9639||2 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2139|4276|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2139|4276||2 131155|H05BX0104|Cinacalcet Mylan|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|32357|27112|lyfalmen|V0722|27112|2|28|0|42,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||18730||18730|27112||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|715|2316|lyfalmen|||2|100|0|33,3333|Vistor hf|Meda AB|Fenýtóín||715||715|2316||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|1177|2952|lyfalmen|||2|100|0|15,0000|Vistor hf|Meda AB Solna|Fenemal||1177||1177|2952||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|1334|3168|lyfalmen|||2|100|0|50,0000|Vistor hf|Meda AB Solna|Fenemal||1334||1334|3168||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|1897|3943|lyfalmen|||2|100|0|100,0000|Vistor hf|Meda AB Solna|Fenemal||1897||1897|3943||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|2847|5250|lyfalmen|||2|28|0|14,0000|Alvogen|Alvogen|Galantamín||2847||2847|5250||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3727|2880|lyfalmen|V0581|2295|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1125||1125|2880||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2317|2880|lyfalmen|V0580|2295|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1125||1125|2880||1 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|333566|420652|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||333566||333566|420652||1 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|7111|11119|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||7111||7111|11119||1 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|1929|2258|lyfalmen|V0089|2258|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||673||673|2258||2 132662|R05DA0403|Kodein Meda|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MAB|0|0|1|100|SEK|948|2637|lyfalmen|||2|100|0|25,0000|Vistor hf|Meda AB|Kódein||948||948|2637||1 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4452|7459|lyfalmen|V0681|6477|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4452||4452|7459||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4655|9002|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||4655|9002||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3396|lyfalmen|V0335|3157|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3396||2 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|422|1913|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Proxýmetakaín||422||422|1913||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993|31.05.2017|R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|891|2558|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||891||891|2558||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|17345|25205|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||17345||17345|25205||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|23063|32080|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||23063||23063|32080||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|31360|42574|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||31360|42574||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|BVB|0|0|0|100|DKK|166171|212460|lyfsjukr|||1|2|0||Lyfjaver ehf|Shire Services BVBA|C1 hemill||||166171|212460||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|6016|9612|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||6016||6016|9612||1 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|1876|3914|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||1876||1876|3914||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3618|lyfalmen|V0333|3618|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3618||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2317|4521|lyfalmen|V0378|3307|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2317||2317|4521||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6241|9922|lyfalmen|V0378|9922|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||6241||6241|9922||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGH|0|0|0|100|XEU|1914|3966|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||1914||1914|3966||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|42349|56473|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||42349||42349|56473||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|85009|110430|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||85009||85009|110430||2 134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3815|2708|lyfalmen|V0007|2708|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||1000||1000|2708||2 134920|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13615|lyfalmen|V0828|13615|2|100|0|11,1100|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13615||2 134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2061|4085|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||2000||2000|4085||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|289491|365835|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer AG|Riociguatum||289491||289491|365835||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|7328|11418|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7328||7328|11418||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990|30.04.2017|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|683|2272|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||683||683|2272||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|901|2572|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||901||901|2572||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988|31.05.2017|R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|891|2558|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||891||891|2558||1 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|28560|39033|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||28560||28560|39033||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MAB|0|0|0|100|SEK|4426|7424|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Ísóníazíð||4426||4426|7424||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|49043|64940|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||49043||49043|64940||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2279|4469|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2279||2279|4469||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|323|1776|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||323||323|1776||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól|||||||1 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|4175|7078|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||4175||4175|7078||1 137615|S01EE0106|Latanoprost Mylan|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.04.2017||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|642|2215|lyfalmen|V0376|1010|2|2,5|0|25,0000|Icepharma hf|Mylan AB|Latanóprost||642||642|2215||2 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TEV|0|0|0|100|IKR|39000|43384|lyfalmen|V0261|43384|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||32000||32000|43384||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|VOG|0|0|0|100|XEU|15193|22243|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||15193||15193|22243||1 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|1|0|0|0|1|VOG|0|0|0|100|XEU|4417|7411|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4417||4417|7411||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|VOG|0|0|0|100|XEU|3858|6642|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||3858||3858|6642||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|VOG|0|0|0|100|XEU|4360|7333|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4360||4360|7333||1 137881|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|8649|11986|lyfalmen|V0691|11986|2|90|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||7741||7741|11986||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|10231|5376|lyfalmen|V0689|4789|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2938||2938|5376||2 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2074|4186|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2074||2074|4186||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1172|2945|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1172||1172|2945||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12101|17988|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||12101||12101|17988||1 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2575|4876|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2575||2575|4876||2 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|3644|4884|lyfalmen|V0691|3995|2|30|0|18,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2581||2581|4884||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|1958|4016|lyfalmen|V0373|3881|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1950||1950|4016||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|86693|112560|lyfsjukr|||1|56|0|28,0000|Celgene AB|Celgene Europe Limited|Apremilast||86693||86693|112560||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|V0807|4226|0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4226||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|870|2529|lyfalmen|V0266|2104|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||870||870|2529||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|11346|12939|lyfalmen|V0588|12939|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||8433||8433|12939||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|7744|11991|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||7744||7744|11991||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4024|6870|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||4024||4024|6870||2 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|58584|111316|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||58584||58584|111316||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|39678|53095|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||39678||39678|53095||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|854|2507|lyfalmen|V0413|2332|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||854||854|2507||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2655|4986|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2655|4986||1 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2762|5133|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2762||2762|5133||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|11095|16603|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||11095|16603||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|30734|41783|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||30734||30734|41783||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2841|5242|lyfalmen|V0193|4320|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2841|5242||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|UAK|0|0|1|100|XEU|636|2207|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||636||636|2207||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2901||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|4244|7173|lyfalmen|V0492|7173|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||4244||4244|7173||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4675|7766|lyfalmen|V0267|3632|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||4675||4675|7766||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1258|2999|lyfalmen|V0127|2833|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1211||1211|2999||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|16353|23840|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||16353|23840||5 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3320|3968|lyfalmen|V0384|2967|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3968||2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|598|2155|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||598||598|2155||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2113|4240|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2113||2113|4240||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1544|3457|lyfalmen|||2|100|0|16,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||1544||1544|3457||2 142878|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|539|1607|lyfalmen|V0021|1607|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1607||2 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2043|3176|lyfalmen|V0049|3176|2|100|0|66,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1340||1340|3176||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16654||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1179|2955|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1179||1179|2955||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1594|3526|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1594||1594|3526||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|11643|6221|lyfalmen|V0687|6149|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3552||3552|6221||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|2535|4821|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||2535||2535|4821||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|411|1741|lyfalmen|V0542|1741|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||297||297|1741||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|773|2396|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Trópíkamíð||773||773|2396||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|961|2654|lyfalmen|V0173|2226|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||961||961|2654||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|4616|7685|lyfalmen|V0387|6721|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||4616||4616|7685||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|4644|7724|lyfalmen|V0386|5994|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||4644||4644|7724||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|411|1897|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||411||411|1897||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1143|2798|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1065||1065|2798||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGH|0|0|0|100|DKK|2062|4170|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2062||2062|4170||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1213|3001|lyfalmen|V0174|2226|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1213||1213|3001||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1468|3352|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1468||1468|3352||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|19540|28227|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||19540||19540|28227||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|48973|64851|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||48973||48973|64851||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2559|4854|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||2559||2559|4854||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|32653|44210|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||32653||32653|44210||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|7186|10822|lyfalmen|V0587|10822|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||6895||6895|10822||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|16327|23804|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||16327||16327|23804||1 144808|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|430|1924|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||430||430|1924||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|55182|72704|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||55182||55182|72704||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1261|2478|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1261||1261|2478||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1912|3758|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1912||1912|3758||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MAB|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Meda AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2942|5752|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2942||2942|5752||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4103|7955|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4103||4103|7955||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7122|11134|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7122||7122|11134||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4055|6913|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4055||4055|6913||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|21001|29472|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||21001||21001|29472||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|RGO|0|1|0|100|DKK|20264|28540|lyfsjukr|||1|1|0|4,8000|Vistor hf|Glaxo Group Limited|Belimumab||20264||20264|28540||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|6042|9648|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||6042||6042|9648||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|12539|18590|lyfalmen|V0817|15099|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12539||12539|18590||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|232|1651|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||232||232|1651||1 147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2252|4431|lyfsjukr|||2|20|0||Alvogen|Hospira Nordic AB|Cýtarabín||||2252|4431||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|3725|5848|lyfalmen|V0691|3995|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3281||3281|5848||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3204||1 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|1873|3910|lyfalmen|V0353|3849|2|30|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1873||1873|3910||2 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|6431|6149|lyfalmen|V0687|6149|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3500||3500|6149||2 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|79166|103039|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||79166||79166|103039||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|849|2297|lyfalmen|V0577|2297|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||701||701|2297||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1264|3072|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1264||1264|3072||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|4345|7023|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||4135||4135|7023||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|43538|57977|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||43538||43538|57977||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|43538|57977|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||43538||43538|57977||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGH|0|0|0|100|SEK|295|1668|lyfalmen|V0601|1668|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||244||244|1668||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|809|2445|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||809||809|2445||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81451|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81451||5 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|9646|14609|lyfsjukr|||2|10|0||Alvogen|Hospira Nordic AB|Vínkristín||9646||9646|14609||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|20635|29009|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||20635||20635|29009||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|2558|5024|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||2558||2558|5024||2 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|208374|264948|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||208374||208374|264948||1 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1730|3713|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1730||1730|3713||1 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3367|5966|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||3367||3367|5966||1 150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|135703|174566|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||135703||135703|174566||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|31195|42366|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||31195|42366||1 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4300|7250|lyfalmen|V0607|7180|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||4300||4300|7250||2 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|4505|7532|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||4505||4505|7532||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1010|2722|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1010||1010|2722||1 151250|J05AX6701|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AX67|01.10.2015||R|0|0|0|1|0|1|ABV|0|1|0|100|DKK|1392429|1737581|lyfsjukr|||1|56|0||Vistor hf|AbbVie Ltd.|Ombitasvir, paritaprevir og ritonavir||1392429||1392429|1737581||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|29465|40178|lyfalmen|V0607|7180|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||29465||29465|40178||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|298|1742|lyfalmen|V0633|1673|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||298||298|1742||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3206|5744|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||3206|5744||2 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|10143|8764|lyfalmen|V0682|8208|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||5400||5400|8764||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|840|2488|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||840||840|2488||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1768|3475|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1768|3475||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1104|2851|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1104||1104|2851||1 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|629|2198|lyfalmen|V0050|2198|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||629||629|2198||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1345|3183|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1345||1345|3183||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|1560|3460|lyfalmen|V0123|3460|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1546||1546|3460||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2080|4195|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2080||2080|4195||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3337|5925|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3337||3337|5925||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|6102|9731|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||6102||6102|9731||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152636|A02BC0113|Omeprazol Sandoz|sþ-hylki|10|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2513|3879|lyfalmen|V0002|3879|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1851||1851|3879||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|1882|lyfalmen|V0033|1882|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||400||400|1882||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|13254|19575|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||13254||13254|19575||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|4016|lyfalmen|V0182|3946|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||1950||1950|4016||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5235|8214|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||5000||5000|8214||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|781|2407|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||781||781|2407||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1156|2923|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1156||1156|2923||2 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1176|2158|lyfalmen|V0444|2023|2|5|0|25,0000|LYFIS ehf|ratiopharm GmbH|Brinzólamíð||600||600|2158||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|23397|32503|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||23397|32503||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1459|3340|lyfalmen|V0561|2868|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1459||1459|3340||2 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1021|2737|lyfalmen|V0560|2707|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1021||1021|2737||2 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|TCA|0|0|1|100|XEU|||lyfalmen|V0575|2210|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3332||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|151293|193956|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||151293||151293|193956||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|508|2031|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||508|2031||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|22743|31676|lyfalmen|V0452|31676|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||22743||22743|31676||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|2748|5114|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||2748||2748|5114||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|454|1957|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||454||454|1957||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|770|2392|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||770||770|2392||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|VBT|0|0|1|100|XEU|449|1950|lyfalmen|||2|30|0|30,0000|Medical ehf|Teva B.V.|Deslóratadín||449||449|1950||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|16432|15484|lyfalmen|V0183|15484|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||10282||10282|15484||1 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|6645|10478|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||6645||6645|10478||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14321|21043|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||14321||14321|21043||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16363|23854|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||16363||16363|23854||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20470|28801|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||20470||20470|28801||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18676|27037|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||18676||18676|27037||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18709|27083|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||18709||18709|27083||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22675|31590|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||22675||22675|31590||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|12210|18138|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||12210||12210|18138||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2325|4532|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2325||2325|4532||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18043|26166|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||18043||18043|26166||1 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1074|2810|lyfalmen|V0336|2288|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1074||1074|2810||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2470|3290|lyfalmen|V0334|3094|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1423||1423|3290||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4899|3290|lyfalmen|V0335|3094|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1423||1423|3290||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2092|4211|lyfalmen|V0901|3809|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2092||2092|4211||2 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1245|1889|lyfalmen|V0247|1889|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||405||405|1889||1 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2248|3040|lyfalmen|V0248|1973|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1241||1241|3040||1 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|4055|3425|lyfalmen|V0249|3425|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1521||1521|3425||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|12488|18520|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||12488||12488|18520||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1095|2839|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1095||1095|2839||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1347|2433|lyfalmen|V0466|2109|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2433||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|8539|5815|lyfalmen|V0253|5589|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3257||3257|5815||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|472|1981|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||472||472|1981||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|853|2506|lyfalmen|V0590|2506|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||853||853|2506||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2 155628|V08CA0101|Magnevist|stl|0,5|mmol/ml|20|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|48604|64385|lyfsjukr|||1|100|0||Icepharma hf|Bayer AB|Gadópentetat||48604||48604|64385||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4186|7093|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4186||4186|7093||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|16000|23354|lyfalmen|V0383|23354|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||16000||16000|23354||2 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|3803|6566|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3803||3803|6566||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4257|7191|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||4257||4257|7191||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|277|1713|lyfalmen|||2|15|0|3,7500|Vistor hf|Meda AB|Nítrófúrantóín||277||277|1713||1 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|PLA|0|0|0|100|DKK|6918|10854|lyfalmen|||1|84|0|28,0000|Icepharma hf|CHEPLAPHARM Arzneimittel GmbH|Orlístat||6918||6918|10854||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|479|1991|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||479||479|1991||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|IKR|6850|13166|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6850||6850|13166||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|30107|40990|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||30107|40990||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1076|2813|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1076||1076|2813||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|4738|7853|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||4738||4738|7853||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|711|2310|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||711|2310||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|18589|26918|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||18589|26918||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|32091|43499|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||32091|43499||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|42239|56334|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||42239||42239|56334||1 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2835|4076|lyfalmen|V0143|3531|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1994||1994|4076||1 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|235054|298131|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||235054|298131||2 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|659|2111|lyfalmen|V0469|2020|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||566||566|2111||2 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|10256|15099|lyfalmen|V0817|15099|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||10002||10002|15099||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1487|3059|lyfalmen|V0219|3059|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1255||1255|3059||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|2549|4798|lyfalmen|V0220|4798|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2518||2518|4798||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|3660|6023|lyfalmen|V0221|6018|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3408||3408|6023||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|3968|6491|lyfalmen|V0223|6491|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3748||3748|6491||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2295|lyfalmen|V0581|2295|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||700||700|2295||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|18124|lyfalmen|V0421|17284|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||12200||12200|18124||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|1|0|1|IPC|0|1|0|100|SEK|97094|125715|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||97094||97094|125715||1 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|338|1797|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||338||338|1797||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1024|2741|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1024||1024|2741||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|96790|125330|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||96790||96790|125330||1 159845|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|100|stk|1|þpakki||A02BC05|01.10.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|5271|5502|lyfalmen|||2|100|0|133,3300|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||3030||3030|5502||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2965|5796|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||2965||2965|5796||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|IKR|4411|3429|lyfalmen|V0010|2177|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1524||1524|3429||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|5319|4425|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2247||2247|4425||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1589|3519|lyfalmen|V0191|3519|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||1589||1589|3519||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|570|2116|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||570||570|2116||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2878|5293|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2878||2878|5293||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|NOK|822|2463|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||822||822|2463||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|482|1995|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||482||482|1995||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|651|2228|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||651||651|2228||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1039|2762|lyfalmen|V0169|2224|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1039||1039|2762||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1793|3800|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||1793||1793|3800||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|429|1922|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||429||429|1922||1 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1193|2320|lyfalmen|V0143|1177|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||718||718|2320||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|40491|54123|lyfalmen|V0452|31676|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||40491||40491|54123||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|4597|7659|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||4597|7659||2 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|21026|29504|lyfalmen|||1|90|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||21026||21026|29504||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|8682|13282|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||8682||8682|13282||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|103548|134574|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||103548||103548|134574||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|385668|485453|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||385668||385668|485453||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|3706|lyfalmen|V0020|3706|2|180|0|90,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||1725||1725|3706||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1429|3299|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1429||1429|3299||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|3993|7746|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||3993||3993|7746||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1845|2599|lyfalmen|V0041|2599|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||921||921|2599||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|387|1800|lyfalmen|V0500|1763|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||340||340|1800||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|580|2130|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||580||580|2130||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|500|2020|lyfalmen|V0502|1808|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||500||500|2020||2 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|984|2686|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||984||984|2686||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|7207|11251|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||7207||7207|11251||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|867|2525|lyfalmen|V0671|2226|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||867||867|2525||1 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2939|5377|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2939||2939|5377||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|961|2654|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||961||961|2654||1 163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1271|2846|lyfalmen|V0213|2846|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1100||1100|2846||2 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4464|7476|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4464||4464|7476||1 163389|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.09.2015||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||2 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8555|13107|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||8555||8555|13107||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1717|3695|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1717||1717|3695||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|370724|466866|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||370724||370724|466866||2 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1397|3255|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1397||1397|3255||1 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|430|1816|lyfalmen|||2|30|0|20,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||352||352|1816||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1185|2496|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Íbúprófen||846||846|2496||2 164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2801|5187|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2801||2801|5187||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|27926|38231|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||27926||27926|38231||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|6795|13062|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||6795||6795|13062||1 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|289491|365835|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||289491||289491|365835||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|752|2367|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||752||752|2367||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|924|2604|lyfalmen|V0314|2604|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||924||924|2604||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4033|6883|lyfalmen|V0014|6883|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4033|6883||2 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGH|0|0|0|100|XEU|1076|2813|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1076||1076|2813||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|4885|9438|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||4885||4885|9438||2 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|123843|159816|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||123843||123843|159816||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20782|29195|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||20782||20782|29195||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30259|41182|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||30259||30259|41182||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2017||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|450|1951|lyfalmen|V0904|1951|1|100|0|50,0000|Vistor hf|TERALI PRODUCTS|Meklózín||450||450|1951||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|130|1511|lyfalmen|V0505|1511|1|25|0|12,5000|Vistor hf|TERALI PRODUCTS|Meklózín||130||130|1511||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|TER|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|TERALI PRODUCTS|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|143709|184523|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||143709||143709|184523||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2960|5406|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2960||2960|5406||1 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40368|53968|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||40368||40368|53968||2 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|4226|8188|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||4226|8188||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3311|6452|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||3311|6452||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|298671|377253|lyfalmen|V0819|377253|1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||298671||298671|377253||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1207|2993|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1207||1207|2993||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|11040|16527|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||11040||11040|16527||1 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2665|2708|lyfalmen|V0113|2660|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1000||1000|2708||2 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1425|3048|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1247||1247|3048||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2698|5045|lyfalmen|V0428|5045|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||2698||2698|5045||2 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|104856|136201|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||104856||104856|136201||1 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|317|1768|lyfalmen|V0333|844|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||317||317|1768||1 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1267|2582|lyfalmen|V0005|2404|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||908||908|2582||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|125125|161410|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||125125||125125|161410||2 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|11400|lyfalmen|V0420|11400|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||7315||7315|11400||1 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|322|1775|lyfalmen|V0119|1775|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||322|1775||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|3892|3906|lyfalmen|V0007|2654|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3906||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|2426|4671|lyfalmen|V0458|2888|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||2426||2426|4671||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1974|4049|lyfalmen|V0621|2465|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||1974||1974|4049||1 168629|L04AX0307|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1701|3673|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||1701||1701|3673||2 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1868|3903|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||1868||1868|3903||2 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2224|4393|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2224||2224|4393||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2160|4305|lyfalmen|V0240|4303|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2160||2160|4305||1 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3986|6818|lyfalmen|V0433|6817|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||3986||3986|6818||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|19885|28701|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||19885||19885|28701||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|9007|5594|lyfalmen|V0688|5233|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3097||3097|5594||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|99423|128660|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||99423||99423|128660||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|14597|21423|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||14597||14597|21423||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3558|6229|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||3558||3558|6229||1 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|1168|2939|lyfalmen|V0411|2934|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1168||1168|2939||1 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|647|2222|lyfalmen|V0177|2222|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2222||1 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|638|2210|lyfalmen|V0418|2210|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||638||638|2210||1 169784|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|393|1873|lyfalmen|V0176|1873|2|10|0|2,5000|Alvogen|Alvogen ehf|Cíprófloxacín||393||393|1873||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1914|3966|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||1914||1914|3966||2 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2060|4167|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2060||2060|4167||2 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|15136|22165|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||15136|22165||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|37565|50422|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||37565|50422||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|3736|6474|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3736||3736|6474||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|74744|97446|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||74744||74744|97446||2 170486|C10A00001|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|146890|188480|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||146890|188480||1 170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|1665|3623|lyfalmen|V0618|3623|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||1665|3623||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|9177|13963|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||9177||9177|13963||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1566|3487|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||1566||1566|3487||2 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|8078|12450|lyfsjukr|||2|1600|0|6,6700|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||8078||8078|12450||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|19432|28078|lyfsjukr|||2|1600|0|20,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||19432||19432|28078||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|29148|39777|lyfsjukr|||2|2400|0|30,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||29148||29148|39777||1 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|25319|34934|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||25319|34934||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2372|2628|lyfalmen|V0203|2628|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||942||942|2628||1 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|||1158||1158|2276||2 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|40657|54333|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||40657||40657|54333||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1938|3809|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||1938||1938|3809||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2373|4598|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2373||2373|4598||2 171609|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.05.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|2983|lyfalmen|V0213|2789|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1200||1200|2983||2 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2396|4630|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2396||2396|4630||2 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|GBP|0|0|0|100|DKK|896|2565|lyfalmen|||1|30|0|20,0000|Icepharma hf|BGP Produtcs B.V.|Mebeverín||896||896|2565||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2014|4104|lyfalmen|V0247|1889|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2014||2014|4104||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3499|6148|lyfalmen|V0248|1973|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3499||3499|6148||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|31698|43002|lyfsjukr|||1|75|0||Icepharma hf|Bayer AB|Gadópentetat||31698||31698|43002||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|21132|29638|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadópentetat||21132||21132|29638||2 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|80131|104260|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||80131|104260||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6478|10248|lyfalmen|V0249|3425|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||6478||6478|10248||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|11789|17558|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||11789||11789|17558||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|48604|64385|lyfsjukr|||1|100|0||Icepharma hf|Bayer AB|Gadópentetat||48604||48604|64385||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33859|lyfalmen|||3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33859||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15916|23239|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||15916||15916|23239||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7128|11143|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||7128||7128|11143||1 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000|30.06.2017|R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|4470|7484|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||4470||4470|7484||2 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000|30.06.2017|R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8312|12772|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||8312||8312|12772||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1923|2104|lyfalmen|V0284|2087|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||561||561|2104||1 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000|30.06.2017|R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|14407|21162|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||14407||14407|21162||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|433211|544583|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||433211||433211|544583||1 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000|30.06.2017|R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|18549|26863|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||18549||18549|26863||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|269|1702|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||269||269|1702||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|7520|9680|lyfalmen|V0118|9533|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||6065||6065|9680||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2200|4360|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2200||2200|4360||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3180||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3768|6518|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||3768||3768|6518||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|9365|14222|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||9365||9365|14222||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|29458|14657|lyfalmen|V0684|14657|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9681||9681|14657||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|10223|15403|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||10223||10223|15403||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|1435|3307|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1435||1435|3307||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|402|1885|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||402||402|1885||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|410|1896|lyfalmen|||1|14|0|7,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||410||410|1896||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1014|2727|lyfalmen|V0368|1986|1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1014||1014|2727||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5323|lyfalmen|||2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5323||2 174615|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.01.2017||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|249|1674|lyfalmen|V0312|1534|2|30|0|30,0000|Icepharma hf|Mylan AB|Zópíklón||249||249|1674||2 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|8477|13000|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||8477||8477|13000||1 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3362|5959|lyfalmen|V0368|5959|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3362||3362|5959||1 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|37881|50822|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||37881||37881|50822||1 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|209784|266702|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||209784||209784|266702||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|0|0|TEV|0|0|0|100|IKR|1262|3069|lyfalmen|||2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|3069||2 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|6041|5900|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3319||3319|5900||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|3776|7334|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||3776||3776|7334||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|11235|16796|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||11235|16796||1 175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|388|1866|lyfalmen|V0065|1866|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||388||388|1866||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|1692|2162|lyfalmen|V0033|1882|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||603||603|2162||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|3524|6182|lyfalmen|V0278|2477|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3524||3524|6182||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2947|5388|lyfalmen|V0429|5388|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2947||2947|5388||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|1952|4018|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||1952||1952|4018||1 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4668|9027|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||4668||4668|9027||2 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|304821|384902|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||304821||304821|384902||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5824|9348|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||5824||5824|9348||2 177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|0|0|100|DKK|394006|495823|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||394006||394006|495823||1 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|584|2136|lyfalmen|V0231|2136|2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||584||584|2136||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|3241|6319|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||3241||3241|6319||2 177652|V08CA0101|Magnevist|stl|0,5|mmol/ml|15|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|31698|43002|lyfsjukr|||1|75|0||Icepharma hf|Bayer AB|Gadópentetat||31698||31698|43002||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|6629|8680|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||5339||5339|8680||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|24251|33583|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||24251||24251|33583||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|629262|788415|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||629262||629262|788415||1 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4998|2708|lyfalmen|V0320|2708|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1000||1000|2708||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|100356|130604|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||100356||100356|130604||1 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|6846|10755|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||6846|10755||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|12662|18760|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||12662||12662|18760||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|82629|107419|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||82629||82629|107419||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|3510|6163|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||3510||3510|6163||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|3396|lyfalmen|V0148|3383|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1500||1500|3396||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|564|2108|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||564||564|2108||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|6924|10862|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||6924||6924|10862||1 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4334|7297|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||4334||4334|7297||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5032||2 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2116|lyfalmen|V0556|2116|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|2116||1 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|8511|13046|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||8511||8511|13046||1 182435|A10BB0903|Gliclazid LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|4497|lyfalmen|V0020|3706|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2300||2300|4497||2 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11533|17206|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||11533||11533|17206||2 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|12162|15099|lyfalmen|V0817|15099|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||10002||10002|15099||1 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|11679|22328|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||11679||11679|22328||1 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|14607|27883|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||14607|27883||2 182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|24478|21913|lyfalmen|V0636|21913|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||14953||14953|21913||1 182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|1|0|1|AHL|0|0|0|100|IKR|9983|4667|lyfsjukr|||2|5|0|1,0000|Alvogen|Accord Healthcare Limited|Zoledronsýra||2423||2423|4667||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2574|4875|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2574||2574|4875||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|3818|7414|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||3818||3818|7414||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1348|2270|lyfalmen|V0234|1453|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||682||682|2270||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4099|6974|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4099|6974||1 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4931|9526|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||4931||4931|9526||2 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|842|2491|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Flúdrókortisón||842||842|2491||2 184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|590207|739842|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||590207|739842||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|549|2087|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||549||549|2087||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1517|2568|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||898||898|2568||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|2419|4661|lyfalmen|V0017|4661|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||2419|4661||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|36003|48447|lyfalmen|V0185|11017|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||36003||36003|48447||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1138|2693|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||989||989|2693||1 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|0|PHM|0|0|0|100|XEU|9053|17346|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||9053||9053|17346||2 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3362|5186|lyfalmen|V0690|5186|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||2800||2800|5186||2 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|LYFIS ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|0|ASR|0|0|0|100|IKR|985|1862|lyfalmen|V0545|1862|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||385||385|1862||2 186052|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|20|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015|31.05.2017|R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1007|2718|lyfalmen|||2|20|0|13,3400|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1007||1007|2718||1 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|13753|13031|lyfalmen|V0419|13031|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|13031||1 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|681|2269|lyfalmen|V0597|2269|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||681||681|2269||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|9294|7327|lyfalmen|V0607|7327|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Memantín||4356||4356|7327||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4412|7404|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4412||4412|7404||1 187032|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|100|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015|31.05.2017|R|1|0|1|0|0|0|GPA|0|0|1|100|XEU|3011|5476|lyfalmen|||2|100|0|66,6600|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||3011||3011|5476||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|3215|5457|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||2997||2997|5457||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4716|lyfalmen|V0462|4716|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4716||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4130|7118|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4130||4130|7118||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2951|5394|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||2951||2951|5394||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2565||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|54655|72038|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||54655||54655|72038||1 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1113|2465|lyfalmen|V0621|2465|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||823||823|2465||1 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|12425|18434|lyfalmen|V0726|10202|1|28|0|28,0000|Vistor hf|Teva B.V.|Rasagilín||12425||12425|18434||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2072|4184|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2072||2072|4184||1 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|4155|7051|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||4155||4155|7051||1 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|2826|5221|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||||2826|5221||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|1|0|1|PSA|0|0|0|100|DKK|6836|10741|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||6836||6836|10741||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|30999|42118|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||30999||30999|42118||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5070|8310|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||5070||5070|8310||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|3765|6514|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||3765||3765|6514||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2003|4089|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2003||2003|4089||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|727|2332|lyfalmen|V0413|2332|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||727||727|2332||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|352|1816|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||352||352|1816||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|326|1780|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||326||326|1780||1 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1209|2996|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1209||1209|2996||2 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|191|1595|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||191||191|1595||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|5468|8858|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer AB|Nífedipín||||5468|8858||2 190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|16754|24392|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||16754||16754|24392||1 190894|N04BC0507|Pramipexole Sandoz|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.09.2015|30.04.2017|R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|10179|13679|lyfalmen|||2|100|0|20,8000|Artasan ehf|Sandoz A/S|Pramipexól||8971||8971|13679||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3220||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2735|5096|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2735||2735|5096||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|4950|6218|lyfalmen|V0117|6026|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||3550||3550|6218||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2577|4879|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2577||2577|4879||1 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|1754|2041|lyfalmen|V0088|2041|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||515||515|2041||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2688|5032|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2688||2688|5032||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|369|1840|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||369||369|1840||1 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|16790|8552|lyfalmen|V0689|8552|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||5246||5246|8552||1 192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|809|1590|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||809||809|1590||1 192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|29972|18866|lyfalmen|V0721|15199|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||12739||12739|18866||1 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||1 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2708|5059|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2708||2708|5059||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|3389|5389|lyfalmen|V0429|5388|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||2948||2948|5389||1 192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|450|1951|lyfalmen|V0904|1951|1|100|0|50,0000|Vistor hf|TERALI PRODUCTS|Meklózín||450||450|1951||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1340|3176|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1340||1340|3176||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4625|7698|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4625||4625|7698||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5098|8349|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5098||5098|8349||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|IRE|0|1|0|100|XEU|124670|160844|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||124670||124670|160844||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1925|2270|lyfalmen|V0233|1897|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||682||682|2270||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|662|2243|lyfalmen|V0447|2233|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||662||662|2243||1 193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|20519|15199|lyfalmen|V0721|15199|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||10075||10075|15199||2 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|15905|23223|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||15905||15905|23223||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2594||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|29315|47256|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||29315||29315|47256||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|2031|2158|lyfalmen|V0556|2116|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|2158||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|3868|7509|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||3868||3868|7509||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4577|5230|lyfalmen|V0012|5230|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2832||2832|5230||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1178|2953|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1178||1178|2953||2 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13154||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|41281|55122|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||41281||41281|55122||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|99538|128806|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||99538||99538|128806||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|701|2297|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||701||701|2297||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|468|1976|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||468||468|1976||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|627|2195|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Fenýlprópanólamín||627||627|2195||1 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|799|2432|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Fenýlprópanólamín||799||799|2432||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1505|3403|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1505||1505|3403||2 196106|C10AA0107|Simvastatin LYFIS|filmhtfl|40|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2047|2502|lyfalmen|V0110|2383|2|100|0|133,3333|LYFIS ehf|LYFIS ehf|Simvastatín||850||850|2502||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1681|3645|lyfalmen|||2|100|0|75,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3645||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|GBP|5048|8280|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5048||5048|8280||2 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|15598|22801|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||15598|22801||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|564|1882|lyfalmen|V0119|1775|2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||400||400|1882||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|1|0|1|VOG|0|1|0|100|XEU|44810|59586|lyfsjukr|||2|1|0|26,6700|Alvogen HS|Hospira UK Ltd.|Infliximab||44810||44810|59586||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1186|2964|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1186||1186|2964||2 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|154381|197796|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||154381||154381|197796||1 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1883|2158|lyfalmen|V0069|2158|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||600||600|2158||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|5050|8283|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||5050||5050|8283||1 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2642|4968|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2642||2642|4968||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|25479|35136|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||25479||25479|35136||1 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|5908|9464|lyfalmen|||1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||5908|9464||2 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|445|1944|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||445||445|1944||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|66272|86731|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||66272|86731||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3286|5855|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||3286||3286|5855||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997|30.04.2017|R|0|0|0|0|0|1|BBV|0|0|0|100|SEK|39428|52779|lyfsjukr|||1|5|0|0,4000|Vistor hf|Janssen-Biologics B.V.|Abciximab||39428||39428|52779||1 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|1816842|2265432|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||1816842||1816842|2265432||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|435|1930|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||435||435|1930||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|27590|52514|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||27590||27590|52514||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1222|2999|lyfalmen|||2|20|0|7,5000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2999||2 370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|0|0|1|0|1|ALO|0|1|0|100|XEU|180441|230208|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||180441||180441|230208||1 371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|5007|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||5007||1 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|6407|10150|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||6407||6407|10150||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||7660||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|600639|752816|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration Limited|Alectinib hydrochloride||600639||600639|752816||2 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3538|6201|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3538||3538|6201||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2452|4707|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2452||2452|4707||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2349||2 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|5144|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5144||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|8798|13441|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||8798||8798|13441||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|67688|88522|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||67688||67688|88522||2 373252|N05AX1205|Aripiprazol Krka|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3507|6159|lyfalmen|V0204|6159|2|28|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||3507||3507|6159||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50/100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2734|5095|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||2734||2734|5095||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50/250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3284|5852|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3284||3284|5852||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50/500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4200|7113|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4200||4200|7113||1 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|2986|5442|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2986||2986|5442||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|4452|4806|lyfalmen|V0420|3800|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||2524||2524|4806||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|312|1746|lyfalmen|V0541|1746|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||301||301|1746||1 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|5963|9539|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||5963||5963|9539||3 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEA|0|0|0|100|SEK|249433|316014|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||249433||249433|316014||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|157315|201445|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||157315||157315|201445||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|362|1830|lyfalmen|V0500|1763|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||362||362|1830||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4116|6997|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4116||4116|6997||1 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|5864|7113|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|7113||2 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2696|5043|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2696||2696|5043||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|7627|11830|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||7627||7627|11830||1 374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|0|0|100|DKK|394006|495823|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||394006||394006|495823||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|3200|5736|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||3200||3200|5736||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|4845|8000|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4845||4845|8000||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5718|9202|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5718||5718|9202||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|6697|10550|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6697||6697|10550||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|8525|13066|lyfalmen|V0383|11677|2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||8525||8525|13066||2 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|5331|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2720||2720|5331||2 375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4000|4085|lyfalmen|V0605|4085|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2000||2000|4085||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|19891|28710|lyfalmen|V0459|28710|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||19891||19891|28710||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4430|7429|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4430||4430|7429||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12748|18878|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12748||12748|18878||1 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|65489|85741|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||65489||65489|85741||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|611302|766078|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||611302||611302|766078||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|8955|15435|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||8955||8955|15435||2 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|151554|194280|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||151554||151554|194280||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|7387|5959|lyfalmen|V0182|3946|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||3362||3362|5959||1 378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|401213|504786|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||401213||401213|504786||2 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1392|3248|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1392||1392|3248||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|4783|4041|lyfalmen|V0733|4041|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1968||1968|4041||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|11511|17176|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||11511||11511|17176||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1247|3048|lyfalmen|V0677|2231|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1247||1247|3048||1 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|108538|140780|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||108538|140780||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|70567|92163|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||70567||70567|92163||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|92821|120310|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||92821||92821|120310||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|119873|154878|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||119873||119873|154878||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|101689|132262|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||101689||101689|132262||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4103|5559|lyfalmen|V0532|5559|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3071||3071|5559||1 379875|N05BA0105|Stesolid|innhl|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|1574|3498|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1574||1574|3498||1 379883|N05BA0105|Stesolid|innhl|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|2245|4422|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2245||2245|4422||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14716|21587|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||14716||14716|21587||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1144|2906|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1144||1144|2906||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|20805|29224|lyfalmen|V0653|29224|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||20805|29224||1 380486|N06AB0606|Sertralin Hexal|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1395|2653|lyfalmen|V0322|2653|2|100|0|100,0000|Artasan ehf|Hexal A/S|Sertralín||960||960|2653||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|17988|19913|lyfalmen|V0195|19913|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||13500||13500|19913||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3868|4675|lyfalmen|V0902|4675|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2429||2429|4675||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011|30.06.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2231|3845|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2231||2231|3845||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|31654|42946|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||31654|42946||1 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|233477|296170|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||233477||233477|296170||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5626|7874|lyfalmen|V0533|7874|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||4753||4753|7874||1 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3552|6221|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3552||3552|6221||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4376|7355|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||4376||4376|7355||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|906|1562|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||906||906|1562||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1006|2716|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1006||1006|2716||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|27907|38207|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||27907||27907|38207||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2433|lyfalmen|V0006|1054|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||800||800|2433||2 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|4944|8137|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||4944||4944|8137||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5343|8686|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5343||5343|8686||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|298087|376526|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||298087||298087|376526||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|10809|8744|lyfalmen|V0111|8744|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||5385||5385|8744||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6759|10635|lyfalmen|V0670|10635|1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||6759||6759|10635||1 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|104703|136011|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||104703||104703|136011||2 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|653|2169|lyfalmen|V0308|2169|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||608||608|2169||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|81983|106602|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||81983||81983|106602||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4056|7866|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4056||4056|7866|| 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10566|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10566||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|4731|7844|lyfalmen|||2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||4731||4731|7844||2 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|106022|137651|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||106022||106022|137651||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2018|4109|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2018||2018|4109||2 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2202|4363|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||2202||2202|4363||2 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|7261|11326|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||7261||7261|11326||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|3965|6789|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur||3965||3965|6789||2 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|47523|27322|lyfalmen|V0722|27112|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||18883||18883|27322||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6887|10811|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||6887||6887|10811||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|1804|3815|lyfalmen|V0410|3815|1|84|0|84,0000|Vistor hf|Meda AB|Noretísterón og östrógen||1804||1804|3815||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|1284|3099|lyfalmen|||1|84|0|84,0000|Vistor hf|Meda AB|Noretísterón og östrógen||1284||1284|3099||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|492|2009|lyfalmen|V0128|2009|1|84|0|84,0000|Vistor hf|Meda AB|Estradíól||492||492|2009||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|391|1870|lyfalmen|||1|84|0|42,0000|Vistor hf|Meda AB|Estradíól||391||391|1870||1 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|313406|395579|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||313406|395579||2 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|602|2160|lyfalmen|V0367|1455|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||602||602|2160||1 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2304|3632|lyfalmen|V0267|3632|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1671||1671|3632||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|31927|43292|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||31927|43292||2 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|12114|18005|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12114||12114|18005||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|57975|76237|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||57975||57975|76237||1 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|4931|8119|lyfalmen|V0429|5388|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||4931||4931|8119||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1954|4021|lyfalmen|V0037|2425|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1954||1954|4021||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|16626|24216|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||16626|24216||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|9533|14453|lyfalmen|V0196|6196|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||9533||9533|14453||1 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|188925|240759|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||188925||188925|240759||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|994393|1242536|lyfsjukr|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||994393|1242536||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|190099|150183|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||116098||116098|150183||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1554|3471|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1554||1554|3471||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|393|1873|lyfalmen|V0545|1862|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||393||393|1873||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|136840|175980|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||136840||136840|175980||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|10217|15394|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||10217||10217|15394||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3218|4798|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2518||2518|4798||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|19726|28483|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||19726||19726|28483||2 393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2158|lyfalmen|V0109|2050|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||600||600|2158||2 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3308||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|50538|66831|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||50538||50538|66831||3 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|1633|3432|lyfalmen|V0669|3432|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1526||1526|3432||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|58389|76761|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||58389||58389|76761||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|105103|135696|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||104450||104450|135696||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4521|7554|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4521||4521|7554||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3710|2708|lyfalmen|V0679|2708|2|98|0|196,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1000||1000|2708||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|13127|19400|lyfalmen|V0356|19400|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||13127||13127|19400||3 395954|V08CA0101|Magnevist|stl|0,5|mmol/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|126792|163483|lyfsjukr|||1|300|0||Icepharma hf|Bayer AB|Gadópentetat||126792||126792|163483||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3499|6148|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3499||3499|6148||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2863|5272|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2863||2863|5272||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|15056|28735|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||15056||15056|28735||2 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2571|lyfalmen|V0006|1054|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||900||900|2571||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3977|7716|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||3977||3977|7716||1 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4186|3947|lyfalmen|V0686|3947|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1900||1900|3947||2 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|1849|2298|lyfalmen|V0250|1924|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||702||702|2298||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|19225|27793|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||19225||19225|27793||2 397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|1686|2983|lyfalmen|V0337|2983|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1200||1200|2983||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|3856|6639|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||3856||3856|6639||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|22176|30958|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||22176||22176|30958||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5662||1 398759|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|14373|13761|lyfalmen|V0622|13627|2|90|0|162,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||9030||9030|13761||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2399|4085|lyfalmen|V0012|2929|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|4085||2 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|132743|170885|lyfsjukr|||1|1|0|27,7700|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||132743||132743|170885||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|22312|31130|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||22312|31130||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|425|1917|lyfalmen|V0225|1679|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||425||425|1917||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|1909|2480|lyfalmen|V0244|2257|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||834||834|2480||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6379|10112|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||6379||6379|10112||1 399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|0|0|100|DKK|394006|495823|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||394006||394006|495823||1 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|DKK|2302|4500|lyfalmen|V0824|4400|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||2302||2302|4500||1 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|856|2510|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||856||856|2510||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1911|3962|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||1911||1911|3962||1 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|41195|55014|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||41195||41195|55014||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|158|1549|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||158||158|1549||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|272|1706|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||272||272|1706||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|137|1520|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||137||137|1520||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|3811|6577|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||3811||3811|6577||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|133192|171443|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||133192||133192|171443||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|1648|2425|lyfalmen|V0037|2425|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||794||794|2425||2 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|702|2226|lyfalmen|V0173|2226|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||650||650|2226||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|6872|10790|lyfalmen|V0459|9570|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||6872||6872|10790||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|583|2134|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||583||583|2134||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|855|2509|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||855||855|2509||1 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|457|1875|lyfalmen|V0038|1757|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||395||395|1875||2 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1006|2716|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1006||1006|2716||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|643618|806270|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||643618||643618|806270||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1405|2761|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1405||1405|2761||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|9953|15031|lyfalmen|V0349|15031|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9953||9953|15031||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|3991|3534|lyfalmen|V0552|3410|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3534||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|3632|7061|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||3632||3632|7061||1 403524|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|24606|12481|lyfalmen|V0683|8208|2|56|0|37,3300|LYFIS ehf|ratiopharm GmbH|Aripiprazól||8100||8100|12481||2 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|26136|35967|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||26136|35967||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|748|2361|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||748||748|2361||1 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|13107|19372|lyfalmen|||1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||13107||13107|19372||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2239||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|46035|61135|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||46035||46035|61135||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|850|2502|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||850||850|2502||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|484|1998|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||484||484|1998||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|7244|11302|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||7244||7244|11302||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1398|3256|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3256||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2236|3854|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2236||2236|3854||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2136||1 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|2436|4360|lyfalmen|V0467|4360|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2200||2200|4360||2 405535|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.11.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|3000|5461|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3000||3000|5461||2 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|12658|18754|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||12658||12658|18754||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2580|4883|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||2580||2580|4883||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|12975|19191|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||12975||12975|19191||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|346|1808|lyfalmen|V0502|1808|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||346||346|1808||1 406106|C10A00001|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|146890|188480|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||146890|188480||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14019|20628|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||14019||14019|20628||1 406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|1|0|100|SEK|527820|662250|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||527820||527820|662250||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|42279|56385|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||42279||42279|56385||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|48729|64543|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||48729||48729|64543||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1241|3040|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1241||1241|3040||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|51116|67562|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||51116||51116|67562||1 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|AGH|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin|||||3566||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13065|24957|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||13065|24957||2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|118|1494|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||118||118|1494||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|244|1668|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||244||244|1668||1 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|24226|33551|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||24226||24226|33551||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|12030|17890|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||12030||12030|17890||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|3242|lyfalmen|V0020|1853|2|90|0|45,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||1388||1388|3242||1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1380|2910|lyfalmen|V0310|2910|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1147||1147|2910||2 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3367|5966|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||3367||3367|5966||2 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|7533|11496|lyfalmen|V0813|11496|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7385||7385|11496||2 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2317|3994|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2317||2317|3994||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|2722|5078|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||2722||2722|5078||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2606|4919|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2606||2606|4919||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6614|10435|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6614||6614|10435||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|45048|59887|lyfalmen|V0728|59887|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||45048||45048|59887||1 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|12182|13419|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8782||8782|13419||1 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|44534|59237|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||44534||44534|59237||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|5362|8712|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||5362||5362|8712||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5650|4360|lyfalmen|V0234|4360|2|18|0|36,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4360||2 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|12199|18122|lyfalmen|V0651|18122|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||12199||12199|18122||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5534|6247|lyfalmen|V0196|6196|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3571||3571|6247||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2606|4919|lyfalmen|V0620|4357|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||2606||2606|4919||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|2619|4440|lyfalmen|V0093|4440|2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2258||2258|4440||1 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|HUN|0|1|0|100|DKK|38988|52222|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||38988||38988|52222||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|729|2335|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||729||729|2335||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RAT|0|0|0|100|IKR|672|2257|lyfalmen|||2|14|0|7,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||672||672|2257||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|436|1932|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||436||436|1932||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1177|2952|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1177||1177|2952||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|341|1745|lyfalmen|V0230|1732|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Paracetamól||300||300|1745||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1805|2281|lyfalmen|V0692|2206|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||690||690|2281||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4585|7643|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4585||4585|7643||2 411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13615|lyfalmen|V0829|13615|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13615||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5069|5472|lyfalmen|V0624|3753|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3008||3008|5472||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|16824|24488|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Lamívúdín||16824||16824|24488||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyfalmen|V0554|1750|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||2126||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4387|7370|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4387||4387|7370||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|14028|19828|lyfalmen|V0183|15484|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||13438||13438|19828||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|2146|4286|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2146||2146|4286||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2194|4312|vetalmen|||0|100|0||Vistor hf|Merial|||2194||2194|4312||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|3481|6775|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||3481||3481|6775||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|72736|94907|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||72736||72736|94907||2 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|37515|50359|lyfalmen|V0711|24725|1|112|0|112,0000|Vistor hf|Teva B.V.|Rasagilín||37515||37515|50359||1 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|38023|51002|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||38023||38023|51002||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2189|4345|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2189||2189|4345||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2259|4441|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2259||2259|4441||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|23804|33018|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||23804||23804|33018||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11250|6168|lyfalmen|V0342|6045|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||3514||3514|6168||2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|92419|119802|lyfsjukr|||1|12|0|24,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||92419||92419|119802||1 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|29417|40117|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||29417||29417|40117||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|903|2575|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||903||903|2575||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|866|2524|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||866||866|2524||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1681|3645|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1681||1681|3645||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|143709|184523|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||143709||143709|184523||1 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|99999|129389|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||99999||99999|129389||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5998|5589|lyfalmen|V0253|5589|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3093||3093|5589||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|1342|2638|vetalmen|||0|30|0||Icepharma hf|VETCOOL BV.|Vedaprófen||1342||1342|2638||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|6710|7421|lyfalmen|V0088|2041|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||4424||4424|7421||1 416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3568|2923|lyfalmen|V0686|2210|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1156||1156|2923||1 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3067|5553|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||3067||3067|5553||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2041|4141|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2041||2041|4141||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|714|2315|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||714||714|2315||2 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|27537|37739|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Abacavír||27537||27537|37739||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PHH|0|1|0|100|DKK|70239|91749|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||70239||70239|91749||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|22776|31717|lyfalmen|V0460|31717|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||22776|31717||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|20914|8795|lyfalmen|V0682|8208|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||5422||5422|8795||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|95182|123296|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||95182||95182|123296||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|4216|7135|lyfalmen|V0014|6883|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4216||4216|7135||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1951|4017|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||1951||1951|4017||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|5919|9479|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||5919||5919|9479||1 419385|J01FA0901|Klacid|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.03.2017||R|1|0|0|0|0|0|DUT|0|0|1|100|DKK|3105|5605|lyfalmen|V0116|4738|1|14|0|14,0000|Icepharma hf|BGP Products AB|Klaritrómýcín||3105||3105|5605||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|35179|47405|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||35179||35179|47405||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5260|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5260||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|28166|38535|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||28166||28166|38535||3 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|9683|14659|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||9683||9683|14659||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|479|1991|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||479||479|1991||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8523|13063|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||8523||8523|13063||1 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|112766|146039|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||112766||112766|146039||2 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|1882|lyfalmen|V0006|1882|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||400||400|1882||2 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|2242|2708|lyfalmen|V0479|2708|2|60|0|6,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1000||1000|2708||2 420568|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|919|2020|lyfalmen|V0023|2020|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2020||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|897|2566|lyfalmen|V0036|2280|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||897||897|2566||1 421729|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|11653|12511|lyfalmen|V0624|12511|2|100|0|120,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||8122||8122|12511||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|23919|45550|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||23919||23919|45550||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|VBT|0|0|1|100|XEU|1580|3209|lyfalmen|V0458|3209|2|100|0|100,0000|Medical ehf|Teva B.V.|Deslóratadín||1364||1364|3209||2 421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|428|1921|lyfalmen|V0596|1921|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||428||428|1921||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2181|4334|lyfalmen|V0049|3112|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2181||2181|4334||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3585|6266|lyfalmen|V0054|4923|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||3585||3585|6266||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|45674|60679|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||45674||45674|60679||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2206|4368|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2206||2206|4368||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|6753|10627|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||6753||6753|10627||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2280|4470|lyfalmen|V0192|3252|1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2280|4470||2 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2199|4085|lyfalmen|V0011|2560|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|4085||2 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|15441|22585|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||15441||15441|22585||1 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|4154|7049|lyfalmen|V0373|3881|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4154||4154|7049||2 424114|V08CA0101|Magnevist|stl|0,5|mmol/ml|10|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|21132|29638|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadópentetat||21132||21132|29638||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|691|2283|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||691||691|2283||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3082|5574|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3082||3082|5574||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1271|3081|lyfalmen|V0213|2846|2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||1271||1271|3081||1 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|11340|16940|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||11340||11340|16940||2 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|433|1928|lyfalmen|||1|20|0|5,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||433||433|1928||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|566|2111|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||566||566|2111||1 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6008|9601|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6008||6008|9601||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|USD|5699|9176|lyfalmen|V0658|9176|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||5699||5699|9176||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||3102||1 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2023||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|30107|40990|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||30107|40990||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|31730|lyfalmen|||3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31730||2 429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|858|2513|lyfalmen|V0129|2513|2|64|0||Vistor hf|Takeda Oy|Estradíól||858||858|2513||1 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2534|4820|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2534||2534|4820||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|68257|89242|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||68257||68257|89242||1 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|9076|11496|lyfalmen|V0812|11496|2|28|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7385||7385|11496||1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3206|5744|lyfalmen|V0093|4440|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3206||3206|5744||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|7287|11362|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||7287||7287|11362||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|749|2363|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||749||749|2363||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1505|3403|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1505||1505|3403||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3616|6173|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||3164||3164|6173||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|68363|89376|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||68363||68363|89376||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|13990|4504|lyfalmen|V0184|4504|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2305||2305|4504||2 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8900|12240|lyfalmen|||2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||7925||7925|12240||2 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|4437|7439|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||4437||4437|7439||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|16413|23923|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||16413|23923||2 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|701|2297|lyfalmen|V0173|2226|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||701||701|2297||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|838|2485|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||838||838|2485||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|6928|10867|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||6928||6928|10867||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|999|2707|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||999|2707||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3071|5559|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3071||3071|5559||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17430|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17430||2 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|1|0|1|TPA|0|1|0|100|DKK|262131|331807|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||262131||262131|331807||1 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1465|3348|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1465||1465|3348||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3259|lyfalmen|V0693|3259|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1400||1400|3259||2 432482|N03AX1211|Gabapentin PCD|hylki|400|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|2200|2667|lyfalmen|V0251|2667|2|120|0|26,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||970||970|2667||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|DKK|26342|36228|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||26342|36228||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2490|4894|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2490||2490|4894||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||2010||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|8419|12920|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||8419||8419|12920||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1774|3773|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||1774||1774|3773||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3898|6697|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||3898||3898|6697||1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|329590|415707|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||329590||329590|415707||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|122491|158134|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||122491||122491|158134||2 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|4552|2247|lyfalmen|V0490|2247|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||665||665|2247||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|54633|83608|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||51866||51866|83608||1 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||15098||15098|28814||2 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6010|9604|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||6010||6010|9604||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3272|3809|lyfalmen|V0010|3809|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3809||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|575|2123|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||575||575|2123||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4113|6993|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4113||4113|6993||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4729|7841|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4729||4729|7841||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|7253|11315|lyfalmen|V0315|4770|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||7253||7253|11315||2 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|0|1|0|1|AMI|0|0|0|100|DKK|1775289|2213752|lyfsjukr|||1|14|0||Vistor hf|Amicus Therapeuticks UK Ltd.|Migalastat||1775289||1775289|2213752||1 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|3209|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3681||1 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|153960|197273|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||153960||153960|197273||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999|30.04.2017|R|1|0|0|0|0|0|HES|0|0|0|100|DKK|2584|4888|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||2584||2584|4888||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|30486|41469|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||30486||30486|41469||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|790|2419|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||790||790|2419||1 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|51770|68389|lyfsjukr|||1|60|0|0,7500|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||51770||51770|68389||3 436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|2052|lyfalmen|V0555|2052|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|2052||1 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|580|2130|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||580||580|2130||1 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|453945|570370|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||453945||453945|570370||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín|||||||2 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|14883|21817|lyfalmen|V0712|21817|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||14883||14883|21817||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|832|2477|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||832||832|2477||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|44263|58894|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||44263||44263|58894||2 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|HRA|1|0|0|100|XEU|16768|31983|vetalmen|||0|1|0||Vistor hf|Dechra Limited|Clodronic acid||16768||16768|31983||1 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1542|3454|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1542||1542|3454||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1035|2756|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||1035||1035|2756||1 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1275|3087|lyfalmen|V0820|3087|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1275||1275|3087||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|5705|4056|lyfalmen|V0605|4003|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||1979||1979|4056||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|170923|218370|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||170923||170923|218370||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|116302|150437|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||116302||116302|150437||1 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3999|6836|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||3999||3999|6836||1 439548|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|123477|143447|lyfsjukr|||2|120|0||Icepharma hf|Mylan AB|Imatiníb||110682||110682|143447||2 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|15115|22136|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||15115||15115|22136||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|40317|11909|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||7685||7685|11909||2 439680|A10BJ0101|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|10969|16429|lyfalmen|||1|60|0|40,0000|Vistor hf|AstraZeneca AB|Exenatide||10969||10969|16429||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|USD|1900|3947|lyfalmen|V0658|3059|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||1900||1900|3947||1 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|12707|18822|lyfalmen|V0818|18822|2|28|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||12707||12707|18822||1 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|993|2484|lyfalmen|V0163|2224|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||837||837|2484||1 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|129335|166646|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||129335||129335|166646||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5619|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5619||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|996|2703|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||996||996|2703||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|1571|3494|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1571||1571|3494||1 440731|N05AX1209|Aripiprazole Sandoz|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|24689|16802|lyfalmen|V0717|16472|2|56|0|112,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||11240||11240|16802||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|727|2332|lyfalmen|V0046|2020|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||727||727|2332||1 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|809|2445|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||809||809|2445||1 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|743|2354|lyfalmen|V0046|2020|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||743||743|2354||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|85467|111009|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||85467||85467|111009||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|741|2352|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||741||741|2352||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1881|2638|lyfalmen|V0283|2638|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||949||949|2638||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1474|1782|lyfalmen|V0685|1193|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||327||327|1782||2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|59239|77836|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||59239||59239|77836||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8069|12438|lyfalmen|V0460|10572|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||8069|12438||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2371|4595|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2371||2371|4595||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|952|1871|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||952||952|1871||2 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|18822|27238|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||18822||18822|27238||1 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|17373|25244|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||17373||17373|25244||1 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|17891|25957|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||17891||17891|25957||3 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|515|1965|lyfalmen|V0038|1882|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||460||460|1965||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1398|2784|lyfalmen|V0039|2784|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1055||1055|2784||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2475|4738|lyfalmen|V0116|4738|2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2475||2475|4738||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|5666|9130|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||5666||5666|9130||1 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2172|4321|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2172||2172|4321||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|671|2255|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||671||671|2255||2 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|1686|2983|lyfalmen|V0337|2983|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1200||1200|2983||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2208|4371|lyfalmen|V0061|2799|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2208||2208|4371||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|16355|23843|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||16355||16355|23843||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1523|3428|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1523||1523|3428||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|IKR|2018|4109|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Betahistín||2018||2018|4109||2 444722|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.07.2016||R|0|0|0|0|G|0|GPA|0|0|1|100|XEU|823|2465|lyfalmen|V0677|2231|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón||823||823|2465||1 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|3887|6682|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||3887||3887|6682||1 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|12940|19142|lyfalmen|V0705|19142|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||12940||12940|19142||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|3554|6223|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||3554||3554|6223||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1320|3149|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1320||1320|3149||1 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12474|8764|lyfalmen|V0684|8208|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||5400||5400|8764||2 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|4470|7484|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||4470||4470|7484||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|3599|6285|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer AB|Nífedipín||||3599|6285||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|12396|18394|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||12396||12396|18394||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|18000|6837|lyfalmen|V0694|6837|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4000||4000|6837||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8516|13053|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||8516||8516|13053||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|4885|8055|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||4885||4885|8055||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|5998|9587|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||5998||5998|9587||1 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7414|11536|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7414||7414|11536||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2887|5305|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||2887||2887|5305||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2836|5235|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2836||2836|5235||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|1762|3757|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer AB|Nífedipín||||1762|3757||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1471|3356|lyfalmen|V0202|3003|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1471||1471|3356||1 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6031|9633|lyfalmen|V0214|9633|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6031||6031|9633||2 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|45048|59887|lyfalmen|V0727|59887|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||45048||45048|59887||1 449125|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|4085|lyfalmen|V0323|4085|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|4085||2 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|809|2445|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||809||809|2445||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|4465|2923|lyfalmen|V0686|2210|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1156||1156|2923||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|739|2349|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||739||739|2349||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|3724|6457|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||3724||3724|6457||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|2445|4697|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||2445||2445|4697||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|3426|6670|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||3426||3426|6670||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|869|2528|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||869||869|2528||2 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|95343|123500|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||95343||95343|123500||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|283248|358071|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||283248||283248|358071||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1746|3127|lyfalmen|V0313|2805|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1304||1304|3127||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|6197|10681|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||6197||6197|10681||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|15090|22102|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||15090|22102||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|27368|37525|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||27368||27368|37525||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|34446|46478|lyfalmen|||1|1|0|30,0800|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34446||34446|46478||1 451378|H02AB0605|Prednisolone Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|528|2058|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||528||528|2058||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30428|41396|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||30428||30428|41396||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40571|54224|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||40571||40571|54224||2 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6441|10197|lyfalmen|V0610|10197|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6441||6441|10197||1 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|XEU|32187|43620|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||32187||32187|43620||2 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5816|9337|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5816||5816|9337||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1025|2743|lyfalmen|V0800|2743|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1025||1025|2743||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7878|13579|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||7878||7878|13579||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5647||1 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRL|0|1|0|100|DKK|684925|857644|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration Limited|Cobimetinib||||684925|857644||2 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|6793|10682|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||6793||6793|10682||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5818|9340|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5818||5818|9340||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|981|2682|lyfalmen|V0597|2269|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||981||981|2682||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2945|5385|lyfalmen|V0598|4239|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||2945||2945|5385||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1875|3913|lyfalmen|V0584|2933|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||1875||1875|3913||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1041|1794|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1041||1041|1794||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5652|9111|lyfalmen|V0585|6759|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||5652||5652|9111||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3156|5676|lyfalmen|V0586|4258|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3156||3156|5676||2 453515|N03AX1211|Gabapentin PCD|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|1800|2309|lyfalmen|V0250|2309|2|120|0|20,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||710||710|2309||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1528|1782|lyfalmen|V0685|1193|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||327||327|1782||1 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|10542|15842|lyfalmen|V0587|10822|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||10542||10542|15842||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1946|4010|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||1946||1946|4010||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013|31.05.2017|R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2419|4661|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2419||2419|4661||1 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|3753|7291|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||3753||3753|7291||2 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8552|13103|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||8552||8552|13103||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|29233|32039|lyfalmen|V0342|6045|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||23030||23030|32039||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|OPH|0|0|0|100|DKK|39660|53072|lyfsjukr|||1|1|0||Artasan ehf|Novartis Europharm Ltd|Tópótecan||39660||39660|53072||1 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|298671|377253|lyfalmen|V0819|377253|1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||298671||298671|377253||2 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|812|1596|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||812||812|1596||1 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|800|2226|lyfalmen|V0174|2226|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||650||650|2226||2 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3427|6049|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3427||3427|6049||1 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5053|8287|lyfalmen|V0713|7272|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5053||5053|8287||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|970546|1212877|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||970546||970546|1212877||2 455492|G04BE0310|Sildenafil LYFIS|filmhtfl|50|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|8916|7113|lyfalmen|V0143|7062|2|24|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4200||4200|7113||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|370|1841|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||370||370|1841||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|630|2199|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||630||630|2199||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|1297|3117|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1297||1297|3117||1 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2740|5103|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2740||2740|5103||2 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|5186|lyfalmen|V0277|5124|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||2800||2800|5186||2 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|9090|11496|lyfalmen|V0816|11496|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7385||7385|11496||1 457149|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4950|2708|lyfalmen|V0327|2708|2|98|0|196,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1000||1000|2708||2 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|38279|42218|lyfalmen|V0451|42218|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||31078||31078|42218||1 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5470|2708|lyfalmen|V0326|2708|2|98|0|147,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1000||1000|2708||2 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1116|2868|lyfalmen|V0561|2868|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1116||1116|2868||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|4912|8093|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||4912||4912|8093||1 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2237|4411|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2237||2237|4411||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1921|2003|lyfalmen|V0003|2003|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||488||488|2003||1 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7878|13579|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||7878||7878|13579||2 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|809|2445|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||809||809|2445||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|286576|362210|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||286576||286576|362210||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|932|2615|lyfalmen|V0577|2297|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||932||932|2615||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|966|2661|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||966||966|2661||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|90628|117537|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||90628|117537||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|7438|10657|lyfalmen|V0653|10437|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||6775||6775|10657||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|691571|865910|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||691571||691571|865910||1 459225|M05BA0805|Zoledronic Acid Hospira|irl|5|mg|100|ml|1|poki|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|0|VOG|0|0|0|100|IKR|39258|52564|lyfalmen|V0715|51361|2|100|0|1,2500|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||39258||39258|52564||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|67688|88522|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||67688||67688|88522||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|606|2166|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||606||606|2166||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1110|2860|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1110||1110|2860||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|14999|28627|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||14999||14999|28627||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2364|lyfalmen|V0284|2087|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||750||750|2364||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1143|2905|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1143||1143|2905||1 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|1|0|1|ACC|0|1|0|100|DKK|100857|131227|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||100857||100857|131227||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2838|5238|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2838||2838|5238||1 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|5819|9341|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||5819||5819|9341||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|173392|221441|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||173392||173392|221441||2 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5321|4499|lyfalmen|V0144|3969|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2301||2301|4499||1 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|4422|8560|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||4422||4422|8560||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|3943|6759|lyfalmen|V0585|6759|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||3943||3943|6759||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|61679|80922|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||61679||61679|80922||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|395132|497223|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||395132||395132|497223||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyfalmen|V0554|1750|2|1|0|0,7500|LYFIS ehf|ratiopharm GmbH|Flúkónazól|||||1750||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1000558|1250204|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1000558||1000558|1250204||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|238357|302239|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||238357||238357|302239||1 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|202|1610|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1610||1 461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|5131|8394|lyfalmen|V0209|8394|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||5131||5131|8394||1 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|312|1761|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||312||312|1761||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|348|1811|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||348||348|1811||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|2030|4126|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer AB|Nífedipín||||2030|4126||2 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|14155|20815|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||14155||14155|20815||1 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3082|5574|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3082||3082|5574||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|PAA|0|0|1|100|DKK|11770|17532|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||11770||11770|17532||1 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1921|lyfalmen|V0108|1921|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1921||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|5062|4112|lyfalmen|V0605|4085|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2020||2020|4112||2 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2698|2020|lyfalmen|V0325|2020|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||500||500|2020||2 463378|J01DH0203|Meropenem Mylan|stl/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.07.2016||R|0|0|0|0|0|1|MHS|0|0|0|100|DKK|8275|12721|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Mylan Hospital AS|Meropenem||8275||8275|12721||2 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|38875|52079|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||38875|52079||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1541|3453|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1541||1541|3453||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2478|4742|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Carvedílól||2478||2478|4742||2 464326|L01XX1905|Onivyde|irþ|5|mg/ml|10|ml|1|hgl||L01XX19|01.04.2017||R|0|0|0|1|0|1|ALT|0|0|0|100|DKK|75312|98165|lyfsjukr|||1|10|0||Lyfjaver ehf|Baxalta Innovations GmbH|Írinótekan||75312||75312|98165||3 464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|11605|17305|lyfalmen|V0718|17305|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||11605||11605|17305||1 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|6742|10611|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||6742||6742|10611||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1713|3690|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1713||1713|3690||2 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0677|2231|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||2465||1 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|1290|3107|lyfalmen|V0376|3030|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1290||1290|3107||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|840|1651|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||||840|1651||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1371|3219|lyfalmen|||1|98|0|49,0000|Icepharma hf|BGP Products ApS|Verapamíl||1371||1371|3219||2 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2479|4744|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2479||2479|4744||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1540|1882|lyfalmen|V0038|1882|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||400||400|1882||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3844|2846|lyfalmen|V0039|2784|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||1100||1100|2846||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|443|1942|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||443||443|1942||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1378|3228|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1378||1378|3228||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|913|2588|lyfalmen|V0545|1862|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||913|2588||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1045|2770|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1045||1045|2770||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3621|6316|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||3621||3621|6316||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|200004|254539|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||200004||200004|254539||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|14094|20731|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||14094||14094|20731||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1943|4006|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||1943||1943|4006||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|5285|8606|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||5285||5285|8606||1 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3197|5732|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3197||3197|5732||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|15016|22000|lyfalmen|V0728|19962|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||15016||15016|22000||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|2341|4554|lyfalmen|V0063|3950|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||2341||2341|4554||1 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|4983|5476|lyfalmen|V0622|4542|2|30|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3011||3011|5476||1 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4615|7684|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4615||4615|7684||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|10255|15447|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||10255||10255|15447||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4392|7377|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||4392||4392|7377||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|19514|28191|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||19514||19514|28191||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|7244|11302|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||7244||7244|11302||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|60441|79356|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||60441||60441|79356||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|310|1758|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||310||310|1758||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4365|5370|lyfalmen|V0317|3464|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2934||2934|5370||1 468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|11443|12683|lyfalmen|V0720|12683|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||8247||8247|12683||2 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|209|1619|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||209||209|1619||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6597|5345|lyfalmen|V0318|4671|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2916||2916|5345||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|1659|2859|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||1659||1659|2859||2 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|4401|8520|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||4401||4401|8520||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5175|8455|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5175||5175|8455||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|2661|4994|lyfalmen|V0467|4449|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2661||2661|4994||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5053|8287|lyfalmen|V0712|7272|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5053||5053|8287||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2300|4497|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2300||2300|4497||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5471|8862|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5471||5471|8862||1 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4332|7294|lyfalmen|V0228|6998|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||4332||4332|7294||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|1775|2425|lyfalmen|V0037|2425|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||794||794|2425||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3603|6291|lyfalmen|V0227|5516|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||3603||3603|6291||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2297|4493|lyfalmen|V0226|4108|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2297||2297|4493||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|6549|6313|lyfalmen|V0622|4542|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3619||3619|6313||1 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|0|1|0|1|IPC|0|0|0|100|DKK|36106|42488|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||31292||31292|42488||1 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2920|5351|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2920||2920|5351||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|19212|27775|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||19212||19212|27775||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|4387|7370|lyfalmen|||1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||4387||4387|7370||1 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|3366|6556|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||3366||3366|6556||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1344|3182|lyfalmen|V0048|2464|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1344||1344|3182||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2088|4206|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2088||2088|4206||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|6936|10878|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||6936||6936|10878||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4793|5461|lyfalmen|V0012|5125|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3000||3000|5461||2 472756|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.10.2015|30.04.2017|R|1|0|0|0|0|0|SHS|0|0|1|100|DKK|841|2086|lyfalmen|||2|300|0|50,0000|Artasan ehf|Sandoz A/S|Paracetamól||548||548|2086||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2305|4504|lyfalmen|V0670|3545|1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2305||2305|4504||1 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1025|2743|lyfalmen|V0800|2743|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1025||1025|2743||2 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|7861|12152|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||7861||7861|12152||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|1977|4053|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||1977||1977|4053||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5923|4237|lyfalmen|V0687|3443|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2111||2111|4237||1 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|21493|40947|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||21493||21493|40947||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013|30.04.2017|R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|23503|10035|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||6323||6323|10035||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|564|2108|lyfalmen|V0266|2104|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||564||564|2108||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|777|2401|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||777||777|2401||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|1100|2846|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2846||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|497|2016|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||497||497|2016||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|627|2195|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||627||627|2195||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1364|3209|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1364||1364|3209||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5695||5695|10975||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|46794|62095|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||46794|62095||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1068|2802|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1068||1068|2802||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3333|5919|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||3333|5919||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|12454|18473|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||12454||12454|18473||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|3221|5765|lyfalmen|||1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||3221||3221|5765||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|41798|55776|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||41798||41798|55776||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TEV|0|0|0|100|IKR|28055|32886|lyfalmen|V0272|32528|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||23700||23700|32886||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3234||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3312||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|519|2046|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||519||519|2046||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3234||1 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|500|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2905||1 477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stl|V07AB|01.11.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|1000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2631||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|378|1778|lyfalmen|V0500|1763|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||324||324|1778||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5358|10336|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||5358||5358|10336||2 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|DKK|1843|3868|lyfalmen|V0825|3868|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1843||1843|3868||1 479310|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016|30.06.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|18299|26519|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||18299||18299|26519||2 479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|749|2363|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||749||749|2363||1 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|0|0|100|DKK|86513|112332|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||86513||86513|112332||1 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2330|4579|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2330||2330|4579||2 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3392|5199|lyfalmen|V0080|5199|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2810||2810|5199||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|9044|6168|lyfalmen|V0341|6045|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||3514||3514|6168||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|9269|14090|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||9269||9269|14090||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|531|2063|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||531||531|2063||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|3407|6021|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3407||3407|6021||1 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|5152|6477|lyfalmen|V0681|6477|2|30|0|27,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3738||3738|6477||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|151|1540|lyfalmen|V0055|1540|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||151||151|1540||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|11517|17184|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||11517||11517|17184||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|48584|54460|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||40757||40757|54460||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|23456|32577|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||23456|32577||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|4656|7740|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||4656||4656|7740||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1470|2708|lyfalmen|V0467|2491|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2708||2 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|3602|6290|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||3602||3602|6290||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990|31.03.2017|R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|||lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól|||||||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|4802|7941|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||4802||4802|7941||1 483711|S01ED5114|Latanoprost/Timolol Alvogen|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1405|3266|lyfalmen|V0374|3266|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1405||1405|3266||1 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2486|4753|lyfalmen|V0902|4363|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4753||2 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|718|2320|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||718||718|2320||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|205|1614|lyfalmen|V0055|1540|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||205||205|1614||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|40426|54041|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||40426||40426|54041||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|3893|6690|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||3893||3893|6690||1 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|263302|333264|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||263302||263302|333264||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|95419|123596|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||95419||95419|123596||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|884|2548|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||884||884|2548||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7334|11426|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||7334||7334|11426||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|35875|48285|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||35875||35875|48285||1 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|7064|11055|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7064||7064|11055||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1011|2723|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1011||1011|2723||2 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|7428|11556|lyfalmen|V0714|11556|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||7428||7428|11556||2 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|289491|365835|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||289491||289491|365835||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|10312|15525|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||10312||10312|15525||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|57971|76232|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Dolutegravír||57971||57971|76232||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486821|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|10620|11986|lyfalmen|V0691|11986|2|90|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7741||7741|11986||1 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|395|1875|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||395||395|1875||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|470|1979|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||470||470|1979||1 487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|591406|741333|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||591406||591406|741333||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012|30.06.2017|R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|12572|13806|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9063||9063|13806||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|1886|3928|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||1886||1886|3928||1 487650|N04BD0204|Rasagiline Mylan|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|29129|24725|lyfalmen|V0711|24725|2|112|0|112,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||16996||16996|24725||2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|23358|32453|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||23358||23358|32453||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|39199|52489|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||39199||39199|52489||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|20904|27636|lyfalmen|V0453|27636|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||19111||19111|27636||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|IKR|1033|2020|lyfalmen|V0469|2020|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Díklófenak||500||500|2020||2 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|6484|12472|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||6484||6484|12472||1 488255|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|870|2529|lyfalmen|V0575|2210|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín||870||870|2529||2 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|198688|252902|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||198688||198688|252902||1 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|4952|8148|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||4952||4952|8148||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|7924|12238|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||7924||7924|12238||1 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 489050|N06AX1105|Mirtazapin Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2846|lyfalmen|V0331|2787|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2846||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|4757|7879|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||4757||4757|7879||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|63847|83664|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||63847|83664||1 489348|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|12512|9000|lyfalmen|V0684|8208|2|56|0|56,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||5571||5571|9000||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996|30.06.2017|R|1|0|0|0|G|0|HES|0|0|1|100|DKK|661|1812|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||349||349|1812||1 490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5151|4431|lyfalmen|V0734|4431|2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2252||2252|4431||2 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1512|3413|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1512||1512|3413||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1401|3260|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1401||1401|3260||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|3446|6075|lyfalmen|V0133|6075|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||3446||3446|6075||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2969|5418|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||2969||2969|5418||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7653|8159|lyfalmen|V0112|2708|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4960||4960|8159||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2833|5231|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||2833||2833|5231||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9343|10837|lyfalmen|V0113|2660|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6906||6906|10837||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10971|13328|lyfalmen|V0114|2777|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||8716||8716|13328||1 491230|J05AX0001|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AX|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|1835691|2288875|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvír og Velpatasvír||1835691||1835691|2288875||2 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|95741|124003|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||95741|124003||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|2889|3052|lyfalmen|V0693|3042|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1250||1250|3052||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|skpokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|2656|4987|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||||2656|4987||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|0|0|100|DKK|389306|489977|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||389306||389306|489977||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2138|4275|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2138||2138|4275||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4971|8174|lyfalmen|V0002|3879|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||4971||4971|8174||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|12333|18307|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||12333||12333|18307||1 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|9083|11496|lyfalmen|V0813|11496|2|28|0|6,3000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7385||7385|11496||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|19745|28509|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||19745||19745|28509||1 493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1125|2880|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||1125||1125|2880||1 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|70081|91549|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||70081||70081|91549||1 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|52187|68916|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||52187||52187|68916||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|833|2478|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||833||833|2478||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1744|3732|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||1744||1744|3732||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|52450|69249|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||52450||52450|69249||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|131124|168871|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||131124||131124|168871||2 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1600|3534|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1600||1600|3534||1 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1597|3530|lyfalmen|V0128|2009|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1597||1597|3530||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2320|4525|lyfalmen|V0410|3815|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2320||2320|4525||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|1942|3817|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||1942||1942|3817||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1291|3109|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1291||1291|3109||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|647125|810632|lyfsjukr|||1|250|0|9,3700|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||647125||647125|810632||3 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|15531|5804|lyfalmen|V0384|4451|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3249||3249|5804||1 495692|N05AX1211|Aripiprazole Mylan Pharma|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|7350|8596|lyfalmen|V0683|8208|2|56|0|37,3300|Icepharma hf|Pharmathen S.A.|Aripiprazól||5278||5278|8596||2 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|4559|7607|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||4559||4559|7607||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1886|3928|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||1886||1886|3928||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33859|lyfalmen|||3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33859||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3235|6308|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3235||3235|6308||2 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|369|1840|lyfalmen|||2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||369||369|1840||1 496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|0|SDF|0|0|1|100|DKK|||lyfalmen|V0807|4226|0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Klemastín|||||4226||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|331|1787|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||331||331|1787||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|598|2155|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||598||598|2155||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|139226|178948|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||139226||139226|178948||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|174782|223169|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||174782||174782|223169||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|1203|2833|lyfalmen|V0127|2833|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1091||1091|2833||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2281|4471|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2281||2281|4471||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|596|2152|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||596||596|2152||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2247|lyfalmen|V0056|2171|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2247||2 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|NOK|6650|3746|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1754||1754|3746||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|438|1935|lyfalmen|V0448|1935|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||438||438|1935||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|873|2533|lyfalmen|V0449|2533|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||873||873|2533||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|890|2557|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||890||890|2557||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4497|lyfalmen|V0472|4497|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4497||2 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12534|8764|lyfalmen|V0683|8208|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||5400||5400|8764||2 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|56046|90346|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||56046||56046|90346||1 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11985|17828|lyfalmen|V0608|8884|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||11985||11985|17828||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12390|18385|lyfalmen|V0609|9974|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||12390||12390|18385||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|13682|20164|lyfalmen|V0610|10197|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||13682||13682|20164||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|18790|27194|lyfalmen|V0718|17305|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18790||18790|27194||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|753|2368|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||753||753|2368||1 499109|N05AH0410|Quetiapin Actavis|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.07.2013|30.06.2017|R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|9316|10331|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||6538||6538|10331||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|6846|10755|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||6846|10755||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4434|7435|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4434||4434|7435||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8788|13428|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||8788||8788|13428||1 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|900|2240|lyfalmen|V0050|2198|2|100|0|15,8300|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||660||660|2240||2 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|51941|68605|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||51941||51941|68605||2 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4087|4116|lyfalmen|||2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|4116||2 501277|N06AX2109|Duloxetine ratiopharm|sþ-hylki|60|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|11839|9315|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||5800||5800|9315|30.4.2017|2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4180|7085|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4180||4180|7085||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|8448|12960|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8448||8448|12960||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|19951|28792|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||19951||19951|28792||2 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2008|4096|lyfalmen|V0434|3762|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2008||2008|4096||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|3224|5769|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||3224||3224|5769||2 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|4381|7362|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||4381||4381|7362||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|10304|15514|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||10304|15514||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|14794|21694|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||14794||14794|21694||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|15905|23223|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||15905||15905|23223||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|3753|6497|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||3753||3753|6497||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|8569|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8569||2 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3035|5509|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3035||3035|5509||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1167|2100|lyfalmen|V0494|2020|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||558||558|2100||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|5060|8296|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||5060||5060|8296||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|26820|36832|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||26820||26820|36832||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|820|2460|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||820||820|2460||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9896|18945|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||9896||9896|18945||1 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|1275|3087|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1275||1275|3087||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2547|4837|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2547||2547|4837||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|5813|9333|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||5813||5813|9333||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|15905|23223|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||15905||15905|23223||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1826|3845|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||1826||1826|3845||2 506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|37113|14657|lyfalmen|V0682|14657|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9681||9681|14657||1 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1742|3729|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||1742||1742|3729||1 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|91243|118314|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||91243||91243|118314||1 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|IKR|3105|5605|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Betahistín||3105||3105|5605||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1379|3230|lyfalmen|V0092|3230|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1379||1379|3230||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|756|2372|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||756||756|2372||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|7236|4237|lyfalmen|V0687|3443|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2111||2111|4237||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|612|2107|lyfalmen|V0555|2052|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|2107||1 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993|30.04.2017|R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1868|3903|lyfalmen|||1|98|0|98,0000|Icepharma hf|BGP Products ApS|Verapamíl||1868||1868|3903||2 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3611|7021|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||3611|7021||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3253|6342|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3253||3253|6342||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9639|18458|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||9639||9639|18458||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|412151|518390|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||412151||412151|518390||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6747|10618|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||6747||6747|10618||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||||5425|10463||2 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|779|2288|lyfalmen|V0336|2288|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||695||695|2288||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|1555|3472|lyfalmen|V0134|2853|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||1555||1555|3472||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|31958|43331|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||31958||31958|43331||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|61411|80583|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||61411|80583||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|11759|17517|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||11759||11759|17517||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|17602|25559|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||17602||17602|25559||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|28873|39429|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||28873||28873|39429||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|44626|59353|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||44626||44626|59353||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|340|1800|lyfalmen|V0601|1668|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||340||340|1800||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|116623|150836|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||116623|150836||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2941|4076|lyfalmen|V0445|4076|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||1994||1994|4076||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1902|3950|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||1902||1902|3950||1 511361|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|539|1607|lyfalmen|V0021|1607|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1607||2 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|14967|21932|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||14967||14967|21932||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|9363|14219|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||9363||9363|14219||1 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|11473|17123|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||11473||11473|17123||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3714|6444|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||3714||3714|6444||1 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2247|lyfalmen|V0057|2247|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2247||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|2050|lyfalmen|V0109|2050|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|2050||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2 513312|A02BC0510|Eradizol|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.06.2017||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6600|Alvogen|Alvogen|Esómeprazól|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|19540|28227|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||19540||19540|28227||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1902|3738|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1902||1902|3738||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1496|2940|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1496||1496|2940||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4085|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4085||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1175|2949|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1175||1175|2949||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|1|0|0|DAN|0|0|0|100|XEU|14456|21229|lyfalmen|V0818|18822|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||14456|21229||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|3800|2364|lyfalmen|V0692|2364|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2364||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PLS|0|0|0|100|IKR|4026|4595|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4595||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|9574|14509|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9574||9574|14509||3 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|104469|135720|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||104469|135720||2 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|3798|5833|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||3270||3270|5833||1 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|13476|19880|lyfalmen|||1|0,94|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||13476|19880||1 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|7836|8902|lyfalmen|V0384|8902|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8902||2 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TEV|0|0|0|100|IKR|18600|20877|lyfalmen|V0273|20877|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||14200||14200|20877||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2088|4206|lyfalmen|V0462|3537|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2088||2088|4206||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|23453|32574|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||23453||23453|32574||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2273|4460|lyfalmen|V0471|3598|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2273||2273|4460||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2444|4696|lyfalmen|V0472|3373|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2444||2444|4696||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|23066|32084|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||23066||23066|32084||2 517914|QI09AL0001|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL|01.01.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|7271|12532|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||7271||7271|12532||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|48669|24731|lyfalmen|V0711|24725|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||17000||17000|24731||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGH|0|0|1|100|DKK|790|2419|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||790||790|2419||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGH|0|0|1|100|DKK|3087|5581|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3087||3087|5581||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1473|3359|lyfalmen|V0590|2506|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1473||1473|3359||1 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|894|2562|lyfalmen|V0004|2562|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||894||894|2562||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|13609|20063|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||13609||13609|20063||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|709|2308|lyfalmen|||1|125|0|3,1250|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||709||709|2308||1 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|1738|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8573||2 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|792|2047|lyfalmen|V0564|2034|2|100|0|50,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||520||520|2047||2 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|2823|5217|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||2823||2823|5217||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEP|0|0|1|100|SEK|1062|2793|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1062||1062|2793||2 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|5131|8394|lyfalmen|V0209|8394|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||5131||5131|8394||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5989|3611|lyfalmen|V0515|3584|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||1656||1656|3611||1 520104|C07BB0701|Bisbetol Plus|filmhtfl|17,5|mg|100|stk|1|þpakki|5+12,5 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2136|4272|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||2136||2136|4272||2 520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|634|1720|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||282||282|1720||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|16764|24406|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||16764|24406||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999|30.04.2017|R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3448|6078|lyfalmen|||1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||3448||3448|6078||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4484|7504|lyfalmen|V0143|1177|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4484||4484|7504||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12661|18758|lyfalmen|V0143|3531|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||12661||12661|18758||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4120|7003|lyfalmen|V0144|1323|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4120||4120|7003||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11399|17021|lyfalmen|V0144|3969|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||11399||11399|17021||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1225|2295|lyfalmen|V0056|2171|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2295||1 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|8682|13282|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||8682||8682|13282||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2163|2295|lyfalmen|V0057|2247|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2295||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|232|1651|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||232||232|1651||1 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|6838|13144|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||6838||6838|13144||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7812|5594|lyfalmen|V0688|5233|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3097||3097|5594||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|86486|112298|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||86486||86486|112298||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|123219|159039|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||123219||123219|159039||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998|30.06.2017|R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|1905|3954|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||1905||1905|3954||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1395|3252|lyfalmen|V0192|3252|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||1395||1395|3252||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|982|2683|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||982||982|2683||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3594|3505|lyfalmen|V0285|3461|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1579||1579|3505||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1750||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|134931|173606|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||134931||134931|173606||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|232121|294483|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||232121||232121|294483||1 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1084|2824|lyfalmen|V0903|2619|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1084||1084|2824||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1163|2933|lyfalmen|V0584|2933|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1163||1163|2933||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|265|1697|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||265||265|1697||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1562|3482|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1562||1562|3482||1 524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|344861|434700|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||344861||344861|434700||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7643|6335|lyfalmen|V0010|3809|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6335||1 524351|L01XX2401|Oncaspar|stl/irl|750|ein/ml|5|ml|1|hgl||L01XX24|01.10.2016||R|0|0|0|1|0|1|ALT|0|0|0|100|SEK|168435|215276|lyfsjukr|||1|5|0||Lyfjaver ehf|Baxalta Innovations GmbH|Pegaspargase||168435||168435|215276||3 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|2729|lyfalmen|V0039|2728|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1015||1015|2729||2 524937|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|13514|9000|lyfalmen|V0683|8208|2|56|0|37,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||5571||5571|9000||1 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|5363|8713|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||5363||5363|8713||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|496|2014|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||496||496|2014||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007|30.06.2017|R|0|0|0|0|0|0|HES|0|0|1|100|DKK|564|2108|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||564||564|2108||1 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993|30.04.2017|R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|1439|3312|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1439||1439|3312||1 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|3508|6160|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||3508||3508|6160||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|9955|19057|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||9955||9955|19057||2 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|24251|33583|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||24251|33583||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3826|6598|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||3826||3826|6598||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3483|6126|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||3483||3483|6126||1 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1823|3841|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||1823|3841||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4697||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4759||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3048|5527|lyfalmen|V0435|5527|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3048||3048|5527||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|4387|7370|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4387||4387|7370||1 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|10810|8744|lyfalmen|V0111|8744|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||5385||5385|8744||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|2781|5160|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2781||2781|5160||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|8736|13356|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||8736||8736|13356||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|13361|5164|lyfalmen|V0516|5158|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2784||2784|5164||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1045|2770|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1045||1045|2770||1 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3000|4664|lyfalmen|V0825|3868|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2421||2421|4664||2 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|189083|240956|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||189083||189083|240956||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1287|2529|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1287||1287|2529||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|708|2020|lyfalmen|V0046|2020|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||500||500|2020||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|12319|15784|lyfalmen|V0635|15784|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||10500||10500|15784||2 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2537||1 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7734|5282|lyfalmen|V0011|4572|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2870||2870|5282||1 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|590|1910|lyfalmen|V0562|1745|2|100|0|33,3300|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||420||420|1910||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1527|3434|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1527||1527|3434||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|4428|7426|lyfalmen|V0356|6467|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||4428||4428|7426||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|4855|8014|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||4855||4855|8014||1 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|48426|64159|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||48426||48426|64159||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|200525|255187|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||200525||200525|255187||1 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1418|2787|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1418||1418|2787||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10278|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10278||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AX1601|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AX16|01.10.2015||R|1|0|0|1|0|1|ABV|0|1|0|100|DKK|121084|156384|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Ltd.|Dasabuvir||121084||121084|156384||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5007|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||5497||1 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1150|2260|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1150||1150|2260||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2016|4107|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2016||2016|4107||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4490|7512|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4490||4490|7512||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|3244|5797|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3244||3244|5797||3 531829|N06AX1105|Mirtazapin Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|2020|lyfalmen|V0329|1999|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|2020||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|480|1992|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||480||480|1992||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|32692|22267|lyfalmen|V0711|22076|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||15210||15210|22267||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|1|0|1|WEH|0|0|0|100|XEU|83078|107987|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||83078||83078|107987||2 532881|C07BB0701|Bisbetol Plus|filmhtfl|35|mg|100|stk|1|þpakki|10+25 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|3843|6621|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||3843||3843|6621||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1477|3365|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1477||1477|3365||2 533048|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|AGP|0|0|0|100|XEU|14273|15141|lyfalmen|V0622|15141|2|100|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||10033||10033|15141||1 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1292|3110|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1292||1292|3110||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|1978|2455|lyfalmen|V0006|1882|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||816||816|2455||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|15974|23318|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||15974||15974|23318||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|41450|55336|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||41450||41450|55336||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|1519|2985|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||1519||1519|2985||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7576|6149|lyfalmen|V0117|6149|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3500||3500|6149||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3960|6782|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||3960||3960|6782||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1586|3515|lyfalmen|V0092|3230|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1586||1586|3515||1 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3200|4795|lyfalmen|V0826|4175|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||2516||2516|4795||2 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1417|2217|lyfalmen|V0692|2206|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||643||643|2217||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|302|1747|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||302||302|1747||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|316|1767|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||316||316|1767||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|21077|29568|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||21077||21077|29568||1 536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|4792|5746|lyfalmen|V0733|4041|2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3207||3207|5746||1 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|69258|90508|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||69258||69258|90508||1 536712|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|7706|5190|lyfalmen|V0690|5186|2|28|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||2803||2803|5190||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1980|4057|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||1980||1980|4057||2 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6279|9974|lyfalmen|V0609|9974|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6279||6279|9974||1 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|13329|19678|lyfalmen|||1|1,41|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||13329|19678||1 537029|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|12145|11393|lyfalmen|V0624|11260|2|90|0|108,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7310||7310|11393||1 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|51941|68605|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||51941||51941|68605||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4374|7352|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4374||4374|7352||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2010||1 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5487|8884|lyfalmen|V0608|8884|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||5487||5487|8884||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|79176|103052|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||79176||79176|103052||2 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2104|4228|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2104||2104|4228||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2682|2708|lyfalmen|V0678|2708|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1000||1000|2708||2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|3654|6361|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||3654||3654|6361||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|6463|10227|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||6463||6463|10227||1 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|61420|80594|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||61420||61420|80594||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|554|2094|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||554||554|2094||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|580|2130|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||580||580|2130||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539906|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|7533|11496|lyfalmen|V0816|11496|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7385||7385|11496||2 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1268|3077|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1268||1268|3077||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15485|22645|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||15485||15485|22645||1 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|32304|15357|lyfalmen|V0721|15199|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||10190||10190|15357||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|1213|2511|lyfalmen|||2|6|0|6,0000|LYFIS ehf|ratiopharm GmbH|Rizatriptan||857||857|2511|31.5.2017|2 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|16600|8795|lyfalmen|V0684|8208|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||5422||5422|8795||1 540709|N04BD0204|Rasagiline Mylan|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|8562|10368|lyfalmen|V0726|10202|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||6565||6565|10368||2 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|514923|646210|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||514923|646210||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|143709|184523|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||143709||143709|184523||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|4144|7036|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||4144||4144|7036||1 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|14569|8795|lyfalmen|V0682|8208|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||5422||5422|8795||2 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|með skammtadælu|G03CA03|01.03.2017||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|858|2513|lyfalmen|V0129|2513|2|64|0||Vistor hf|Takeda Oy|Estradíól||858||858|2513||1 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|18169|8795|lyfalmen|V0683|8208|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||5422||5422|8795||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5409|8777|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||5409|8777||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|757|2374|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||757||757|2374||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|11778|17543|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||11778|17543||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2681|2630|lyfalmen|V0203|2628|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||943||943|2630||2 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|794|2425|lyfalmen|V0373|1294|2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||794||794|2425||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|52568|69398|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||52568|69398||2 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|MAB|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Meda AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|2683|3531|lyfalmen|V0143|3531|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||1598||1598|3531||2 544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|401213|504786|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||401213||401213|504786||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|191982|244561|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||191982||191982|244561||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|9172|13956|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||9172||9172|13956||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|32957|28206|lyfalmen|V0636|21913|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||20000||20000|28206||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|186295|233797|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||183327||183327|233797||2 545110|H05BX0103|Cinacalcet Sandoz|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.05.2016|30.04.2017|R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|46044|36649|lyfalmen|||2|28|0|42,0000|Artasan ehf|Sandoz A/S|Cinacalcet||26675||26675|36649||1 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RAT|0|0|0|100|XEU|1192|2853|lyfalmen|V0134|2853|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Cýpróterón og östrógen||1105||1105|2853||2 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|651|2228|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||651||651|2228||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|618|2182|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||618||618|2182||1 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|0|G|0|VBA|0|0|1|100|XEU|935|2619|lyfalmen|V0903|2619|2|100|0|100,0000|Actavis Group PTC ehf|Actavis BV|Prómetazín||935||935|2619||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1508|3407|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1508||1508|3407||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21348|29911|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||21348||21348|29911||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17212|25022|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||17212||17212|25022||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22977|31972|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||22977||22977|31972|31.5.2017|1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18243|26441|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||18243||18243|26441||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|893|2561|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||893||893|2561||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2295|lyfalmen|V0580|2295|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||700||700|2295||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|3338|4584|lyfalmen|V0010|3887|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2363||2363|4584||1 546947|N05AX1211|Aripiprazole Mylan Pharma|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|7350|8596|lyfalmen|V0682|8208|2|56|0|18,6600|Icepharma hf|Pharmathen S.A.|Aripiprazól||5278||5278|8596||2 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|10641|15978|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||10641||10641|15978||1 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2354|2638|lyfalmen|V0251|2223|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||949||949|2638||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5168||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól|||||||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|DKK|6824|10724|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||6824||6824|10724||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|DKK|2194|4352|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2194||2194|4352||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7522|11685|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||7522|11685||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|FIN|0|0|0|100|DKK|75383|98255|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||75383||75383|98255||2 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1370|3217|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||1370||1370|3217||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|391|1870|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||391||391|1870||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||1826||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|G|0|GGE|0|0|0|100|SEK|10688|6916|lyfalmen|V0694|6700|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||4057||4057|6916||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|113454|146895|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||113454||113454|146895||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5764|9265|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||5764||5764|9265||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|23456|32577|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||23456|32577||2 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|1250|2003|lyfalmen|V0551|1992|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|2003||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4798|lyfalmen|V0471|4798|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4798||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1218|3008|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1218||1218|3008||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5810|9329|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||5810||5810|9329||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|3514|6168|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||3514||3514|6168||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1173|2946|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1173||1173|2946||1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|1878|3917|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||1878||1878|3917||1 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1812|2109|lyfalmen|V0466|2109|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2109||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2691|3800|lyfalmen|V0467|2491|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3800||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1355|1361|lyfalmen|V0003|1001|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1361||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2821|2109|lyfalmen|V0003|2003|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2109||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|5587|3800|lyfalmen|V0010|2177|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3800||1 551969|S01EE0106|Latanoprost Mylan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.04.2017||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1234|3030|lyfalmen|V0376|3030|2|7,5|0|75,0000|Icepharma hf|Mylan AB|Latanóprost||1234||1234|3030||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1246|3047|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1246||1246|3047||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|11821|19055|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||11821||11821|19055||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2272|4459|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2272||2272|4459||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8478|13001|lyfalmen|V0237|13001|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||8478|13001||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|2708|lyfalmen|||2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1000||1000|2708|30.4.2017|2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2899|5322|lyfalmen|V0237|4334|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2899||2899|5322||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|395132|497223|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||395132||395132|497223||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|30900|41993|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||30900|41993||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|7948|15249|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||7948||7948|15249||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4686|5206|lyfalmen|V0029|5206|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||2815||2815|5206||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|985608|1231610|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||985608||985608|1231610||2 554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|1102|2019|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||499||499|2019||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|115530|149477|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||115530||115530|149477||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1605|3541|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1605||1605|3541||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1829|3849|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||1829||1829|3849||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1380|3231|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1380||1380|3231||1 555385|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|3|úðagl||R01AD09|01.02.2017||R|0|0|0|0|G|0|EVO|0|0|1|100|IKR|3000|4773|lyfalmen|||2|420|0|105,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón||2500||2500|4773||2 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|357060|449872|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||357060||357060|449872||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|10371|13942|lyfalmen|V0440|13942|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||9162||9162|13942||1 556377|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.06.2016||L|0|0|0|0|G|0|EVO|0|0|1|100|IKR|||lyfalmen|V0677|2231|2|140|0|35,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón|||||2231||2 556694|C10A00001|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|51005|67421|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||51005|67421||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|14589|21412|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||14589||14589|21412||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3443|6071|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3443||3443|6071||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|6713|10572|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6713||6713|10572||1 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|1|0|0|VAL|0|0|0|100|XEU|7533|11496|lyfalmen|V0814|11496|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||7385||7385|11496||2 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2025|3928|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1886||1886|3928||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|173325|221357|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||173325|221357||1 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 558954|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.01.2017||R|0|0|0|0|0|1|BBV|0|0|0|100|SEK|37230|49999|lyfsjukr|||1|5|0|0,4000|Vistor hf|Janssen-Biologics B.V.|Abciximab||37230||37230|49999||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1051|2778|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1051||1051|2778||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|3298|5871|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||3298||3298|5871||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1646||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|1|0|1|CLC|0|1|0|100|XEU|34484|46526|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||34484||34484|46526||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|855|2434|lyfalmen|V0044|2361|1|25|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||801||801|2434||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1012|2725|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1012||1012|2725||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3460|6094|lyfalmen|||1|125|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||3460||3460|6094||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3806|6570|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||3806||3806|6570||1 560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|69332|90601|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||69332||69332|90601||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|318925|402443|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||318925||318925|402443||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|103864|83180|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||63464||63464|83180||1 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1149|2913|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1149||1149|2913||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|143709|184523|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||143709||143709|184523||1 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1173|2513|lyfalmen|V0098|2426|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||858||858|2513||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|35170|47393|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||35170||35170|47393||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3186|5717|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||3186||3186|5717||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|190697|242963|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||190697||190697|242963||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|RGO|0|1|0|100|DKK|60796|79805|lyfsjukr|||1|1|0|16,0000|Vistor hf|Glaxo Group Limited|Belimumab||60796||60796|79805||1 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|4271|7210|lyfalmen|V0705|6381|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||4271||4271|7210||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|455|1958|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||455||455|1958||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|452|1954|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||452||452|1954||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|976|2675|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||976||976|2675||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|17644|12709|lyfalmen|V0720|12683|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||8266||8266|12709||2 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2435|4683|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2435||2435|4683||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2524|4806|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2524||2524|4806||2 563653|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1326|2020|lyfalmen|V0494|2020|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2020||2 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1486|2921|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1486|2921||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|327818|413503|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||327818||327818|413503||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||1 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|473|1983|lyfalmen|V0596|1921|2|28|0|1,8600|LYFIS ehf|ratiopharm GmbH|Oxýcódon||473||473|1983||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002|30.04.2017|R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|50270|66492|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||50270||50270|66492||1 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|15944|23277|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||15944||15944|23277||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|751|2365|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||751||751|2365||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1865|3899|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1865||1865|3899||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|6012|lyfalmen|V0286|5859|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||3400||3400|6012||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|7428|11556|lyfalmen|V0714|11556|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||7428||7428|11556||1 565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6114|11770|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||6114|11770||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|17329|25183|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||17329||17329|25183||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1167|2938|lyfalmen|V0444|2023|1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1167||1167|2938||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|2171|4320|lyfalmen|V0193|4320|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2171||2171|4320||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|10459|15728|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||10459||10459|15728||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|132624|170737|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||132624||132624|170737||1 567259|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|672|1745|lyfalmen|V0022|1745|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1745||2 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3587|2777|lyfalmen|V0114|2777|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1050||1050|2777||2 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|12199|18122|lyfalmen|V0651|18122|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||12199||12199|18122||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2641||2 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4099|6974|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4099|6974||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|1951|4017|lyfalmen|V0291|2571|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1951||1951|4017||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|GBP|1946|4010|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1946||1946|4010||2 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3779|6533|lyfalmen|V0292|4016|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3779||3779|6533||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|DKK|2066|4175|lyfalmen|V0826|4175|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||2066||2066|4175||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|727|2332|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||727||727|2332||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|3976|6804|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||3976||3976|6804||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2047|2582|lyfalmen|V0058|2571|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||908||908|2582||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2760|3830|lyfalmen|V0059|3259|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||1815||1815|3830||1 568945|N05AX1206|Aripiprazole ratiopharm|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|20454|12481|lyfalmen|V0684|8208|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Aripiprazól||8100||8100|12481||2 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|850|2215|lyfalmen|V0827|2215|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||642||642|2215||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VIH|0|0|0|100|DKK|94364|122262|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||94364||94364|122262||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|7944|12266|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||7944||7944|12266||2 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2846|lyfalmen|V0001|2846|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1100||1100|2846||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|10866|16288|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||10866||10866|16288||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|12496|18531|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12496||12496|18531||1 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|7113|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4200||4200|7113||2 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|6975|lyfalmen|V0657|6975|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4100||4100|6975||2 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2580|lyfalmen|V0110|2383|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2580||1 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2016|4107|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2016||2016|4107||2 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2395|4707|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2395||2395|4707||1 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2770|5144|lyfalmen|V0384|4451|2|15|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2770||2770|5144||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|58467|76859|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||58467||58467|76859||1 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|209784|266702|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||209784||209784|266702||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|385344|485050|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||385344||385344|485050||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 571628|N06AX2109|Duloxetine ratiopharm|sþ-hylki|30|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|7600|7526|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||4500||4500|7526|30.4.2017|2 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|56380|74220|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||56380||56380|74220||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3499|4635|lyfalmen|V0011|4481|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2400||2400|4635||2 573069|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2248|1973|lyfalmen|V0248|1973|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||466||466|1973||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|5300|3760|lyfalmen|V0245|3733|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3760||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2993|5451|lyfalmen|V0464|4130|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2993||2993|5451||1 573382|J05AX6501|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AX65|01.09.2015||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|1780939|2220779|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||1780939|2220779||2 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|61556|80766|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||61556||61556|80766||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|11419|17049|lyfsjukr|||1|10|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||11419||11419|17049||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|18722|27101|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||18722||18722|27101||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996|30.06.2017|R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1797|2598|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||920||920|2598||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3917|4013|lyfalmen|V0144|3969|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||1948||1948|4013||2 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 574357|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|58640|19303|lyfalmen|||2|500|0|500,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||13057||13057|19303||2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|295167|372895|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||295167||295167|372895||2 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|7297|11375|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||7297||7297|11375||1 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1747|2129|lyfalmen|V0151|2129|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||579||579|2129||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5443|5563|lyfalmen|V0322|2600|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3074||3074|5563||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3222|2129|lyfalmen|V0152|2129|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||579||579|2129||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|9809|5563|lyfalmen|V0323|4003|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3074||3074|5563||1 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|608682|762820|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||608682||608682|762820||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1070|2089|lyfalmen|V0159|2056|2|20|0|10,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||550||550|2089||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1285|2433|lyfalmen|V0160|2379|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||800||800|2433||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1392|2502|lyfalmen|V0158|2444|2|20|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||850||850|2502||2 575919|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|9646|14609|lyfalmen|V0900|14609|2|100|0|33,3300|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9646||9646|14609||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|945|1794|lyfalmen|V0243|1581|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1794||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|955553|1194230|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||955553||955553|1194230||2 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5680||5680|10947||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|XEU|7173|11205|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||7173||7173|11205||2 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|15016|22000|lyfalmen|V0727|19962|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||15016||15016|22000||1 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8555|13107|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||8555||8555|13107||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|USD|3376|5978|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3376||3376|5978||1 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|4680|8066|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||4680||4680|8066||2 578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|485|1999|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||485||485|1999||1 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|14134|20786|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||14134||14134|20786||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|800|2433|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||800||800|2433||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1807|3819|lyfalmen|||1|98|0|98,0000|Icepharma hf|BGP Products ApS|Verapamíl||1807||1807|3819||2 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|153238|196375|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||153238||153238|196375||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2708|lyfalmen|V0005|2404|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2708||2 579864|C07AB0214|Bloxazoc|forðatfl|100|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|800|2433|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||800||800|2433||2 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|7268|11335|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||7268||7268|11335||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|2794|2983|lyfalmen|V0107|2846|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||1200||1200|2983||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|11539|8764|lyfalmen|V0111|8744|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||5400||5400|8764||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|527|2057|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||527||527|2057||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6050|9659|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||6050||6050|9659||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|1|0|1|PLC|0|0|0|100|DKK|5336|8676|lyfsjukr|||1|8|0||Icepharma hf|Fresenius Kabi Oncology Plc.|Docetaxel||5336||5336|8676||2 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2642|4968|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2642||2642|4968||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1179|2955|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1179||1179|2955||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2296|4492|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2296||2296|4492||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2561|4357|lyfalmen|V0620|4357|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2198||2198|4357||1 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|17284|lyfalmen|V0421|17284|2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||11590||11590|17284||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|10151|19429|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||10151||10151|19429||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|NRT|0|0|0|100|USD|1900|3947|lyfalmen|V0669|3432|1|2,5|0|25,0000|Alcon Nordic A/S|Novartis Europharm Ltd|Travóprost||1900||1900|3947||1 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|15413|22546|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||15413||15413|22546||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|30163|41060|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||30163||30163|41060||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|13031|19268|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13031||13031|19268||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|60324|79208|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||60324||60324|79208||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17992|26096|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||17992||17992|26096||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20640|29016|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||20640||20640|29016||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46866|62186|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||46866||46866|62186||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18296|26514|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||18296||18296|26514||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|24768|34237|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||24768||24768|34237||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1782|3315|lyfalmen|V0376|1010|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1441||1441|3315||1 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37377|50185|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||37377||37377|50185||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|705|2302|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||705||705|2302||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|63121|82746|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||63121||63121|82746||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19998|28857|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||19998||19998|28857||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31996|43379|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||31996||31996|43379||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59993|78789|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||59993||59993|78789||2 583806|G04BE0310|Sildenafil LYFIS|filmhtfl|100|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|10000|7938|lyfalmen|V0144|7938|2|24|0|48,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4800||4800|7938||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|13068|19319|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||13068||13068|19319||1 584208|L04AC0101|ZINBRYTA|stl|150|mg|1|áf-penni|1|pakki||L04AC01|01.01.2017||R|0|1|0|1|0|1|BIB|0|0|0|100|XEU|169162|216180|lyfsjukr|||1|1|0||Icepharma hf|Biogen Idec Ltd|Daclizumab||169162||169162|216180||2 584610|N03AX1609|Pregabalin Sandoz GmbH|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.02.2016|30.04.2017|R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|1448|1697|lyfalmen|||2|56|0|4,6667|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||265||265|1697||1 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|375378|472655|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||375378||375378|472655||1 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|14596|21422|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||14596||14596|21422||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4264|7201|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||4264||4264|7201||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3143|5658|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3143||3143|5658||1 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|1882|lyfalmen|V0006|1882|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1882||2 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2946|5387|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2946||2946|5387||1 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21732|30397|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21732||21732|30397||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|9969|15053|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||9969||9969|15053||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|266800|337614|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||266800||266800|337614||1 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|49366|65348|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||49366||49366|65348||1 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|1|0|0|GPA|0|0|0|100|XEU|9090|11496|lyfalmen|V0815|11496|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7385||7385|11496||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|20805|29224|lyfalmen|V0652|29224|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||20805|29224||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|6365|6196|lyfalmen|V0196|6196|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3534||3534|6196||1 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|112255|145403|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||112255||112255|145403||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3262|5822|lyfalmen|V0095|5822|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3262||3262|5822||1 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3198|5199|lyfalmen|V0081|5199|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2810||2810|5199||2 588001|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1326|2020|lyfalmen|V0494|2020|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2020||2 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|14569|8795|lyfalmen|V0683|8208|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||5422||5422|8795||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1370|3217|lyfalmen|V0461|3217|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1370||1370|3217||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5478|8872|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||5478||5478|8872||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|15905|23223|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||15905||15905|23223||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6594|4975|lyfalmen|V0282|4975|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2647||2647|4975||1 588912|N03AX1609|Pregabalin Sandoz GmbH|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|6340|4496|lyfalmen|V0734|4431|2|56|0|42,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||2299||2299|4496||1 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|461047|579203|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||461047||461047|579203||1 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|8381|12867|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||8381||8381|12867||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|102542|133323|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||102542||102542|133323||1 590135|C10AA0107|Simvastatin LYFIS|filmhtfl|10|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|1693|2020|lyfalmen|V0108|1921|2|100|0|33,3400|LYFIS ehf|LYFIS ehf|Simvastatín||500||500|2020||2 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2159|2566|lyfalmen|V0041|2547|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||897||897|2566||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|118873|153634|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||118873||118873|153634||1 591110|C10AA0507|Atorvastatin Hexal|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1761|2660|lyfalmen|V0113|2660|2|100|0|100,0000|Artasan ehf|Hexal A/S|Atorvastatín||965||965|2660||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|9133|13902|lyfalmen|V0347|13902|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||9133||9133|13902||3 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1073|2809|lyfalmen|V0168|2809|1|21|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1073||1073|2809||1 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2680|5255|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||2680||2680|5255||1 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|11482|14408|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14408||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEA|0|0|0|100|SEK|508954|638786|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||508954||508954|638786||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|364|1833|lyfalmen|V0238|738|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||364||364|1833||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|641|2214|lyfalmen|V0238|2214|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||641||641|2214||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|939|2624|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||939||939|2624||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11493|6751|lyfalmen|V0694|6700|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||3937||3937|6751||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011|30.06.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 594099|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|919|2020|lyfalmen|V0023|2020|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2020||2 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|13229|19540|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||13229||13229|19540||1 594542|N03AX1604|Brieka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7772|5376|lyfalmen|V0689|4789|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2938||2938|5376||1 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|3986|6818|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||3986||3986|6818||2 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|12199|18122|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||12199||12199|18122||1 595250|D01BA0206|Terbinafin Bluefish|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2016||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|6529|9590|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||6000||6000|9590||2 595653|J01CR0205|Spectracillin|filmhtfl|1000|mg|10|stk|1|þpakki|875+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|752|2171|lyfalmen|V0169|1589|2|10|0|8,7500|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og ensímblokkar||610||610|2171||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|16447|23969|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||16447||16447|23969||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|411|1897|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||411||411|1897||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|38995|52231|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||38995|52231||1 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|12007|17858|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||12007||12007|17858||1 597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|2443|4694|lyfalmen|V0458|2888|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2443||2443|4694||2 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1254|3058|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1254||1254|3058||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|454211|570701|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||454211||454211|570701||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|86486|112298|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||86486||86486|112298||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|1790|3796|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||1790||1790|3796||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|259|1688|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||259||259|1688||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1873||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|434927|546717|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||434927||434927|546717||1 599052|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|5599|5963|lyfalmen|V0690|2593|2|14|0|4,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||3365||3365|5963||1 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2551|5010|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||2551||2551|5010||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3187|6217|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3187||3187|6217||2 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|21732|30397|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||21732|30397||1 599737|N05AX1211|Aripiprazole Mylan Pharma|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|7350|8596|lyfalmen|V0684|8208|2|56|0|56,0000|Icepharma hf|Pharmathen S.A.|Aripiprazól||5278||5278|8596||2 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3396|lyfalmen|V0334|3157|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3396||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|90231|117034|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||90231||90231|117034||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22143|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22143||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2996|4924|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4924||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1803|3813|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1803||1803|3813||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1154|2920|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1154||1154|2920||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1598|3531|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1598||1598|3531||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27304|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27304||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|11057|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|11057||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5363|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5363||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6356|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6356||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6821|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6821||2 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23347|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23347||2 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1995|4078|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||||1995|4078||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|8207|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|8207||2 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|16998|24728|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24728||2